










































































































































































































































Volume 18, Supplement 1
February 2015
HIV and adolescents:  
focus on young key populations
Guest Editors: Linda-Gail Bekker and Sybil Hosek
Scan this QR code with  
your mobile device to view  
the special issue online
Acknowledgements
CIPHER would like to give special thanks to Manoj Kurian and IAS President Chris Beyrer, as well as Charlie Baran and Alice Armstrong  
for their input on the concept for this special issue.  We would also like to thank the editorial team of JIAS, in particular Marlène Bras and 
Susan Kippax, as well as the Guest Editors for their hard work and time, and for going beyond the call of duty to make this issue possible.
Support
The publication of this special issue was supported by the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER), 
which is funded through an unrestricted grant from ViiV Healthcare’s Paediatric Innovation Seed Fund.
Volume 18, Supplement 1 
February 2015
http://www.jiasociety.org/index.php/jias/issue/view/1472
HIV and adolescents:  
focus on young key populations
Guest Editors: Linda-Gail Bekker and Sybil Hosek
Contents
Editorial: Building our youth for the future
Linda-Gail Bekker, Leigh Johnson, Melissa Wallace and Sybil Hosek 1
Tailored combination prevention packages and PrEP for young key populations
Audrey Pettifor, Nadia L Nguyen, Connie Celum, Frances M Cowan, Vivian Go and Lisa Hightow-Weidman 8
HIV testing and linkage to services for youth
Ann E Kurth, Michelle A Lally, Augustine T Choko, Irene W Inwani and J Dennis Fortenberry 23
Providing comprehensive health services for young key populations: needs, barriers and gaps
Sinead Delany-Moretlwe, Frances M Cowan, Joanna Busza, Carolyn Bolton-Moore, Karen Kelley and Lee Fairlie 29
Review: An urgent need for research on factors impacting adherence to and retention in care among  
HIV-positive youth and adolescents from key populations
Priya Lall, Sin How Lim, Norliana Khairuddin and Adeeba Kamarulzaman 41
Mental health and support among young key populations: an ecological approach to understanding and  
intervention
Massy Mutumba and Gary W Harper 54
Adolescent girls and young women: key populations for HIV epidemic control
Rachael C Dellar, Sarah Dlamini and Quarraisha Abdool Karim 64
“We don’t need services. We have no problems”: exploring the experiences of young people who inject  
drugs in accessing harm reduction services
Anita Krug, Mikaela Hildebrand and Nina Sun 71
“First, do no harm”: legal guidelines for health programmes affecting adolescents aged 10–17 who sell  
sex or inject drugs
Brendan Conner 78
Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated  
Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations
Rachel Baggaley, Alice Armstrong, Zoe Dodd, Ed Ngoksin and Anita Krug 85
Editorial
Building our youth for the future
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Abstract
Adolescents and young adults are at increased risk for HIV due to the many developmental, psychological, social, and structural
transitions that converge in this period of the lifespan. In addition, adolescent deaths resulting from HIV continue to rise despite
declines in other age groups. There are also young key populations (YKPs) that bear disproportionate burdens of HIV and are
the most vulnerable, including young men who have sex with men (MSM), transgender youth, young people who inject drugs,
and adolescent and young adult sex workers. As a society, we must do more to stop new HIV infections and untimely HIV-related
deaths through both primary and secondary prevention and better management approaches. Using an interwoven prevention
and treatment cascade approach, the starting point for all interventions must be HIV counselling and testing. Subsequent
interventions for both HIV-negative and HIV-positive youth must be ‘‘adolescent-centred,’’ occur within the socio-ecological
context of young people and take advantage of the innovations and technologies that youth have easily incorporated into their
daily lives. In order to achieve the global goals of zero infections, zero discrimination and zero deaths, a sustained focus on HIV
research, policy and advocacy for YKPs must occur.
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Building our youth for the future
We cannot always build the future for our youth,
but we can build our youth for the future.
*Franklin D. Roosevelt
The inaugural summary on the Global Youth Wellbeing Index
reports that a sobering 85% of youth (age 10 to 24) in the
30 countries included report low levels of overall well-being
[1]. The overall well-being score, as defined by the index, is
composed of six domains shown in Table 1.
If these youth are representative of the one billion youth
alive in the world today, then we must ask ourselves where
have we failed and what more we can do [2]. Young people
are our future as well as the world’s greatest resource.
Overall, there were an estimated 1.3 million adolescent deaths
in 2012, most of them from causes that could have been
prevented or treated. Mortality is higher in boys than in
girls and in older adolescents (15 to 19 years) than in the
younger group (10 to 14 years). Whereas there are many
causes of mortality common to boys and girls, violence is a
particular problem in boys and maternal causes in girls [2].
Figure 1 shows the top 10 causes of death and disability-
adjusted life-years lost in adolescents worldwide.
In contrast to reductions in other population groups,
estimates suggest that numbers of HIV deaths are rising
in the adolescent age group. This increase has occurred
predominantly in the African region, resulting in AIDS being
the leading cause of death among adolescents in Africa
and the second leading cause for adolescents worldwide [3].
There are approximately four million young people aged 15 to
24 living with HIV globally, and 29% of those are adolescents
aged 15 to 19 [4]. Between 2005 and 2012, the number of
AIDS-related deaths decreased by 30% for all ages except
among adolescents, who experienced a 50% increase in that
same period. Similarly, two-thirds of new HIV infections in
2012 occurred among youth aged 15 to 24 [5]. HIV prevention
and decreasing HIV-related deaths depend critically on reach-
ing adolescents.
Young people, adolescents and young adults, are at
increased risk for HIV due in part to the multiple transitions
(i.e., biological, psychological) and developmental tasks (e.g.,
establishing identity) in this period of the lifespan. Among
youth, there are also key populations that bear dispropor-
tionate burdens of HIV and are the most vulnerable. These
young key populations (YKPs) include men who have sex with
men (MSM), transgender people, those who inject drugs and
sex workers, as well as youth who belong in multiple groups
(e.g., transgender youth who inject drugs) [6].
Young key population vulnerabilities
Young MSM
Among young MSM, HIV incidence has been shown to be very
high across multiple countries, and global reports estimate
an HIV prevalence of 4.2% for young gay men under the
age of 25 [4,7]. In the United States, MSM account for
most (72%) new HIV infections among youth aged 13 to 24,
making them the only group that has shown a significant
increase in estimated new infections. Among young MSM in
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the United States, African-American/black youth bear the
greatest burden of HIV [8]. Young MSM who engage in sex
work are even more vulnerable to HIV. A recent study in Kenya
found a baseline HIV prevalence of 40% among young MSM
who sell sex in Nairobi [9].
Transgender youth
While there remains a paucity of studies that focus on
transgender men (female-to-male), data from studies on trans-
gender women (male-to-female) demonstrate they are up to
49 times more likely to acquire HIV than other adults, with an
estimated 19% of transgender women infected with HIV [10].
There is also significant overlap for young transgender women
with other key population categories, including drug use and
sex work [11,12]. For example, a study in Larkana, Pakistan,
among transgender sex workers found an astonishing 27.6%
HIV prevalence [13]. Secondary analysis of that data revealed
that younger age (20 to 24 years) was strongly associated
with higher HIV prevalence [14]. Community-based samples of
young, transgender females in the United States have found
self-reported rates of HIV infection ranging from 19 to 22%
[12,15].
Youth who inject drugs
Surveys have found very high HIV prevalence among young
people who inject drugs. Globally, a recent report from the
Joint United Nations Programme on HIV/AIDS [7] found that
the HIV prevalence among young people under 25 who inject
drugs was 5.2% [7]. In Russia, for example, the prevalence of
HIV among injecting drug users under 25 was estimated at
12% [16]. Despite a decreasing trend, the HIV prevalence in
Ukraine among youth under 25 that inject drugs remains at
7.2% [17]. When youth from other key populations also inject
drugs, such as sex workers and transgender youth, the HIV
prevalence climbs even higher [11,18].
Female and male sex workers
An estimated 20 to 40% of female sex workers began selling
sex before the age of 18 [19]. Among young women in
Cambodia who engage in sex work, an HIV prevalence of 23%
and incidence of 3.6 per 100 person-years was reported,
along with high rates of amphetamine-type substance use
[20]. The prevalence of sex work is a concern for female, male
and transgender youth. In a recent population-based survey
in Kenya, 30.9% of females and 20.9% of males aged 18 to
24 reported a history of sex work [21]. In an HIV-prevention
intervention study among young, male sex workers in Mexico
City, the investigators found a baseline HIV prevalence rate of
38% [22].
Young women in Eastern and Southern Africa
Regions with the highest numbers of HIV-positive adolescents
are sub-Saharan Africa and South Asia. Of the 2.1 million
adolescents (11 to 19 years) infected with HIV, about 1.3 million
(62%) live in Eastern and Southern Africa. Girls and young
women between 15 and 30 years old have an extraordinarily
high incidence, particularly in countries such as South Africa
[2325]. The most recent household survey confirms the
feminization of the epidemic nationally, with adolescent girls
15 to 19 years of age four times more likely to be infected
than their male counterparts [25]. In this supplement Karim
and colleagues make a compelling case for considering young
women in sub-Saharan Africa a key population that urgently
requires attention and intervention [26].
The Collaborative Initiative for Paediatric Education and
Research (CIPHER) has sponsored this supplement of the journal
to highlight where we continue to fall short in our response
to adolescent and YKPs, to identify gaps in our understanding
and to call the world to action on this urgent public health
need [27].
























































































































Figure 1. a) Top 10 causes of mortality in adolescents worldwide.
b) Top 10 causes of disability-adjusted life years in adolescents
worldwide.
Adapted from World Health Organization (WHO) [2].
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Young key populations: opportunities
The starting point for all HIV programming commences
with counselling and HIV testing (HCT) [28]. Thereafter, a
number of interventions should occur, either in an HIV-
positive adolescent with an ultimate goal of viral suppression
(positive/treatment cascade) or in an HIV-negative adolescent
to enhance virus-free living (negative/prevention cascade).
Adolescents live and interact within families, sexual and so-
cial networks and communities, and are affected by society,
policies and broader environments and epidemic settings [29].
The positive and negative cascades should occur on this socio-
ecological backdrop. The assumption in this model is that in-
terventions will be built around ‘‘adolescence’’ as a common
factor and that adolescence gives shared opportunities for
interventions at individual, network and community levels
(Figure 2).
Following the recent ‘‘prevention revolution,’’ there has
been a call for greater focus on tailored combination HIV pre-
vention (primary and secondary) for adolescents, incorpo-
rating structural, biomedical and behavioural interventions
within a rights and privacy framework [30,31]. Pettifor and
colleagues have set out a comprehensive review of some of
the potential prevention interventions available to YKPs [32].
The double helix cascade can be further developed to embrace
a tailored approach (Figure 3).
HIV testing and linkage
Among youth aged 15 to 19 in Eastern and Southern Africa,
only 29% of girls and 20% of boys had ever tested for HIV and
received their results [33]. Gaps exist in our understanding of
the behavioural and structural barriers to HIV testing and
subsequent linkages into either HIV prevention or treatment
[30]. Innovative ways to encourage testing have shown promise
[34], including incentivization, but more evaluation to show
efficacy in this age group is required. Increased awareness
among care providers and policy makers is critical, and provider-
initiated testing as well as the provision of adolescent-friendly
testing services outside of health facilities where youth
naturally gather (e.g. home testing, community based, youth
centre, club, needle exchange and drop-in site testing) is
recommended, as well as the potential for self-testing. A
number of countries require parental consent for HIV testing,
which can be a significant barrier to testing [35]. Kurth and
colleagues in this supplement outline what some of the
difficulties are in testing and offer some approaches to
adolescent HIV testing and linkage [36].
Following testing, encouraging youth to remain engaged
with sexual and reproductive health and other adolescent
health services is key. This is to ensure uptake of risk reduction
interventions as well as utilization of contraception, primary
or secondary HIV, tuberculosis and sexually transmitted in-
fection (STI) prevention interventions, needle and syringe
Figure 2. A framework for adolescent service provision.
Adapted from DiClemente et al. [29].
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exchange and treatments as required. Youth have repeatedly
articulated that engagement with health services should be
local, integrated, quick, confidential, non-prejudicial, ‘‘hassle-
free’’ and free (or inexpensive) [37]. Utilizing venues and
activities where adolescents gather offers opportunities for
youth-friendly interventions, including male and female
condom provision, STI screening and treatment, human pap-
illomavirus vaccination, contraception and risk reduction
counselling. Opportunities should be explored to bring these
services into places where youth already congregate: schools,
institutions of higher learning, after-school clubs, centres
and community venues.Youth-related venues including virtual
‘‘meeting places’’ could be used to deliver programmes,
messages and health-related services. By exploiting the com-
monality of adolescence and group norms, comprehensive
services that meet the needs of the adolescent regardless
of positive or negative status can be offered with subsequent
reduction in stigma, a sense of shared experiences, peer
support and health system efficiencies.
Positive cascade
There are an estimated 2.1 million adolescents aged 10 to
19 living with HIV in the world today [38]. Failure to fully
anticipate this situation has resulted in inadequate care
and support for this group, requiring rapid redress. Yet little
is understood regarding adolescents’ specific healthcare
requirements within this context. Healthcare provision specific
to adolescents is largely unprecedented worldwide [39].
Whereas the most pressing issue is the requirement for access
to antiretroviral therapy, appropriate and effective interven-
tion requires a biopsychosocial approach in order to attend
to both the physical and psychological needs of the adole-
scent, with consideration for the socio-economic context in
which treatment is occurring [29]. In addition, specific needs
exist among different YKPs. Khairuddin and colleagues in their
paper in this supplement have reviewed the evidence for
adherence and retention in programmes of young drug users.
Krug and colleagues, on the other hand, bring the voice of
young people to the supplement in their paper [40,41].
Research suggests the adolescent developmental phase
poses particular challenges: perinatally infected adolescents
may experience puberty later; neurocognitive delays with as-
sociated behavioural issues may occur; and HIV or its treat-
ment may predispose adolescents to mental health problems
[42,43]. Social context is also significant. Many HIV-positive
adolescents will have experienced the death of one or both
parents and are likely to have been subjected to stigmatization
as a result of household illness [44]. Additional poverty-related
challenges exist as well [45]. For those who are behaviourally
infected, adolescence may be a particularly difficult time to
cope with an HIV diagnosis and, without appropriate support;
adolescents may not link into care effectively [39,46]. In terms
of care provision, numerous unmet needs exist including
adherence support, mental health assessment and interven-
tion and sexual health, family planning and secondary pre-
vention [4749]. The need to more effectively link YKPs to
service is addressed comprehensively by Delany and collea-
gues [50]. Matumba and Harper explore more extensively the
mental health needs of adolescents in care [51].
Negative cascade
Historically, adolescent HIV-prevention interventions have
targeted individual behaviour change, but impacting bio-
logical endpoints, such as HIV incidence through such
approaches, has remained elusive. Many would argue unsur-
prisingly with powerful external socio-economic drivers at
Figure 3. A framework for tailored adolescent key population service provision.
Adapted from Coates et al. [31].
Bekker L-G et al. Journal of the International AIDS Society 2015, 18(Suppl 1):20027
http://www.jiasociety.org/index.php/jias/article/view/20027 | http://dx.doi.org/10.7448/IAS.18.2.20027
4
play. Consequently, interventions aiming to address some
of these structural drivers have shown somewhat more
promise. Stepping Stones, a programme targeting gender
inequality in relationships through participatory learning ap-
proaches, was able to show a significantly reduced incidence
of HSV-2 and self-reported intimate partner violence in
participants aged 15 to 26 years, although HIV incidence
did not change significantly [52].
There has also been a growing focus on the efficacy
of structural interventions involving cash transfers and
incentives. Cash transfer may operate on at least two levels:
conditional on safer sex practices as ‘‘contingency manage-
ment,’’ or as a way to reduce economic vulnerability, thereby
encouraging behaviours with social benefits [53]. In a pro-
spective observational study, Cluver et al. conducted inter-
views with over 3000 adolescents (10 to 18 years) and found
an association between household receipt of government
cash transfers and reduced incidence of transactional and
transgenerational sex (but not other risk behaviours) at one
year follow-up in adolescent girls (but not boys), suggesting
that this intervention works through removing or reducing
those risks taken out of economic need [54]. In the Zomba
cash transfer trial in Malawi, adolescent girls who received
transfer money were less likely to have older sexual partners
and had less frequent sex, resulting in lower rates of HIV
infection [55]. In the RESPECT study, beneficiaries were given
rewards every four months for remaining free of curable
STIs [56]. After one year, the study recorded a 25% drop in
STI incidence. Currently, two randomized controlled trials
are underway in South Africa to determine the impact of
incentivizing school attendance on HIV incidence and sexual
behaviour and school attendance, improved academic perfor-
mance and HIV testing on HIV incidence and sexual behaviour
in adolescent girls [57,58].
Whereas structural interventions are necessary in addres-
sing the distal drivers of the adolescent HIV epidemic,
their impact tends to be long-term and difficult to ascertain
accurately. In contrast, biomedical interventions are able to
target biological endpoints directly. Recently, biomedical
HIV prevention has shown a number of successes, including
evidence of the effectiveness of male circumcision and
oral and topical pre-exposure prophylaxis (PrEP) [59]. This
provides ample opportunity for utilization with adolescents,
although with the caveat that research is needed to address
issues of safety, acceptability, preference and adherence
specific to this age group, an area that has thus far largely
been neglected [59]. Pettifor and colleagues raise some of
the logistical and psychosocial considerations in the applica-
tion of combination prevention, including biomedical inter-
vention [32]. Conner addresses the legal aspects of service
provision to a young drug-using community and outline the
responsibilities and complexities that health care providers
face in doing so [60].
Discussion
There are vulnerabilities to communicable diseases that
youth in adolescent transition share as a result of the onset
of increasing socialization. However, there is also an array
of opportunities that present as a result of this increasing
tendency to socially congregate. In addition, the evolving
capacities of adolescents afford opportunities for uptake of
innovation and demand creation. At the end of 2013, there
were 1.2 billion Facebook users in the world and 82% of
them were between the ages of 18 and 35 [61]. Half of these
utilized this technology daily, most before getting out of bed
in the morning! Given that adolescents are the one popula-
tion worldwide that are not seeing a decrease in new HIV cases
nor HIV-related mortality, new approaches to both preven-
tion and treatment programming are urgently called for.
Throughout this supplement, we have suggested that our
approach should be adolescent-centred rather than issue-
centred and should take into account lifestyles, common
venues of adolescents and a community-based model rather
than conforming to the rigid medicalized, health facility-based
model. In addition, we suggest that HIV testing becomes an
entry point to an intertwined treatment and prevention
cascade with numerous opportunities to provide comprehen-
sive, peer-guided, youth-friendly, ‘‘one-stop shop’’ services
in a diverse array of community based settings (Figure 2).
Social media and other innovations may inform, create
demand and help monitor uptake and use of services [62].
These approaches are endorsed in guidelines for services
for YKP emanating from the World Health Organization and
are described by Armstrong and colleagues in their contribu-
tion to the supplement [63].
In East Africa, 49% of the almost 350,000 medical male
circumcisions performed between 2008 and 2011 were in
young men aged 15 to 19 [64]. Although the idea is yet to
be tested, youth may be just the population who need,
understand and take up novel biomedical interventions such
as topical and systemic PrEP, harm reduction and other
interventions. These discreet, user-controlled methods may
be an excellent intervention to tide youth over the difficult
transition of sexual debut, experimentation and unbalanced
sexual relationships that occur during this time. Mathematical
models have suggested that, over the long term, it is more
efficient to promote HIV prevention programmes in adoles-
cents than in other age groups [65,66]. There are a number
of reasons for this conclusion: Firstly, adolescents have
high HIV prevalence relative to other age groups [67,68].
Secondly, in the absence of adolescent-focused interventions,
adolescents tend to be relatively disadvantaged in their access
to prevention services, because adolescent sexual activity
is often covert and adolescents prefer not to attend health
facilities [37]. Adolescent-focused interventions are needed
to remedy the existing inequalities in access to prevention
services. A third reason why it is more efficient to focus
prevention efforts on adolescents is that individuals who
acquire HIV at younger ages have greater future potential to
transmit HIV than individuals who acquire HIV at older ages.
Because HIV risk behaviour is generally highest at young ages
and decreases as individuals enter into long-term relation-
ships and age, individuals who become infected at young ages
have more high-risk transmission potential ahead of them
[69,70]. In addition, individuals who have high propensity for
sexual and other risk behaviours tend to become infected at
younger ages than individuals who have lower propensity for
risk behaviours [71].
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It is therefore important to focus HIV primary and secondary
prevention efforts in adolescents, not only because they are
at high risk of acquiring HIV, but also because they have a
high risk of transmitting HIV to others. The latter point has
often been overlooked in the HIV-prevention literature.
Adolescents need to be considered as a ‘‘core group’’ in the
same way as other high risk groups such as sex workers and
their clients, in the development of HIV, tuberculosis and STI
prevention strategies. For this reason, testing, linkage to care
and earlier treatment with viral suppression both for personal
health and to reduce onward transmission are urgent goals for
every Adolescents Living with HIV (ALWH) [72].
The goal of zero infections, zero discrimination and zero
deaths in the adolescent population for HIV is a goal within
our reach and a very important one to attain, not only
because efficiencies and impact on the broader epidemics
require this, but also because the youth of today represent
our collective hope for the future.
Young people should be at the forefront of global
change and innovation. Empowered, they can be
key agents for development and peace. If, however,
they are left on society’s margins, all of us will be
impoverished. Let us ensure that all young people
have every opportunity to participate fully in the
lives of their societies.
*Kofi Annan
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Abstract
Introduction: Young key populations, defined in this article as men who have sex with men, transgender persons, people
who sell sex and people who inject drugs, are at particularly high risk for HIV. Due to the often marginalized and sometimes
criminalized status of young people who identify as members of key populations, there is a need for HIV prevention packages
that account for the unique and challenging circumstances they face. Pre-exposure prophylaxis (PrEP) is likely to become an
important element of combination prevention for many young key populations.
Objective: In this paper, we discuss important challenges to HIV prevention among young key populations, identify key
components of a tailored combination prevention package for this population and examine the role of PrEP in these prevention
packages.
Methods: We conducted a comprehensive review of the evidence to date on prevention strategies, challenges to prevention and
combination prevention packages for young key populations. We focused specifically on the role of PrEP in these prevention
packages and on young people under the age of 24, and 18 in particular.
Results and discussion: Combination prevention packages that include effective, acceptable and scalable behavioural, structural
and biologic interventions are needed for all key populations to prevent new HIV infections. Interventions in these packages
should meaningfully involve beneficiaries in the design and implementation of the intervention, and take into account the con-
text in which the intervention is being delivered to thoughtfully address issues of stigma and discrimination. These interventions
will likely be most effective if implemented in conjunction with strategies to facilitate an enabling environment, including
increasing access to HIV testing and health services for PrEP and other prevention strategies, decriminalizing key populations’
practices, increasing access to prevention and care, reducing stigma and discrimination, and fostering community empowerment.
PrEP could offer a highly effective, time-limited primary prevention for young key populations if it is implemented in combination
with other programs to increase access to health services and encourage the reliable use of PrEP while at risk of HIV exposure.
Conclusions: Reductions in HIV incidence will only be achieved through the implementation of combinations of interventions
that include biomedical and behavioural interventions, as well as components that address social, economic and other structural
factors that influence HIV prevention and transmission.
Keywords: HIV; key populations; combination prevention; pre exposure prophylaxis.
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Introduction
Globally young people face a high burden of HIV infection. It is
estimated that 39% of new infections occur among adoles-
cents annually, and despite global declines in HIV mortality
among adults [1], HIV-related deaths among young people
increased by 50% between 2005 and 2012 [2]. Key popula-
tions, defined here as men who have sex with men (MSM),
transgender persons, sex workers and people who inject
drugs (PWID), experience a high burden of HIV infection and
incidence rates in both concentrated and generalized epi-
demic settings. It is estimated that up to 50% of new infec-
tions occur among key populations annually [2].
Young people (which we define as persons between 10
and 24) who fall under the umbrella term ‘‘key population’’
are at particularly high risk for HIV and may engage in over-
lapping risk behaviours, such as injecting drugs and selling
sex.While data are scarce on the size of adolescent key popu-
lations (defined as ages 1019 years), in areas of the world
where the epidemic is concentrated among key populations,
adolescents clearly face an increased burden. It is estimated
that 95% of new infections among adolescents in Asia are
among key populations (PWID, MSM and sex workers) [3]
and that 70% of all individuals who inject drugs are under the
age of 25 [4]. A number of studies have documented that
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many individuals who engage in sex work or injection drug
use began before the age of 18 [5,6]. Among MSM globally,
infection rates continue to increase in many settings [7]. HIV
incidence data from the United States highlight the crisis
of HIV among young MSM (YMSM); from 2008 to 2011, HIV
incidence for YMSM aged 1324 years increased 26% [8].
Due to this increased risk, multiple programmatic calls have
been issued to refocus prevention efforts on adolescent and
youth key populations. Reductions in HIV incidence will only
be achieved through the implementation of combinations of
interventions that include biomedical and behavioural inter-
ventions, as well as components that address social, econo-
mic and other structural factors that influence HIV prevention
and transmission [915]. Antiretroviral-based prevention, spe-
cifically pre-exposure prophylaxis (PrEP), is one biomedical
prevention approach that has recently shown great promise in
reducing risk of HIV acquisition [1620]. However, its effec-
tiveness in some adolescent key populations remains unclear.
In this article, we review the current evidence on pre-
vention strategies for young key populations and specific
challenges to HIV prevention unique to young key popula-
tions, describe what an effective and tailored combination
prevention package would look like for young key popula-
tions and discuss the role of PrEP as a potential component
of that prevention package.
Methods
We conducted a comprehensive review of the evidence to
date on prevention strategies, challenges to prevention and
combination prevention packages for young key populations.
We focused specifically on the role of PrEP in these preven-
tion packages for young key populations under the age of
24, and under the age of 18 in particular. We examined the
published literature by searching PubMED using the following
search terms: PrEP, MSM, IDU, PWID, Sex work and HIV
prevention. We also examined the works cited of published
articles. We identified ongoing studies of PrEP by examining
the AVAC database of ongoing and planned PrEP evaluation
studies, conference abstracts and the NIH Research Portfolio
Online Reporting Tools (RePORT). We did not utilize any
exclusion criteria; however, we focused our search on studies
or evaluations of PrEP among young [1824], key populations
(MSM, PWID and people who sell sex).
Results and discussion
Challenges to HIV prevention among young key
populations
Young key populations are at increased risk of HIV infection
compared to adults due to cognitive, contextual and struc-
tural factors that increase their vulnerability to peer pressure,
manipulation and exploitation or abuse by older people [21].
At the same time, young key populations are a heteroge-
neous group and the risk factors for HIV differ across young
key populations and vary by age and setting.
Young PWID
Young PWID face a number of challenges to HIV prevention.
PWID aged 1829 are more likely to inject daily than other
age groups [22], more likely to share syringes than other age
groups [22], less likely to use harm reduction and treatment
services, more likely to be reliant on older people for access
to drugs and injecting equipment, more likely to obtain
needles from unofficial sources, and less informed about
risks and their rights [23]. Female PWIDs frequently experi-
ence violence from intimate partners, police and sex trade
clients [24], as well as homelessness [25] and psychiatric co-
morbidities [26], which may act synergistically, increasing
their risk for HIV infection [23]. Young female PWID in parti-
cular may face unique risks for HIV, including mental health
disorders [27], and high suicide risk [28]. In addition, young
female injectors have higher injecting risk behaviours comp-
ared to young male injectors, including multiple sex partners
[29] and co-infection with HIV and HCV [30].
Despite existing evidence-based prevention tools for PWID
populations, including opioid substitution therapy (OST) [3134],
needle and syringe exchange programs (NSP) [31,35,36] and
HIV testing and counselling (HTC) [31,37], the epidemic among
PWID continues to accelerate in many settings [38] while the
proportion of youth who are PWID continues to increase [39].
Young MSM and transgender persons
Young MSM experience multiple life stressors and high levels
of victimization based on sexual identity that can lead to
engagement in higher sexual and drug use activities, and also
make practicing HIV prevention strategies challenging [4042].
Compared to their heterosexual peers, YMSM have been
found to have an increased risk of depressive symptoms,
anxiety disorders, suicidal ideation and attempts, and PTSD
[4345]. Some YMSM may experience homelessness or un-
stable housing as a result of being driven out of their family
homes. Further, YMSM face additional social challenges in
developing a positive self-identity due to stigmatization, dis-
crimination and homophobia. The challenges that place YMSM,
and in particular YMSM of colour, at risk for HIV infection also
impact their awareness, access to, and adherence to preven-
tion services, including PrEP [4650]. For instance, despite
routine testing recommendations, MSM who are younger
(B25 years), black, and/or have low income are less likely to
test or be aware that they are HIV-infected [5155]. These
challenges are magnified in areas where homosexuality is
criminalized.
Young transgender women are also at extremely high risk
of HIV infection due to multiple concurrent risk factors, includ-
ing substance use, sex work, depression, unstable housing,
discrimination, violence and victimization [5659]. Limited
access to gender-sensitive health services can also interfere
with HIV prevention efforts.
Young people who sell sex
Young people who sell sex also face challenges that put them
at greater risk of HIV when compared to adult sex workers.
These include a heightened risk of physical and sexual vio-
lence by clients and law enforcement agents [6063]. As a
result of exploitation by adults, young people who sell sex
may lack control over the frequency and location of where
they sell sex, and may be more likely to work on the streets
than adults [6467]. Young people who have been orphaned
or abandoned by their family face social and economic
marginalization; consequently, in many parts of the world,
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children living on the street sell sex as a survival strategy
[6870]. In addition, young people who sell sex use condoms
less consistently than adult sex workers due to lack of access
to condoms, poor negotiating skills and limited knowledge
of issues related to sexual and reproductive health. Young
people who sell sex also face stigma and discrimination,
which not only affects their ability to access services but may
also lead to low self-worth and self-stigmatization [71]. Young
people who sell sex may also be more difficult to reach with
services because initiation into sex work may be gradual and
thus they may not recognize themselves to be at risk.
Legal and structural barriers to HIV prevention
Across all young key populations, parental permission laws in
many settings poses an additional challenge for delivering
effective prevention packages to this age group because they
prevent minors from accessing prevention and care services
without the involvement of a parent. A recent survey by
UNAIDS found that over 33 countries in Africa have age based
criteria for HTC [72]. In addition, young people often do not
seek health services due to stigma associated with youth
attending HIV prevention services, and lack of youth friendli-
ness and confidentiality in many health settings [73]. These
structural barriers are even greater for young key populations
because their behaviours are stigmatized and illegal in many
settings, resulting in discrimination, marginalization, possible
legal consequences (such as imprisonment) and fear of pun-
ishment [3]. In countries where homosexuality is illegal, YMSM
who fear being outed by health workers may delay care. Laws
that classify sex work among people who are under 18 as
sexual exploitation (designed to protect minors involved in
the sex industry), may have the unintended consequence of
encouraging young women who sell sex to deny involvement
or avoid health services because of fear of being sent to state
institutions or suffering abuse and harassment by law en-
forcement [7480]. Laws requiring parental permission for
prevention services also fail to recognize that many adoles-
cents engaged in injecting drug use or selling sex do not live
with family or may be orphans.
Combination prevention packages for young key
populations
Combination prevention packages that include effective, ac-
ceptable and scalable behavioural, structural and biologic
interventions are needed for all key populations in order to
have the greatest impact on preventing new infections. This is
supported by mathematical modelling which has found that
existing structural and behavioural prevention approaches for
key populations could be further strengthened by combining
them with newer biomedical prevention interventions, such
as PrEP [915]. Combination prevention packages should aim
to achieve high coverage of HIV testing and knowledge of
HIV serostatus, parsimony in selecting evidence-based inter-
ventions, synergy such that the effect of a combination of
interventions is at least the sum of the parts, if not greater,
and intervention coverage, which is a function of access to,
utilization of, and high retention (see Table 1) [81]. Based on
recent guidelines from the WHO for HIV prevention, diag-
nosis, treatment and care for key populations, combination
prevention packages should also include the key health care
sector interventions as summarized in Table 2 and strive to
create an enabling environment. Among key populations,
interventions that meaningfully involve beneficiaries in the
design and implementation of the intervention, and take into
account the context in which the intervention is being deli-
vered to thoughtfully address issues of stigma and discrimina-
tion are most likely to be most effective.
PrEP as a potential component of combination
prevention packages
PrEP has recently emerged as a promising biomedical inter-
vention to prevent HIV infection [1620] (see Table 3). For
adolescent and young key populations, PrEP could offer a
highly effective, time-limited primary prevention if they can
access health services and are motivated to use PrEP while at
risk of HIV exposure. Although no PrEP efficacy trials comp-
leted to date exclusively recruited adolescents and young
persons, all the trials included persons between ages 18 and
24 (see Table 4 and Figure 1). Nonetheless, young key
population face unique challenges that may influence their
willingness to use and adhere to PrEP. Addressing these
Table 1. Principles of combination prevention
Principle Details
1. High coverage of HIV testing and knowledge of HIV
serostatus
HIV testing is the ‘‘gateway’’ to both the HIV treatment and prevention
cascades; HIV testing programs need to facilitate linkages to care and
prevention
2. Parsimony in selecting evidence-based interventions Scale, coverage, affordability and impact could be compromised with more
complex combination packages
3. Pilot work to determine the acceptability and feasibility of
scaling these interventions
Achieve high coverage by prioritizing the subset of the population most at risk
of HIV transmission or acquisition
4. Synergy such that the effect of a combination of
interventions is at least the sum of the parts, if not greater
Delivering non-overlapping and complimentary interventions to reduce HIV
infectiousness and susceptibility
5. Intervention coverage A function of access to the interventions, willingness of persons prioritized
based on risk to utilize the interventions, high retention in the prevention/
treatment cascade
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challenges will be key to the success of PrEP as an inter-
vention strategy in this vulnerable population.
Adherence to medications is known to be a significant
challenge for young people, [8891] and thus adherence to
PrEP must be an important focus of any intervention provid-
ing PrEP to this population [92]. Across all the PrEP trials,
there is robust evidence that PrEP has high effectiveness, but
this effectiveness is highly dependent on adherence [11,93].
Sub-analyses of existing trial data suggest that younger and
unmarried participants as well as those with highest beha-
vioural risk were the least likely to adhere to PrEP [17,20,94].
These results are in line with evidence from other medical
conditions, which have found that between 10 and 90% of
adolescents demonstrate inadequate adherence to therapy,
and those least likely to adhere are the most vulnerable
psychosocially [89,95,96]. Notably, all the PrEP trials had a
subset of persons who had consistent and sustained use of
PrEP, which ranged from 30% in the VOICE [94] and FEM-PrEP
[82] trials to 80% in the Partners PrEP Study [17].
Concerns about adherence to PrEP and subsequent drug-
resistance are particularly strong for PWID [97], whose barriers
to antiretroviral therapy (ART) adherence include interrup-
tions in care due to low social support, incarceration, and
compulsory detoxification and detention [98]. At the same
time, a recent meta-analysis revealed that PWID had compar-
able rates of ART adherence to non-drug using populations
[98] suggesting that these concerns may be unfounded.
There are limited data on adherence to ART among persons
who sell sex [99,100]. Some reports suggest that persons
who sell sex may be poorly adherent due to their social
instability, increased mobility and police harassment, but
there are also data suggesting that persons who sell sex can
adhere if properly supported. However, while we can learn
from studies on ART adherence, the barriers to adherence
may be quite different among HIV-negative PrEP users [101].
There is a critical need to understand the reasons for poor
PrEP adherence among young women, including sex workers
[102]. Several upcoming studies and demonstration projects
are examining the impact of different adherence counselling
programs and delivery mechanisms to improve PrEP adher-
ence among participants (see Table 5, Supplementary files).
The differential uptake and sustained use among popula-
tions enrolled in placebo-controlled PrEP efficacy trials in part
reflects population differences in terms of levels of uncer-
tainty and ambivalence about using antiretrovirals for pre-
vention, risk perception, concerns about side effects, stigma,
reactions of others, partner support, participation in a placebo-
controlled trial to obtain access to health care and other
services, and concerns about randomization to placebo or a
product of uncertain efficacy [103105]. Uptake and adher-
ence among participants in clinical trials who are randomized
to placebo or active product and counselled about unknown
efficacy may not predict uptake and adherence among at risk
participants who are offered open-label product and coun-
selled about known efficacy and the importance of adherence.
Encouragingly, two studies of daily and intermittent oral
PrEP among MSM were recently stopped early due to high
effectiveness: 1) the immediate daily oral PrEP arm in the
Table 2. Key components of a comprehensive prevention package
The WHO comprehensive package for prevention
Essential health sector interventions IDU Sex workers MSM
1. Comprehensive condom and lubrication
programming
ª ª ª
2. Harm reduction interventions for substance
use
Needle and syringe programs and opioid
substitution therapy
3. Behavioural interventions ª ª ª
4. HIV testing and counselling ª ª ª
5. HIV treatment and care ª ª ª
6. Sexual and reproductive health interventions ª ª ª
7. Prevention and management of co-infections
and other co-morbidities






Essential strategies for an enabling environment Examples
1. Supportive legislation, policy and financial
commitment




2. Addressing stigma and discrimination ª ª ª
3. Community empowerment ª
4. Addressing violence against people from key
populations
ª ª ª
PrEP plus adherence support ªa ªa ª
aNote that the WHO has currently only issued a strong recommendation for PrEP use among MSM. The WHO has made no recommendations
regarding PrEP among PWIDs and sex workers but has called for PrEP demonstration projects to assess how to implement PrEP as part of
comprehensive risk reduction services in these populations.
OST, opioid substitution therapy; NSP, needle and syringe exchange programs.
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Table 3. Completed PrEP studies among key populations and young people
































Blood plasma: TDF detected in 66% in TDF
group (overall); TDF detected in 39% among
participants who seroconverted; TDF detected












 TDF vaginal gel
(BAT24)
 Placebo
39% (95% CI: 6, 60%;
p0.017)
Monthly (applicator) count divided by number
of sex acts that month: 72.20% (all participants);
61.3% among women who did not seroconvert;












Stopped for futility Self-report: 95%
Pill count: 88%
Blood plasma: TVD detected in 26% at
beginning of infection window, 21% at end of
window and 15% at both visits among women
who seroconverted; TVD detected in 35% at
beginning of the infection window, 37% of
women at end of the window and 24% at both
visits among women who did not seroconvert
iPrEx [16]


















Self-reported pill use: 95%
Pill count of unused study product: 8995%
Blood plasma: TVD detected in 9% among
participants who seroconverted; TVD was
detected in 51% among participants who did
not seroconvert
iPrEx OLE [83]












 1225 (76%) received
TDF






































































































Table 3 (Continued )

































TDF: 67% (95% CI: 44,
81%; pB0.001)







Blood plasma: TDF/TVD detected in 31% among
participants who seroconverted; TDF/TVD
detected in 82% among participants who did
not seroconvert
Project PrEPare (ATN 082) [84]
US (Baltimore, Boston, Chicago,

















 3MV with TVD
(N20)
 3MV with placebo
n/a - Feasibility and
acceptability study
Self-reported: 62% (range 4383%)
Blood plasma: 63.2% (week 4), 20% (week 24)
TDF2 (CDC 494) [19]
Botswana











62.2% (95% CI: 21.5,
83.4%; p0.03)
Pill count: 84.2% (TVG group)
Self-reported 3 days prior: 94.4% (TVD group)
Blood plasma: TVD detected in 50% among
participants who seroconverted; TVD detected
in 81% among participants who did not
seroconvert
US Safety study (CDC 4323) [85]
US (San Francisco, Atlanta,
Boston)




Phase II safety study
 TDF upon enrolment
 Placebo upon
enrolment
 TDF 9 months after
enrolment
 Placebo 9 months
after enrolment






































































































Table 3 (Continued )















(95% CI; p-value) Adherence











 TDF vaginal gel
 Placebo (pill)
 Placebo (gel)
Stopped for futility Self-report and pill/applicator count: 90%
Blood plasma: TVD detected in 29% in TVD
group (overall); TVD detected in 21% in TVD
group (525, single); TVD detected in 54% in
TVD group (25, married); TDF detected in
28% in oral TDF group; TDF detected in 23% in
TDF gel group
Willingness of PWID to use PrEP
in Ukraine [87]
Ukraine






53% stated they would
‘‘definitely’’ be willing to
use PrEP (based on a 4-
point Likert scale)
32.6% stated they would
‘‘probably’’ be willing to
use PrEP
n/a






































































































United Kingdom compared to the delayed PrEP arm in the
PROUD study [106], and 2) the intermittent, event-driven
dosing of Truvada arm compared to the placebo arm in France
and Quebec in the IPERGAY study [107]. The high effectiveness
demonstrated early in these studies indicate that adherence
to oral PrEP among MSM is high in the context of known
efficacy even when delivered with less intensive adherence
counselling.
In addition, new studies and ongoing demonstration
projects are examining new PrEP formulations and coitally-
dependent pill/gel-schedules, which may simplify and im-
prove adherence (see Table 5, Supplementary files). Long
acting injectable and slow release delivery mechanisms (for
example, using a vaginal ring) are currently being evaluated
for efficacy and may be available for more real world eva-
luation within the next 13 years. Antiretrovirals (including
dapivirine and tenofovir) are being formulated in sustained
release vaginal rings combined with levonorgestrol for con-
traception (multi-purpose technologies), which may further en-
hance uptake and adherence for young women [108,109].
These new PrEP delivery mechanisms are likely to be highly
applicable to adolescent key populations as they do not require
daily pill taking which may prove difficult for some adolescents,
particularly those with unpredictable lives, unstable living
situations, and/or mental health or substance use issues.
In sum, the efficacy of oral TDF and FTC/TDF has been
demonstrated across multiple studies, and demonstration
projects are currently evaluating strategies to improve access
to, uptake of and adherence to PrEP in key populations (see
Table 4 and Table 5 in Supplementary files). PrEP has great
promise if integrated into a combination prevention package
that provides support for the structural and behavioural
barriers to this innovative biomedical prevention strategy,
including accessing health care, assessing one’s risk and
motivation for prevention, and developing adherence habits.
Below we will highlight what an ideal combination package
Table 4. Overview of completed and ongoing PrEP studies targeting young people and key populations, by population and PrEP
type/mode of delivery
Target population Oral PrEP and combination prevention
Dosing/alternative
formulations of oral PrEP Topical PrEPc
Under 18 years old CHAMPS-SA Plus Pillsa
FACTS 002a
Project PrEPare (ATN 113)a
MSM/TGW California Collaborative
Treatment Group Consortium/ALERT (CCTG 593)
DemoPrEP
The Demo Project (NIAID)
East Bay Consortium/CRUSHb
HPTN 073
Los Angeles County PATH PrEP Demo Project
LVCT and SWOP
Project PrEPare (ATN 110)b




Sustainable Health Center Implementation PrEP







SW Durbar (DMSC) and Ashodaya Samithi
LVCT and SWOP
SAPPH-IRe
TAPS: Expanded use of ART for treatment and
prevention for female sex workers in South Africa
Wits Reproductive Health and HIV Institute
PWID Bangkok Tenofovir Study Open-Label Extension
Sustainable Health Center Implementation PrEP
Pilot Study (SHIPP) (CDC Foundation)
aParticipants 18 and younger.
bparticipants 24 and younger.
cnote that there are other efficacy trials of topical PrEP (e.g., FACTS 001, ASPIRE, Ring Study) but they do not exclusively target young people or
key populations.
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for young key populations might look like and the potential
role of PrEP within such a package.
Combination prevention for MSM and transgender
persons
An ideal combination prevention package for YMSM and
young transgendered persons would include effective inter-
ventions to address behavioural risk factors, PrEP uptake and
adherence support as well as addressing structural barriers to
prevention (including criminalization, stigma, discrimination
and homophobia). High rates of mobile phone ownership and
technology use among youth provide a unique platform to
deliver tailored, engaging HIV health promotion interventions
to YMSM and young transgendered persons [110112]. For
example, a combination prevention app could include fea-
tures to 1) increase HIV testing (e.g. provide youth with
access to nearby HIV testing locations or facilitate ordering of
home HIV tests); 2) help YMSM and young transgendered
persons successfully access and adhere to PrEP (e.g. tracking
of pill taking, side effects, pharmacy refill information); and
3) enhance patient provider interactions to ensure timely and
comprehensive follow-up (e.g. symptom tracker to document
any symptoms of acute HIV infection, reminders for HIV and
other testing). However, to date behavioural and structural
HIV prevention interventions designed specifically for YMSM
and young transgendered persons are severely lacking. A recent
review of primary HIV prevention interventions for adolescents/
young adults found that of the 92 articles reviewed, only three
unique interventions were specifically tailored to the needs of
gay/bisexual male adolescents and young adults [113].
Young transgender women may require a fairly different
package of combination HIV prevention interventions than
young MSM. Although they may share some similar structural
and social barriers, they face unique challenges, including
those related to transitioning, gender discrimination, trans-
phobia and violence [114]. A recent review has highlighted
the lack of evidence-based interventions for transgender
populations and the need to understand differences between
MSM and transgender populations and the heterogeneity
within the group so that prevention and care can be im-
plemented more effectively [115].
Currently two studies have been conducted that have
offered PrEP to younger MSM (Project PrEPare and iPrEx
OLE), while only one study has included transgender persons
(iPrEx OLE) [83,84] (see Table 3). Transgender persons have
been largely underrepresented in biomedical and behavioural
prevention trials and more work is needed to determine
the ideal set of interventions in a combination prevention
package for this population [114]. In contrast, in the two
years since the FDA approved Truvada for PrEP, there is
growing momentum in policy related to PrEP for MSM. CDC
guidance in 2014 made PrEP a central part of US prevention
efforts [116], and it has been featured as one of the three key
components of the New York state response to reduce new
HIV infections [117]. In 2014 WHO issued guidelines for PrEP
implementation which focused on MSM [118].
Project PrEPare was a pilot study conducted in the US that
used a randomized 3-arm design to compare an efficacious
behavioural HIV prevention intervention (Many Men, Many
Voices*3 MV) alone with 3 MV combined with PrEP
(tenofovir/emtricitabine), and 3 MV combined with placebo
[84]. For the purposes of this trial, the 3 MV intervention was
adapted for use with youth groups of mixed racial and ethnic
identities. Sixty-eight youth (mean age19.97 years; 53%
African American, 40% Latino) were enrolled, 58 were
randomized, 20 received PrEP and no one under the age of
18 was included [84]. Although acceptability (size of the FTC/
TDF pill) was an issue for some men, the study found that
Figure 1. Representation of key populations and young people included in completed PrEP studies.
Bangkok and TDF2 participants in ‘‘participants B25 category’’ includes participants under 30 years of age.
Number of participants in ‘‘participants B25’’ unknown for US Safety study and VOICE study.
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62% had tenofovir detected in plasma samples, which is an
encouraging finding in this age group, and likely could be
improved with an adherence support intervention during
PrEP use. Future PrEP demonstration projects among YMSM
should focus on acceptability, motivation and adherence
support for men who are motivated to take PrEP.
To date some of the structural barriers to uptake of PrEP
among YMSM have included cost of the medication and
the comprehensive services required for those on PrEP, and
limited access to primary care. Providers may also be not
offering PrEP to those most in need. To improve uptake of
PrEP, we recommend more fully integrating the provision of
PrEP into sexually transmitted infection (STI) services and
educating health care providers about the efficacy of PrEP
and strategies for providing culturally competent and non-
judgmental care for young key populations. We anticipate
that the provider reluctance to prescribe PrEP will decrease
in the wake of the PROUD and IPERGAY results, which indi-
cate that MSM were able to make informed decisions about
their risks and need for PrEP and adhere sufficiently to obtain
substantial prevention benefits.
Combination prevention for young people who sell sex
Combination prevention for HIV in young people who sell sex
should include behavioural, structural and biomedical inter-
ventions. Community empowerment, condom promotion,
HTC with linkage to treatment and care services, STI treat-
ment and health education have been shown to be effec-
tive interventions for sex workers, but they have not been
taken to scale or adequately resourced in most parts of the
world [9].
To be effective, interventions targeting young people who
sell sex must address their specific needs and the unique
barriers they face to accessing programs for adult sex workers.
For example, young sex workers may not perceive HIV pre-
vention programs to be relevant to them, and may face
competition from adult sex workers, who act as gatekeepers
to sex worker HIV prevention programs. Tailored programs for
younger women also need to encompass interventions that
address issues of social protection which can be implemented
as required on a case by case basis. Given that the majority of
sex workers who acquire HIV are infected early in their career,
programs need to have a strategy for identifying young people
shortly after they start selling sex, and to facilitate their timely
engagement with prevention services [119].
Access to prevention services is also often hampered by the
legal and policy environment. UNAIDS defines sex workers as
‘‘people who receive money or goods in exchange for sexual
services, either regularly or occasionally’’[120], while the Con-
vention on the Rights of the Child considers anyone selling sex
under age 18 years to be sexually exploited [71]. Governments
have a legal obligation to protect those under 18 from sexual
exploitation and this obligation frequently results in a ‘‘raid
and rescue’’ response to HIV prevention which perversely
results in increased vulnerability and decreased access to HIV
prevention services [121]. Criminalization of sex work in many
settings results in young people who sell sex being afraid
to seek services because of fear of arrest or imprisonment.
Some countries have mandatory reporting laws for people
under 18 selling sex which put health care providers in direct
conflict with their responsibility to provide confidential care [75].
Although there are examples of small scale HIV prevention
programs targeting young people who sell sex, these existing
approaches need to be scaled up more widely and evalua-
ted to realize improvements in HIV prevention and sexual
and reproductive health among this group. For example the
SHARPER project in Accra, Ghana effectively uses young peer
educators who are paired with older women in the com-
munity ‘‘peer protectors’’. The program focuses on health
education, skills building, assisting with linkage to services
and violence prevention [122]. In the Philippines, the River of
Life Initiative works with young MSM who sell sex and uses
peer to peer outreach to contact these hard to reach young
men [123].
To date, there have been no completed trials of PrEP
conducted specifically among sex workers (although two of
the six trials demonstrating efficacy included sex worker
participants, see Table 3). However, when the number needed
to treat (NNT) to avert one HIV infection was estimated
among sub-sets of women in the Partners PrEP trial, the NNT
was lowest among women under 30 years and women who
reported multiple high-risk behaviours. These findings sug-
gest that the number of young women who sell sex that
would need to access PrEP to prevent one infection is likely
to be favourable PrEP can be safely and effectively imple-
mented [124].
We know already that PrEP for young people who sell
sex should not be considered as a stand-alone intervention,
but will need to be implemented within a comprehensive
package of interventions that strengthen community cohesion
(such as those described in the examples above) alongside
behavioural/technological approaches to build individual
agency, self-efficacy and skills. The intervention components
will need to be relevant to, and address the specific concerns
of, young people who sell sex and be implemented in con-
junction with them. It is likely that the exact form and delivery
of comprehensive prevention will be context and culture
specific. The next step will be to use formative research to
develop and test comprehensive prevention packages for
young people who sell sex, which can then be rigorously
evaluated as they are scaled up using impact evaluation.
People who inject drugs
UNAIDS has identified nine interventions considered essen-
tial to prevent HIV among IDUs. These interventions consist
of needle syringe programs, opioid substitution treatment,
HTC, ART, STI treatment, condom distribution, information
and education campaigns, vaccination and treatment of viral
hepatitis, and prevention and treatment of tuberculosis [29].
In this context, PrEP is a promising addition to the existing
cadre of evidence-based interventions especially given that
tenofovir does not alter the pharmacokinetics or pharmaco-
dynamics of methadone or benprenorphine [125].
While evidence on PrEP among key populations is growing,
studies with empirical data collection among PWID are limited
to one PrEP efficacy trial among PWID (see Table 3). The
Bangkok Tenofovir Study which was a phase III randomized
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double-blind placebo-controlled trial to evaluate the efficacy
of PrEP with daily oral tenofovir on HIV infections in PWID [18].
Despite the promising results of the Bangkok Tenofovir
Study, some have questioned whether PrEP provided protec-
tion against parenteral HIV exposure, given the low and
declining incidence of reported injection and needle sharing
behaviours during the trial. Although it is not possible to
distinguish between the proportion of infections in the
Bangkok Tenofovir Study that were attributable to parenteral
versus sexual transmission [126], the key finding was the
halving of HIV incidence in the PrEP arm. This is a general-
izable result for HIV protection for PWIDs given that many
PWID populations are at risk of HIV through both parenteral
and sexual exposure. Notably, the majority of study partici-
pants were on methadone maintenance and in both arms,
and injecting risk behaviours, including injecting and needle
sharing decreased dramatically over three years of follow-up,
suggesting that parenteral transmission may have only
contributed a small proportion of the incidence. Thus, the
Bangkok Tenofovir Study demonstrates that daily oral teno-
fovir significantly reduces HIV transmission among PWID in
the context of opiate substitution therapy, and thus is a
demonstration of effective combination prevention for PWID.
Several challenges remain for implementing PrEP among
PWID outside a research setting. In many settings, injecting
drug use is highly stigmatized, and PWID-specific HIV pre-
vention interventions do not have adequate governmental
or public support [127,128] leading to suboptimal imple-
mentation of known highly effective prevention methods
[23,129]. Until these evidence-based intervention compo-
nents including NSP, OST and HTC are successfully imple-
mented, the role of PrEP may be limited. A recent systematic
review of barriers to treatment among PWID [93] found that
structural barriers, including incarceration, inadequate hous-
ing, and lack of a legal income [130,131], were more common
than individual-level barriers to accessing HIV treatment and
care. In order for PrEP to be successfully implemented, a
supportive political, social and environmental platform is
imperative.
PrEP is not a replacement for other evidence-based programs.
Rather, PrEP should be considered as part of a combination
prevention package that includes other proven prevention
strategies such as OST, NSP and HTC [23,31,34,129,132]. A
package that integrates and provides PrEP into drug treatment
programs and pharmacies and HTC clinics where there is the
ability to frequently perform HIV testing and create linkages to
providers to monitor patients would be ideal. In addition, it
will be important to package PrEP with interventions that have
been shown to increase adherence among PWID, particularly
when targeting adolescent PWID, such as directly observed
therapy and methadone maintenance therapy. Sub-populations
of adolescent PWID such as young injecting initiates are
more likely to be homeless [133] and engage in a range
of risk behaviours including hazardous alcohol use, cocaine
use, crystal methamphetamine use [133], unprotected sex
[134,135] and survival sex [133]. The concurrent high-risk
behaviour and lack of effective treatments for cocaine or
methamphetamine dependency underscore the importance
of PrEP in this population [129] while at the same time
highlighting their specific adherence challenges related to
alcohol use [136,137] and homelessness [138,139]. Beha-
vioural strategies that are part of a comprehensive approach
for young people should encourage the delay of sexual debut,
emphasize a reduction in the number of sexual partners and
encourage the use of voluntary HTC services without concern
for penalization. Further research is still needed to identify the
most effective combination of interventions for PWID with
an understanding that packages will need to be tailored for
specific settings and sub-populations of drug users, such as
adolescent and young PWID.
Conclusions
Effective yet scalable combination packages are needed for
young key populations. To date, adolescents generally, and
adolescent key populations specifically, have not been in-
cluded in studies of biomedical and combination prevention
due to regulatory and parental permission related issues
[140]. In an era of constrained resources, we need to identify
intervention components that are most effective at addres-
sing the key issues for the target population. In many settings,
young key populations are at highest risk of infection. While
the key populations highlighted in this paper face unique risks
for HIV, they also share many important challenges to pre-
vention, including stigma, marginalization, discrimination and,
in some cases, criminalization. It is critical that we address
these structural risk factors when developing prevention
packages for these populations.
With regard to PrEP as part of any combination prevention
package, the World Health Organization strongly recommends
the use of oral PrEP among MSM based on the evidence that
PrEP works in this population and is safe if taken as prescribed
[21]. Improving knowledge about PrEP, and uptake of and
adherence to this intervention among YMSM who have an
incredibly high incidence of infection is a priority. For young
PWID, expansion of harm reduction, specifically needle and
syringe programs, and OST is a critical first step to creating an
environment conducive to PrEP. Among sex workers, although
no PrEP trials to date have specifically targeted sex workers,
in particular young sex workers, PrEP has shown to be
efficacious in trials that included individuals who report
trading sex for money or housing. Structural impediments,
including policy/law, stigma and access to health service will
not be addressed by efficacy or behavioural trials, thus major
policy, educational and advocacy work will be needed along
with the prevention components discussed here. For all of
these populations, there is a need to address critical enablers
to access to HIV testing and health services for PrEP and other
prevention strategies, including decriminalization of key
populations’ practices, improved access to prevention and
care, a reduction in stigma and discrimination, and commu-
nity empowerment.
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Abstract
Introduction: HIV testing is the portal to serostatus knowledge that can empower linkage to care for HIV treatment and HIV
prevention. However, young people’s access to HIV testing is uneven worldwide. The objective of this paper is to review the
context and concerns faced by youth around HIV testing in low- as well as high-income country settings.
Discussion: HIV testing is a critical entry point for primary and secondary prevention as well as care and treatment for young
people including key populations of vulnerable youth. We provide a framework for thinking about the role of testing in the con-
tinuum of prevention and care for young people. Brief case study examples from Kenya and the US illustrate some of the
common barriers and issues involved for young people.
Conclusions: Young people worldwide need more routine access to HIV testing services that effectively address the
developmental, socio-political and other issues faced by young women and men.
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Introduction
Youth aged 1524 represent 39% of new HIV infections in
people aged 15 years and older (2012) [1]. Among young
people with HIV, most (4 million) live in sub-Saharan Africa
[2]. Access to HIV testing and to antiretroviral therapy
(ART) for youth remains a concern globally. Young people’s
HIV testing levels in low- and middle-income countries
(LMICs), that contain most global HIV disease burden, is
uneven [3]. Fewer than one in five boys and one in three
girls aged 1519 years in Africa report ever HIV testing [2].
The United States has poor sexual health statistics including
in HIV testing access [4]; the proportion of US youth who HIV
test has remained low at 22% and stagnant since 2005 [5].
For key populations (KPs), including males who have sex with
males (MSM), people who inject drugs (PWID), transgender
people (TG) and sex workers (SW), access to HIV testing is
even more challenging due to marginalization and stigma.
The seek, test, treat, retain and suppress continuum has
been promulgated as an approach with potential to bend
the curve of the HIV epidemic [6]. Knowledge of serostatus is
a starting point for lifesaving ART and to reduce sexual,
parenteral, or vertical transmission. The particular HIV testing
barriers and facilitators for youth in the HIV continuum of care
have had less focus, however. Attention to developmental
milestones is critical, e.g., yet most of what is known regarding
linkage and retention in care has been based on adult, not
youth populations. The sense of invulnerability that many
adolescents feel  despite epidemiologic risks  also con-
tributes [7,8]. Young people who are part of KP subgroups face
overt discrimination and have lower testing rates than general
population youth, facing additional barriers including fear,
concerns about confidentiality and cost [4], low self-efficacy
[9] and lack of KP-youth-friendly services. In this paper, we
highlight critical issues involved for youth, including KPs, along
the HIV testingpreventiontreatment continuum.
Framework: testing as entry to prevention and treatment
Testing for HIV is offered via provider-initiated testing and
counselling (PITC) in health facilities, on a self-initiated basis
through voluntary counselling and testing sites (VCT), deliv-
ered by staff in homes (home-based or HBCT), through com-
munity campaigns and through self-testing. Each modality has
benefits and drawbacks specific to youth, yet HIV testing
overall serves as a critical core component of the HIV con-
tinuum for vulnerable youth. In Figure 1, we graphically
summarize a model where testing for HIV functions as a
triage portal for needed youth-friendly services around an HIV
Continuum of Prevention and Care, including housing, mental
health treatment, substance abuse treatment and sexually
transmitted infection (STI) services.
At-risk and KP youth [10] need safe opportunities to
test, and re-test, for HIV. Acute HIV infection is important to
identify [11] and US guidelines call for 4th generation screen-
ing tests [12], though these may not be available in many
settings globally. Linkage to care for positive youth is especially
challenging. Even with dedicated outreach and youth-friendly
clinics, only 70% of HIV-infected youth in the US Adolescent
Trials Network were successfully linked [13].
The primary goal of HIV care is viral suppression, with
strong evidence for immunological advantage from early sup-
pression [14]. Individuals also gain emotional assurance that
viral suppression minimizes risk for transmission. This benefit
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can be realized on a population level [15]. Lifelong ART is
challenging, with high attrition post-ART initiation among
youth noted in Africa [16] and elsewhere. Technologies that
are highly acceptable to young people, such as text messa-
ging, to support adherence are promising [17]. Technology
tools also have been used successfully to support HIV test-
ing uptake among adolescents including in US emergency
departments [18]. Partner services are critical for HIV-infected
youth. Keeping HIV-negative youth healthy and uninfected
remains a key goal.
Since the global burden of HIV disease is in sub-Saharan
Africa, with two-thirds of all HIV cases and four-fifths of
all young persons living with HIV, making new modalities
such as self-tests available may help KP youth gain access to
serostatus knowledge. In Malawi, in work done by Choko and
colleagues, uptake of HIV self-testing among young people
aged 1624 years was consistently higher than among adults
aged ]25 years: 93.7% among those under age 25 versus
65.5% among adults 25 years and older (pB0.001). However,
only 42.4% of the youth in that study had ever HIV tested,
compared with 57.6% of those 25 and older (pB0.001) [19],
indicating an unmet need as the younger age group is
sexually active and exposed to HIV including through sex with
older partners more likely to be HIV-infected [20].
In Kenya, where an estimated 100,000 new HIV infections
occurred in 2013, girls and KPs are disproportionately
affected by HIV [21]. School-based HIV education does not
equip youth to seek testing, and there are few youth-friendly
facilities available. Policy guidance says minors require
parental/guardians’ consent for HIV testing, though Kenya
has eliminated age limit as the only criteria. Many healthcare
providers are ignorant of this provision, however, and deny
unaccompanied adolescents an HIV test. In the country’s
new HIV roadmap [21], there is commitment to reviewing
parental consent for HIV testing for adolescents. Youth who
discuss testing with their parents are more likely to HIV test
[22]. However, youth often rightfully fear negative reactions
from parents and providers, including in schools where they
fear isolation and missed opportunities and employment
prospects if known to be HIV-positive. In some communities,
women cannot give consent without consent by family
members (case example, Box 1).
Box 1. Benta [a pseudonym], 17 years old, was admitted
with her 2 year-old child into the paediatric ward. She
comes from a pastoral community, got married at 15 and
never attended antenatal clinic. She does not know her
HIV status. She and her child are offered provider-initiated
HTC. She has to get permission from her mother-in-law
who says Benta and her child can be tested but only if the
father of the child consents. He cannot be reached by
phone, does not visit the family in the hospital for 10 days,
and Benta and her child leave hospital without knowing
their HIV status.
KPs including MSM and transgender youth in sub-Saharan
Africa are often hidden and it is not safe to self-identify to
providers (Box 2). Issues faced by youth for HIV testing cut
across country contexts or resource boundaries, especially
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Figure 1. Framework for HIV services for youth in the HIV continuum.
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Box 2. Paul [a pseudonym] is a transgender youth in
Kenya. After high school, he was not able to get a job. One
day he dressed like a female and got employed as house
help looking after two girls. One day the girls and their
mother saw Paul in a mall, dressed as a young man. The
mother confronted him claiming Paul was masquerading
as a woman with intent to abuse her children. A crowd
gathered and physically assaulted Paul. Police officers
forcibly took him to a nearby clinic where he was tested
for STIs including HIV without consent. Results were
disclosed without consent. He lost his job and had to
re-locate.
Box 3. Michael [a pseudonym] is an 18-year-old who has
been homeless for 12 months. He exchanges sex with
other men for money in order to survive, and most do not
use condoms. He was recently tested for HIV, and he was
told it was positive. He is sure it was a mistake, and avoids
going to any health facility.
Discussion
Developmental issues relevant to HIV testing
The dividing line of adolescence and adulthood is often
seen as a sharp transition (e.g. at 18 or 21 years). These age
transitions mark relevant thresholds for age of consent for
HIV testing, for HIV medical services, and for partnered sex
(Figure 1). Although adolescence is developmentally continuous
and subject to substantial individual, cultural and national
variation, it is useful to think of the HIV service continuum in
the context of early (1014 years), middle (1517 years) and
late adolescence (18 years and older).
Early adolescence (1014 years)
Early adolescence is marked by puberty, achievement of adult
size and gender-typical body contours with new assump-
tions about responsibility for sexual behaviour. Family and
economic situations may require contributions to household
income and sibling care that affect schooling and vocational
opportunities [23]. Puberty in many cultures is associated
with initiation rites that may not include HIV prevention
messages [2426] and that carry potential risks including
non-medical circumcision [27,28]. (Voluntary medical male
circumcision plays a critical role in HIV prevention and is
well-accepted by many young men and parents [29].)
Development of sexual orientation is a key task. Often
heterosexual identity is assumed as the ‘‘normal’’ outcome
while other identities may be considered deviant [30]. During
early and middle adolescence, sexual orientation has sub-
stantial variation and fluidity and often, lack of congruence
between identity and behaviour [31].
Much emphasis is given to timing of coitus [32,33].
Over-emphasis on adolescent coitus complicates appropriate
matching of services because many adolescents do not have
coitus yet engage in other partnered sexual behaviours asso-
ciated with HIV risk. Same-sex partnered behaviours often
are omitted from sexuality education or relegated to being
entirely risky without contribution to sexual or relationship
satisfaction.
As pointed out in Figure 1, there may be a mismatch
and delay between when young people begin having sex
and when they can legally obtain HIV testing independently.
HIV tests before first partnered sexual event have unproven
benefits (e.g. normalization of testing) and harms (e.g. false
security). After first partnered sex, it is unclear when young
people begin to seek HIV testing on their own, or when
clinicians recommend testing [33], despite guidelines that
paediatricians and youth providers offer on HIV testing
around age 13 onward [7].
Health providers should ask about sexual activity among
younger patients. Many youth are not consensually sexually
active and may acquire HIV via sexual abuse, or may have
acquired HIV perinatally. In both these cases the young person
may not be willing to share their sexual activity history at
their first encounter with a new provider. Adolescents’ non-
consensual sexual experiences and intimate partner violence
(IPV) may increase risky behaviours [34,35]. Few IPV victims
report discussions with a provider, demonstrating the im-
portance of routine assessment for partner violence [36].
Sexuality education may occur in secondary schools, al-
though content varies greatly [3739] and this misses out-of-
school youth. Primary emphasis on abstinence-until-marriage
is less effective for HIV prevention than age-appropriate,
comprehensive programs [4042]. Informal sources of infor-
mation including social media are ubiquitous in adolescents’
daily lives worldwide [32,4345].
Middle adolescence (1517 years)
By this stage some functional competencies needed to
manage one’s health may be in place. However, many ado-
lescents lack skills or status to negotiate complex systems [46].
Adolescents’ participation in the HIV continuum of care
as consumers of health products (e.g. condoms, pregnancy
tests) is infrequently explored. Sale of HIV self-testing kits
is not age-restricted although costs, test implementation
fidelity and point-of-sale confidentiality have not been fully
explored with young, high-risk persons [4749]. Early data
on self-testing acceptability, as seen in the Malawi example,
are encouraging.
Many youth in this age group routinely have sex, especially
in subgroups where survival depends on sexual exchange,
which is often unprotected given power differentials in these
encounters. Many KP youth live on their own, though are not
yet an age of legal majority.
Late adolescence  youth (1824 years)
Age 18 often is considered adulthood; however, it is now
known if significant brain development including in the
prefrontal cortex responsible for decision-making does not
actually mature fully until age 25, which may influence
vulnerability and resilience of young people [50] in terms
of HIV risk and testing decisions.
Legal issues and the HIV continuum of care for adolescents
Three highly variable (from jurisdiction to jurisdiction) mile-
stones dictate legal thresholds for adolescents’ engagement
in the HIV continuum of care: age of consent for partnered
sex; for HIV testing; and, for HIV medical services (Figure 1).
Adolescents’ differential legal access to HIV-related testing
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and other services is based on traditional assumptions of
parental rights as well as restricted autonomy of children
[51].
Identification of sexual activity of minors less than the
age of consent threshold may mandate reporting to child
protection authorities [52]. Given concerns about widespread
victimization and HIV (especially of girls and younger ado-
lescents) [53], some countries have enacted ‘‘defilement’’
laws that can be enforced without regard for consensuality
of the partnered sex [54].
The ethical concept of ‘‘the mature minor,’’ while infre-
quently given legal sanction for adolescents’ self-consent
for general medical treatment [55], informs legal exceptions
to consent requirements for HIV [56,57]. Age thresholds for
consent of diagnostic HIV testing are widely variable, often as
young as 12 years of age. These laws recognize that parental
permission is a critical barrier to HIV testing, and could
invoke physical danger if non-marital or same-sex activity is
suspected or disclosed. Age thresholds for minor self-consent
for HIV is sometimes addressed within the context of laws
that allow for STI assessment [58,59]. However, medical HIV
treatments are lifelong and expensive, requiring ongoing
relationships with providers [60].
Cross-cutting issues for youth that affect HIV testing uptake
Across all age groups, stigma adversely affects each phase
of adolescents’ engagement with the HIV continuum [61].
Internalized stigma may particularly effect HIV testing be-
haviours while anticipated stigma may have especially strong
effects on care-seeking and adherence [58,59].
Physical, sexual and emotional aggression is experienced by
many youth, especially in KP groups (e.g. sexual minorities),
where microaggressions also have a damaging impact [62].
Legal protection, and campaigns to reduce bullying and other
forms of aggression, are needed. Finally, many young people
are economically disadvantaged relative to adults and cost
barriers to HIV testing must be effectively addressed.
Solutions to increase HIV testing uptake among youth
including KPs
HIV testing services must be available to all young people,
particularly those from KPs. Health literacy is an issue for
many adolescents [63] which ‘‘youth-friendly’’ programs may
address [64]. Demand creation strategies have been used
effectively for HIV testing via social marketing campaigns [65]
and should be further employed. Testing availability where
youth gather, and user-friendly free or subsidized test kits,
may increase uptake. Once confirmed positive, linkage to
care is critical and youth should access treatment services in
whatever clinical venue is preferred, whether paediatric or
adult (to reduce loss to follow-up when forced into adult
services at arbitrary age cutoffs like 18 years). Testing and care
are enhanced by respectful health care teams, and reduction
of resource barriers such as transport fees and homelessness,
that disrupt treatment continuity. Counselling can address
the utility of ART taking into account developmental stages
in which many young people may feel invulnerable and find
navigating complex health systems overwhelming, especially
in the commonly-occurring context of depression, substance
use and other co-morbidities. Failure to link/retain adequately
has dire consequence; Zanoni and Mayer estimate that
only 6% of HIV-positive US youth are virally suppressed.
They recommend that HIV testing be integrated wherever
youth interact with health systems, as well as in youth venues,
to normalize and promote testing and recurrent testing
among high-risk and KP youth [66].
Conclusions
Recommendations and research gaps
Adolescents and young adults worldwide deserve better
access to HIV testing and re-testing. We recommend that
testing venues be made more youth-friendly, and promising
new approaches like self-testing be monitored regarding
how well they work for youth. Implementation science can
identify optimal ways to improve HIV testing access and
delivery for youth [67]. HIV testing in prevention of maternal
to child transmission (PMTCT), antepartum care and voluntary
medical male circumcision (VMMC) campaigns alone is in-
sufficient. For youth, HIV testing is a key portal for linkage to
necessary HIV care and prevention services.
Despite international and national guidelines, HIV testing
for adolescents is still not consistently done in high- [68] or
lower-income countries. Providers worldwide [69] must con-
sistently assess sexual behaviours or partnership risks, so that
appropriate counselling based on the young person’s actual
needs is not pre-empted [10]. HIV testing can be made more
youth-friendly [70] even under the constraints of ART scale-
up [71], but truly supportive services ultimately must rely
on empathetic, self-aware [72] and professional health pro-
vider behaviours [73] including assurance of confidentiality
around test results [74], reinforcement for those testing HIV-
negative, and social and clinical support for those testing
HIV-positive. Ensuring youth rights cannot occur only within
clinic walls but must extend to the community and to social
as well as legal norms [75].
There are social justice and public health imperatives to
focus on structural factors that keep young people from freely
HIV testing  including laws that harm KPs and program
structures and costs that restrict access. The HIV Investment
Framework points out that contraceptive services are a cost-
effective portal for youth HIV testing [76], of even more
importance in LMIC settings where a higher proportion of
the population are of reproductive ages [77]. Achieving
universal access to youth-friendly services worldwide would
cost around US$ 1 per adolescent [78]. Program quality moni-
toring of HIV testing access [79], and implementation of best
HIV testing practices, for young people must a part of the
HIV agenda if we are to achieve generations with fewer HIV
infections and provide better care of those living with HIV.
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Abstract
Introduction: Adolescence is a time of physical, emotional and social transitions that have implications for health. In addition to
being at high risk for HIV, young key populations (YKP) may experience other health problems attributable to high-risk behaviour
or their developmental stage, or a combination of both.
Methods: We reviewed the needs, barriers and gaps for other non-HIV health services for YKP.We searched PubMed and Google
Scholar for articles that provided specific age-related data on sexual and reproductive health; mental health; violence; and
substance use problems for adolescent, youth or young sex workers, men who have sex with men, transgender people, and
people who inject drugs.
Results: YKP experience more unprotected sex, sexually transmitted infections including HIV, unintended pregnancy, violence,
mental health disorders and substance use compared to older members of key populations and youth among the general
population. YKP experience significant barriers to accessing care; coverage of services is low, largely because of stigma and
discrimination experienced at both the health system and policy levels.
Discussion: YKP require comprehensive, integrated services that respond to their specific developmental needs, including health,
educational and social services within the context of a human rights-based approach. The recent WHO Consolidated Guidelines
on HIV Prevention, Diagnosis, Treatment and Care for Key Populations are an important first step for a more comprehensive
approach to HIV programming for YKP, but there are limited data on the effective delivery of combined interventions for YKP.
Significant investments in research and implementation will be required to ensure adequate provision and coverage of services
for YKP. In addition, greater commitments to harm reduction and rights-based approaches are needed to address structural
barriers to access to care.
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Introduction
Young people aged 1024 represent at least a quarter of
the world’s population, but are disproportionately affected
by HIV [1,2]. Globally, the health of young people is important
as it is an indicator of future population health, and also
social and economic development. Although the rate of new
HIV infections has declined or stabilized in many populations,
over a third of new HIV infections continue to occur among
the 15- to 24-year age group [3]. HIV risk and prevalence are
not uniform; people who sell sex (SW), inject drugs (PWID),
men who have sex with men (MSM) and transgender people
(TG) have been shown to have higher risks for HIV infec-
tion than the general population [46]. Many practice more
than one risk behaviour. For example, young MSM may also
use drugs and sell sex for drugs, emphasizing the need for
comprehensive, integrated health services. Key populations
(KP) contribute disproportionately to HIV transmission dy-
namics within countries, with recent estimates suggesting that
50% of new HIV infection occur among these populations [7].
In addition to their high-risk behaviour, KP frequently
experience significant stigma, discrimination and violence,
which further limits their ability to adopt preventive beha-
viours and access health services [8]. In YKP, the effects of
stigma, discrimination and violence are exacerbated by policy
and legal barriers related to the age of consent for sex as well
as selected medical interventions, further limiting access to
a range of health services [7]. As a consequence, YKP are
frequently a hidden population, and reliable and representa-
tive epidemiological data on their health are scarce [7]. This
paucity of data often leads to neglect of their specific needs
by programmes designed either for young people more
generally, or for adult KP. Failure to identify the comprehensive
health needs of YKP, and their specific barriers to care, has
the potential to undermine the success of HIV prevention
programmes targeted at these populations [9].
Conceptual framework for adolescent health
While YKP require specific interventions for the prevention,
treatment and care of HIV, YKP also require non-HIV-related
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health services that respond to the health needs of their
particular developmental life stage. The complex physical,
psychological, emotional and social changes that take place
during adolescence have immediate and long-term implica-
tions for individuals [9]. For example, the onset of puberty
is linked to the initiation of sexual activity, and subsequent
exposure to the risk of pregnancy and STIs, including HIV.
Awareness of sexual orientation emerges during this period.
Mental health disorders also emerge during the second
decade of life. High rates of self-harm are observed in
young people, and suicide is a leading cause of death [10].
Increased risk-taking and a heightened sensitivity to peers
may influence adolescent experimentation with substance
use. Although risk-taking is considered a normal part of
adolescent development, risk-taking by YKP can have serious
adverse consequences. More than any other life stage,
adolescent health is strongly determined by social context.
Both structural determinants of health (e.g. national wealth,
income inequality, access to education and health services,
employment opportunities and gender inequality) and more
proximate determinants of health (e.g. connectedness of
adolescents to family and school) affect health-related be-
haviour and outcomes during adolescence [11]. It is not
surprising therefore that poor sexual and reproductive health
(SRH), mental health disorders, violence and injury, and
substance use account for the majority of disability and
disease experienced by people aged 1024 globally [12].
Sawyer and colleagues have proposed a conceptual frame-
work to enhance our understanding of adolescent health and
development (Figure 1) [9]. The horizontal axis describes a
life-course perspective from the pre-conceptual and prenatal
period through to adulthood. The vertical axis describes the
social determinants of health and the pathways by which
these influence health outcomes. The nexus of these two
axes is the period of adolescence, a time of enormous
physical, emotional, mental and social transition. Policy and
programmatic responses to adolescent health operate along
the vertical axis, but should not be developed without
an appreciation for the importance of adolescence within
a life-course perspective [9]. Guided by this conceptual ap-
proach, we review the needs, barriers and gaps for non-HIV-
related services for YKP as part of a special series of papers
on YKP.
Methods
We focused our review on those non-HIV-related services that
are developmentally relevant to this population based on the
conceptual framework outlined above, and/or included as
recommended interventions in the recently published WHO
Consolidated Guidelines on HIV Prevention, Diagnosis, Treat-
ment and Care for Key Populations (Table 1). We undertook
a targeted, web-based search to identify age-specific data
on the health needs and barriers to care for YKP aged 1024.
Using PubMed and Google Scholar, we focused on articles
published in English since 1990, with a particular emphasis
on systematic reviews and more recent publications. In order
to identify age-specific data or references we used the key
words ‘‘young,’’ ‘‘youth,’’ ‘‘adolescent,’’ and ‘‘age’’ in combi-
nation with search terms for each KP (e.g. ‘‘MSM,’’ ‘‘men
who have sex with men,’’ ‘‘gay,’’ ‘‘bisexual’’) and for each
health topic (e.g. ‘‘condoms,’’ ‘‘unprotected sex,’’ ‘‘STI,’’ etc.).
Abstracts were retrieved and read, and if relevant age-related
data were provided, full-text articles were retrieved. Over
a 2000 abstracts were identified in the initial searches, but
Figure 1. Conceptual framework of adolescent health, adapted from Sawyer et al. [9].
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far fewer contained age-specific information relevant to YKP
and 110 articles with age-specific information were included.
Due to the paucity of age-specific data on YKP, articles that
referred to KP or adolescent populations were used to
supplement searches.
Results
Poor SRH outcomes, mental health disorders, violence and
injury, and substance use account for the majority of
disability and disease experienced by young people aged
1024 globally [12]. We summarized the findings of our
review which demonstrate overall that YKP experience an
even higher burden of disease than older KP, as well as a
higher burden of disease than their age peers in the general
population.
Unprotected sex
Unprotected sex is an important risk factor for negative
health outcomes among young people, accounting for 4% of
disability-adjusted life years (DALYs) in those aged 1024 [12].
Several studies have shown younger age is associated with
more frequent unprotected sex among KP [13], often due
to lower levels of education, knowledge, and risk perception
[1315]. Young key populations (YKP) may also be unaware
of where to access condoms and other contraception. The
combination of low condom self-efficacy and more frequent
sex or change in sexual partners also puts YKP at higher risk
of sexually transmitted infection (STI) [1618]. For many,
the ability to negotiate safer sex with partners is limited by
imbalances in relationship power, compounded by adolescent
aspirations for love and intimacy. For example, although
condom use rates may be higher among sex workers than
Table 1. Summary of relevant WHO recommendations for linked services key populations [7]
HIV Prevention
Post-exposure prophylaxis (PEP) should be available to all eligible people from key populations on a voluntary basis after possible exposure to
HIV.
All pregnant women from key populations should have the same access to services for prevention of mother-to-child transmission (PMTCT) and
follow the same recommendations as women in other populations.
Harm reduction
All people from key populations with harmful alcohol or other substance use should have access to evidence-based interventions, including
brief psychosocial interventions involving assessment, specific feedback and advice.
Prevention and management of co-infections and co-morbidities
Key populations should have the same access to hepatitis B and C prevention, screening and treatment services as other populations at risk of or
living with HIV.
Routine screening and management of mental health disorders (depression and psychosocial stress) should be provided for people from key
populations living with HIV to optimize health outcomes and improve their adherence to ART. Management can range from counselling for
HIV and depression to appropriate medical therapies.
Sexual and reproductive health
Screening, diagnosis and treatment of sexually transmitted infections should be offered routinely as part of comprehensive HIV prevention and
care for key populations.
People from key populations, including those living with HIV, should be able to experience full, pleasurable sex lives and have access to a range
of reproductive options.
Abortion laws and services should protect the health and human rights of all women, including those from key populations.
It is important to offer cervical cancer screening to all women from key populations.
(Note: for adolescent populations, HPV vaccination is an additional recommendation for prevention of HPV-associated disease including
anogenital cancers).
It is important that all women from key populations have the same support and access to services related to conception and pregnancy care, as
women from other groups.
Critical enablers
Laws, policies and practices should be reviewed and, where necessary, revised by policymakers and government leaders, with meaningful
engagement of stakeholders from key population groups, to allow and support the implementation and scale-up of health care services for key
populations.
Countries should work towards implementing and enforcing anti-discrimination and protective laws, derived from human rights standards, to
eliminate stigma, discrimination and violence against people from key populations.
Health services should be made available, accessible and acceptable to key populations, based on the principles of medical ethics, avoidance of
stigma, non-discrimination and the right to health.
Programmes should work towards implementing a package of interventions to enhance community empowerment among key populations.
Violence against people from key populations should be prevented and addressed in partnership with key population-led organizations. All
violence against people from key populations should be monitored and reported, and redressal mechanisms should be established to provide
justice.
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the general population, several studies have shown how
younger sex workers may be less experienced than older sex
workers with condom negotiation, and more vulnerable to
being forced to have sex without a condom either by clients or
managers [19,20]. Unprotected sex may also be associated
with expressions of intimacy or trust, with higher rates for sex
with primary partners, who are often older and thus have had
a longer period of potential exposure to HIV and other STI
[2123]. In one study of young MSM aged 1620, considering
a relationship to be serious was associated with an eight-fold
increase in the rate of unprotected sex [24]. For TG women,
condom negotiation may be more difficult given their female
gender identity and socially constructed role, and young TG
people may be more likely to have unprotected sex to validate
their gender identity [13]. Among young PWID, low rates
of condom use are often associated with other high-risk pra-
ctices such as needle sharing or smoking drugs together [23].
Among young PWID, there are gender differences in risk with
higher rates of unprotected sex and sexual risk observed in
young women [25]. Given the lower levels of condom use
among YKP, the potential for negative health outcomes in this
population is high.
Sexually transmitted infections
The prevalence of STIs is also higher in YKP than among older
KP peers. Studies show elevated rates of syphilis [26],
gonorrhoea [27], chlamydia [28,29] and herpes simplex [30]
among YKP compared with adult KP. Young MSM and TG
may be more likely to have anal or rectal infections that are
asymptomatic and/or remain undiagnosed [31]. STIs are also
more common in those populations with more than one risk
behaviour. For example, a prospective study among PWID in
British Columbia, Canada, found that incident STIs were more
frequent among those involved in the sex trade compared
with those who did not sell sex, over a three-year period [32].
In addition to causing significant morbidity and mortality,
STIs also increase the risk of HIV transmission.
Two of the viral STIs associated with cancer outcomes are
now vaccine preventable. HPV is a common STI that causes
cervical and other anogenital cancers. A high prevalence of
HPV infection has been observed in adult KP. In a study of
anal HPV prevalence and risk factors among men in Brazil,
Mexico and the United States, among MSM, younger age was
associated with increased prevalence of any anal canal HPV
[33]. YKP may be exposed to HPV earlier and may be more at
risk of developing of pre-neoplastic and neoplastic lesions in
later life, especially if they are co-infected with HIV. Although
access to HPV vaccination has expanded significantly in the
past five years, young MSM or TG women may not benefit
from vaccination programmes targeted at young girls, and
may not receive the benefit afforded to heterosexual men
through herd immunity [34].
YKP may be at increased risk for viral hepatitis. Hepatitis C
virus (HCV) incidence in young PWID is high, raising concerns
about the prevention and control of an expanding epidemic
in young people [35]. A study on young PWID in Afghanistan
showed that risk of HCV infection increased with each
additional year of injecting among young PWID [36]. Young
female PWID were reported to have a higher incidence of
HCV, associated with higher risk injection practices, when
compared to young men [37]. Young MSM are also at
increased risk of viral hepatitis A and B [38]. YKP would
benefit from vaccination against hepatitis A and B in settings
where universal childhood vaccination is not routine. Where
vaccination is offered to MSM, coverage is still relatively
low, although promising data from several studies show that
vaccine uptake is associated with younger age [39].
Reproductive health
In addition to STIs, a frequent outcome of unprotected sex in
female YKP is unintended pregnancy, which during adoles-
cence can pose particular risks to both mother and infant
[40]. Data on pregnancy intentions, outcomes, and use of
contraception or prevention of mother-to-child-transmission
(PMTCT) in YKP are limited. Studies in adult female sex workers
show that pregnancy is frequently unwanted, termination
of pregnancy is common and contraceptive use, including of
emergency contraception, is low, suggesting significant unmet
needs [4143]. A recent study among Chinese adolescent
sex workers showed that a quarter had never used a modern
contraceptive method [44]. The main method of pregnancy
prevention in this population was condoms, although condom
use was often inconsistent. Half of those interviewed reported
a previous induced abortion, although only a third of those
had sought care from public sector services. These data are
supported by another study in Chinese sex workers show-
ing that younger sex workers were less likely to terminate
their pregnancy, but those that did were more likely to seek
termination from informal providers [45]. For HIV-positive YKP,
PMTCT is a priority. While few data are available on access
to PMTCT in YKP, given high rates of HIV infection in this
population, there is likely to be a significant need. In a study of
PWID in Ukraine, PWID were more likely than non-PWID to
be diagnosed during labour and to have more advanced HIV
disease, but less likely to receive prophylaxis or HAART
to prevent vertical transmission. As a consequence, vertical
transmission rates in this population were higher than in the
general population [46].
Young TG have specific health needs related to their gender
identity. Hormone therapy may have significant benefits for
TG people, but access is frequently limited by cost or provider
attitudes. As a consequence, some TG may seek hormone
therapy from the non-medical sources [47], despite potential
side effects from unmonitored treatment including overdose
[48], or the risk associated with injecting hormones or silicone
[49]. In some cases, young TG may engage in sex work to fund
treatments [50]. Services for YKP need to be able to provide
reliable, evidence-informed information regarding TG-specific
medical and surgical procedures.
Sexual assault
YKP are more likely to require sexual assault services including
access to post-exposure prophylaxis (PEP). While no age-
specific data were provided, a recent systematic review of the
prevalence and correlates of violence against sex workers
estimated that the lifetime prevalence of any violence ranged
from 45% to 75% [51]. Young trafficked sex workers may have
experienced violent rape in order to coerce them to sell sex
[18,52]. Young male sex workers are not immune, and studies
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show that they also experience verbal, physical and sexual
abuse [53]. In a study of MSM in Thailand, 18% had ex-
perienced forced sex, the majority by someone they knew,
and the forced sex occurred more than once, with the first
experience occurring during adolescence [54]. While esti-
mates of the prevalence of sexual assault among PWID are
limited, a recent study among women aged 1629 attending
family planning services in Pennsylvania, USA, showed 11%
of women had experienced sexual violence in the previous
three months, and that sexual assault was associated with
injection drug use, their own or their partners [55]. Experi-
ences of violence are strongly associated with increased risk
behaviour and risk for HIV [18,56,57], as well as other negative
SRH outcomes [58,59]. Interventions that address sexual
assault and that provide access to PEP are a critical component
of a package of services for YKP [7].
Mental health
While emergence of mental health problems in the second
decade of life is common, data suggest that YKP experience
higher rates of mental health problems when compared with
their same age counterparts in the general population, or
older key population peers. For example, a study of young
SW in China showed that those younger than age 20 ex-
perienced the highest rates of depression, suicide and sub-
stance use compared to those older than 20 [60]. A study in
lesbian, gay, bisexual, and transgender (LGBT) youth in the US
observed higher rates of mental disorders in this population
compared to the general population [61]. Major depression,
personality and substance use disorders are more common in
young PWID [62], with higher rates of mental health disorders
observed in young women [63].
Among the factors that influence poor mental health in
young KP, stigma, discrimination, social exclusion and victimi-
zation are substantial contributors. For example, a study
among young PWID in Russia showed that a large proportion
had experienced discrimination resulting in loss of jobs, lack
of access to health care and being forced from their family
homes. Over one-third had clinical depression [64]. A study
in Chinese sex workers showed that the majority had high
levels of self-stigma, and that this was significantly associated
with poor mental health [65]. In a US study of young MSM,
experiences of victimization were strongly associated with a
syndemic of depression, substance use, risky sex and intimate
partner violence; these factors were also strongly associated
with an increase in suicide attempts [66]. These findings were
echoed in a global study of MSM in 151 countries [67], and
a study in young TG women [68]. Violence experienced at the
hands of family, partners, clients or police is associated with
increased reporting of poor mental health outcomes [6972].
Substance use
Substance use and experimentation are common in ado-
lescence, but evidence suggests that YKP are more likely
to initiate substance use at an earlier age, to engage in
polysubstance use and to experience more rapid increases in
substance use over time [73,74]. This is of particular concern
given the findings that substance use in adolescence may be
more harmful to brain function and behaviour while the brain
is still developing [75]. YKP may frequent social spaces where
alcohol and drug use are tolerated and consumption normal-
ized. YKP may initiate substance use to self-medicate against
the anxiety associated with group behaviours, or associated
negative experiences [76,77]. A study in Australian LGBT youth
highlighted a higher prevalence of alcohol and drug use in
this population compared to the general population. In this
study, alcohol use was significantly higher in those younger
than 18, and those who believed that homophobia influenced
alcohol and drug use were significantly more likely to use
alcohol or drugs [78]. Substance use may increase sexual
desire, lower inhibitions and impair decision-making. A study
of young TG women in the US documented that this group
was significantly less likely to use condoms with main partners
while under the influence of drugs or alcohol. Substance
use may reduce an individual’s concerns about safe sex in the
face of other, more important desires and immediate priorities
[22]. Several other studies among YKP have shown that
drinking beforehand can be associated with unprotected sex
and injecting behaviours [76,79,80].
The risks associated with injecting drug use are dis-
proportionately high. Problem drug use often starts with
recreational drug use, and studies show that the transition
from non-injecting to injecting drug use in young people is
rapid and high [77]. Early initiation of injecting drug use is
associated with younger age and being female [25,81].
Young PWID are frequently initiated into drug use by peers
[82,83]; young women more often are initiated by a sex
partner [77,84]. A study in Ukraine reported that in 56% of
boys and 72% of girls, the first injection was unplanned and
often occurred after exposure to injecting among friends,
with around 32% of girls initiated by their sexual partners
[85]. Young PWID are more likely to inject in groups, and
develop rituals associated with injecting that expose them
to sharing of non-sterile equipment. Studies in young PWID
show more frequent sharing of equipment, more frequent
injecting and injecting in public spaces [86,87]. Young PWID
are more likely to practice unprotected sex, have increased
numbers of partners, or trade sex for drugs than their older
peers [88,89]. Young PWID may also be less likely to engage
in care for their addiction, and are also more likely to report
relapse after treatment [72,90]. Young PWID have much
higher mortality rates than their peers in the general popu-
lation, associated with overdose or injury [91]. They have a
substantial need for harm reduction and addiction treat-
ment services, as well as links to services to address their
integrated health and social needs.
Educational, vocational and social support
In addition to health care, YKP frequently require social
support because of their life stage as well as socio-structural
factors that influence their behaviour. YKP may be orphaned
or rejected by their families, experiencing homelessness, food
insecurity and economic instability [56,92,93], and may often
prioritize food, shelter and money over health [94]. Female
YKPmay have concerns about thewelfare of their own children
[95]. Access to social support and benefits is therefore
essential to reducing their risk. Completion of education,
initiating employment and transitioning out of the child-
hood home may be considered a normal part of adolescent
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development, yet YKP may not experience these positively.
For example, school bullying and victimization may severely
impair educational attainment and future employment oppor-
tunities of young MSM and TG [96]. For some, low educational
attainment may become a reason to sell sex [97]. Young PWID
who drop out of schoolmay be at higher risk for HIV [15]. Linkage
to educational and vocational support interventions are an
important part of a developmentally appropriate response to
YKP, and while not directly linked to HIV programme activities
educational and vocational interventionsmay be critical enablers
for HIV programme success in this age group.
Barriers to care
Adolescence is marked by high rates of attrition along the
continuum of HIV prevention, diagnosis and treatment ser-
vices. YKP are less likely to be engaged in care [98], and
coverage of services is low. While data are limited for YKP,
evidence from young adult and adult populations shows that
KP experience poor access to condoms and HIV testing [99],
may present later for HIV treatment [100] and have lower
rates of adherence [101], viral suppression [102] and retention
in care [103]. PMTCT outcomes and access to linked mental
health, substance use and SRH services are poor [46,104].
PWID may experience difficulty in accessing safe injecting
equipment or treatment for dependence. Using the concep-
tual framework (Figure 1), reasons for poor access to care
can be categorized as individual-level, health-system-level or
structural-level barriers, and are common to all YKP.
Individual-level barriers to care
Low levels of education and HIV knowledge or risk percep-
tion are associated with low uptake of HIV services [13]. YKP
with less formal education and/or less sex education may
be less familiar with what constitute safe sex or safe injec-
tion practices. YKP with internalized stigma experience more
social isolation and are less able to ask trusted adults for
support in decision-making [105]. They may also experience
bullying by older KP [106]. YKP who have experienced poor
mental health, violence or low levels of social support may
have lower levels of self-efficacy for health-seeking [107].
Health-system-level barriers to care
Perhaps the most significant barrier to health-seeking among
YKP is the experience of stigma, discrimination or victimization
at the hands of health care providers (HCP). In a study of
young migrant sex workers in North Vietnam, despite health
care being available, the young women perceived the stigma
attached to sex work as a barrier to receiving health care, and
preferred to receive health education and care frompeers [52].
In another study involving male, female and TG sex workers
in Africa, denial of treatment for injuries following physical
assault or rape and general hostility from public sector pro-
viders were common [108]. Similar experiences were reported
by PWID in India [70]. Younger PWID expressed a preference
for syringe-dispensing machines over staffed needle exchange
programmes because of their desire to hide their identity or
because they did not like the way they were treated at staffed
services [109]. Concerns about privacy and confidentiality are
an important barrier to care. In a US-based study, LGBT youth
expressed greater concerns about confidentiality and were
less likely to seek care from school-based services compared
to heterosexual peers [110]. In addition to concerns about
poor attitudes, HCP may not have sufficient skill, competence
or training to deal with the specific health and social needs
of YKP. A US survey of HCP reported that the majority of
respondents would not regularly discuss sexual orientation,
sexual attraction or gender identity while taking a sexual
history from a sexually active adolescent. The majority of
physicians did not believe that they had all the necessary skills
to address issues of sexual orientation with adolescents [111].
Studies reveal that provider willingness to answer questions,
their respect for and understanding of adolescents and the
responsiveness of the social and physical environment towards
youth are all associated with young people’s intention to
seek and engage in care [112]. Negative experiences with
providers may prompt YKP to seek care from non-conventional
services [47]. For YKP, cost and waiting time are also barriers
to care [103]. Young people are less likely to have access to
ready cash and may have competing demands or less control
over their time. In several studies, YKP highlight the impor-
tance of integrated services that address their multiple health
needs [113]. Lack of service integration adds time and cost
to clinic visits and may be a further barrier to care. In many
cases, services for KP may not be sufficiently ‘‘youth-friendly.’’
Providers may not have an appreciation for the specific
health and communication needs of YKP. YKP may experience
discomfort when seeking care with adults. Location and
transport may also be a barrier to care. Larger, more formal
venues can enhance prevention initiatives, including on-site
services. Geographical targeting of services for YKP can be
complicated by the social and sexual networking patterns of
YKP whomay find partners through the Internet, meet them in
informal venues, and generally be more mobile. This can
increase the risk involved and makes it harder for services to
identify and reach them [114].
Structural-level barriers
Criminalization reduces YKP’s control over their behaviour,
impedes their access to health services and obstructs health-
service provision and legal protection. In many settings, YKP
are criminalized for their behaviour/s and risk incarceration
[115,116]. Even in settings where activities are not crimina-
lized, they may experience significant stigma, discrimination
or police harassment, as a result of both their group identity
and their age [117119]. Studies of MSM in African countries
where homosexuality is criminalized demonstrate how crim-
inalization makes MSM more vulnerable to violence and less
able to access health care or preventive services [99,119,120].
YKP are vulnerable to harassment and exploitation by the
police, and may go to substantial lengths to avoid police.
A mapping study in Canada showed a significant geographic
relationship between a heavily concentrated core area of
health and syringe availability and avoidance of these settings
by substance using street-based sex workers due to policing;
this correlation was strongest among younger women [121].
Several studies have highlighted how police arrest YKP for
carrying drug paraphernalia or confiscate it without arrest
[70,122]. Arrest and detention are frequently associated with
police beatings; a Thai study among young PWID showed that
Delany-Moretlwe S et al. Journal of the International AIDS Society 2015, 18(Suppl 1):19833
http://www.jiasociety.org/index.php/jias/article/view/19833 | http://dx.doi.org/10.7448/IAS.18.2.19833
34
younger age was associated with more frequent reports of
police beating [118]. In addition to physical violence, YKP are
also vulnerable to sexual coercion and violence at the hands of
authorities [123].
Access to care is further confounded by the legal status
of YKP as minors. In many countries, adolescents require
parental permission to access testing, treatments or proce-
dures. This is a particular problem for minors who do not live
with their parents or do not wish to disclose their behaviour
to them. For example, young women seeking contraception
or safe abortion services are likely to seek care outside of
conventional health services [45]. In many countries where
opioid substitution services are available, age restrictions
are placed on them [124]. In some settings, HCP are legally
obliged to report underage sex or other illegal activities.
This may compromise disclosure and provision of adequate
care for risky behaviours. Age restrictions are also placed on
access to housing and other social services which may be
needed.
An absence of clear legal status may also be a barrier for
access to health services. TG people may experience signifi-
cant barriers to obtaining services, legal entitlements and
legal protection because the gender assignment on their
administrative documents may be in conflict with their gender
identity [113]. Migrant YKP may also not have adequate
legal documentation of citizenship, and may not be able to
access services in their host country. As adolescents, they are
often dependent on parents for the provision of information
necessary for citizenship or travel documentation.The absence
of appropriate official documentation may make them vulner-
able by limiting their access to health and social services and
benefits that they might otherwise be entitled to.
Many YKP experience additional stigma and discrimina-
tion associated with their racial or ethnic identity, in addition
to their group identity. There is overwhelming evidence
from the United States that young Black MSM have the
highest concentration of HIV of any sub-population despite
little evidence of higher risk behaviour. Instead, social and
structural factors act as barriers to health care access [125].
In other settings, YKP from either indigenous or migrant
populations aremarginalized and have limited access to health
services [87].
Discussion
Despite the paucity of age-specific data for YKP, this review
confirms that in addition to interventions for the prevention,
treatment and care of HIV, YKP also require other, non-
HIV-related health services that respond to their significant
health and development needs as adolescents. The WHO
recommendations for a comprehensive package of services
that includes SRH services and care for mental health disorders
is an important first step in recognizing the impact of these
other health concerns on the success of HIV prevention,
treatment and care interventions [7]. These guidelines speci-
fically recognize the health and developmental needs of
YKP, and provide commentary on specific considerations for
the delivery of health sector interventions to YKP.
The next priority is to ensure that these recommendations
are implemented at scale and with sufficient intensity to
ensure an impact on the HIV epidemic, and the health of
YKP. While there is substantial evidence for effective inter-
ventions to prevent and treat HIV infection in adults, less is
known about the delivery of these interventions to adoles-
cents [126]. Current coverage of services for YKP is generally
low [127,128], and consideration of optimal service delivery
models that respond to current barriers to care are now
a priority. The requirement to make services accessible,
acceptable and available to YKP provides an opportunity to
evaluate interventions aimed at addressing health system
barriers to care. Beyer and colleagues have proposed three
models of service provision for KP: integrated models of care,
stand-alone models of care or hybrid models of service
provision [8]. Integrating HIV and related service provision for
YKP into primary health care (PHC) offers significant potential
for expanding coverage and access to care for YKP, and may
be the only option for service delivery in some settings.
Integrated models have the potential to address several of
the health systems barriers. Sensitization of services and
training of all staff in facilities, not just HCP, is a potentially
powerful structural intervention to enhance the effective-
ness of HIV programmes for YKP and reduce stigma more
generally. There are a number of positive approaches to
stigma reduction, with growing experience on how to work
with HCP and communities to reduce anticipated and en-
acted stigma [129]. There is accumulating evidence to sug-
gest that interventions using a combination of sensitization
and participatory activities can reduce HIV stigma in health
care [130,131] and community settings [132,133]. A recent
systematic review identified 48 evaluations in which HIV-
related stigma was assessed as an outcome [134]. While the
studies found that information, skills building, counselling
and PLHIV testimonials were associated with less stigmatiz-
ing attitudes among participants, the evidence base had
many gaps. Training and sensitization of HCP to the needs
of MSM has also been shown in a study in Kenya to reduce
homophobic attitudes up to three months after training
[135]. In addition to stigma reduction interventions, initia-
tives to make PHC more ‘‘adolescent and youth-friendly’’ are
likely to benefit the subset of YKP. Evidence from several
systematic reviews confirms that implementation of a com-
bination of interventions, including training of HCP, outreach
activities and out-of-facility services tailored to context and
target population, demonstrated some impact on uptake
of health services by young people [126], although training
of service providers in adolescent-friendly service provision
alone appears to be less beneficial [128].
Peer approaches are potentially a critical component of
services for YKP, given the particular developmental suscept-
ibility of adolescents to peer influence. Peers are in a unique
position to identify and reach out to YKP who may be
experiencing barriers to health care through lack of knowl-
edge, risk perception or self-efficacy. Evidence from a
systematic review of interventions to improve linkage and
retention in HIV care in low- and middle-income countries
supports integrating formalized care with peer support to
increase the uptake of HIV services, although data on
adolescents are limited [136]. While peer interventions for
YKP have been found to be positively associatedwith increased
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knowledge and condom use in some programmes [13],
they are optimal when included as part of a comprehensive
empowerment approach [137]. There is growing evidence
that empowerment approaches for SW in particular improve
HIV programme outcomes [138]. In addition, empower-
ment approaches are likely to have benefits for other health
challenges, particularly violence. Evidence from programme
assessments show that it is possible to prevent violence
using empowerment approaches, with some interventions
achieving significant effects within programme timeframes
[139]. Integrated services delivered at scale offer a signifi-
cant platform for the delivery of community mobilization
and empowerment interventions. Despite the growing evi-
dence that empowerment approaches produce health bene-
fits, effective implementation of empowerment processes
within many settings, particularly in Africa, has been limited
[140]. Challenges to the sustainability of empowerment
interventions include lack of social cohesion within transient
communities, limited capacity and resources, and variable
commitment of programmers to empowerment interventions.
Given these challenges, and the fact that integrated models
may not sufficiently address the barriers presented by lack
of privacy and accessibility, cost or waiting times, or the need
for access to a range of non-health services, alternativemodels
warrant further exploration.
While there is a precedent for stand-alone models of
service delivery for KP [141], they may not be suitable in
many settings. While these services may be able to provide
KP-sensitive services, they may also increase stigma and
marginalization, and provide targets for attack. An alternative
to stand-alone facilities are out-of-facility-based delivery
strategies. Currently data are limited on the benefits of out-
of-facility-based approaches to health care delivery among
adolescents, although two reviews suggest that services
delivered through mixed-use youth centres are not well-
used or particularly effective for adolescents in the general
population [128]. The authors do note, however, the absence
of studies or evaluations examining outcomes among vulner-
able or marginalized adolescents. Programmatic experience
suggests that drop-in centres provide a valuable opportunity
to offer a range of services specific to the needs of YKP.
For example, as an alternative to integrating adolescent PWID
into programming targeted at adult injectors, who can appear
threatening and model harmful behaviours, Moldovan NGOs
established drop-in centres welcoming adolescents with
overlapping risks, including those living on the street, injecting
drugs or involved in sex work. A case management approach
then linked individuals to a network of health and social
services [142]. Linkage to non-health services is generally
valued by YKP [103,113], and may even encourage retention in
care. Medical and food incentives have been found to increase
retention in care prior to antiretroviral treatment initiation
[136], emphasizing the importance of non-HIV-related service
delivery provision. Other out-of-facility options include the
training of pharmacist to counsel and provide adolescents
with appropriate needle exchange and drug substitution
services [143]. Work place policies have been used with
particularly good effect in sex work establishments in Asia;
however, there is less evidence for how these policies may
benefit YKP [13]. In these cases, strong linkages with child
protection services ensure enforcement of anti-trafficking
laws.While schools are an important venue for the delivery of
health education, they may not be an optimal for the delivery
of services to YKP and should be used to complement, not
replace, health care services for adolescents located outside
schools [126].
Internet-based interventions represent a different type of
out-of-facility service. The rapid expansion of access to the
Internet and social media in the past two decades, even in
low- and middle-income countries, through mobile phone
technology, represents a significant opportunity to engage
with previously hidden populations, or those that are socially
or geographically isolated [144,145]. The Internet provides a
novel way to expand access to standardized information,
to build virtual communities of supportive peers and to
link YKP to services. There is accumulating evidence of the
acceptability of delivering digital-based media interven-
tions to adolescents, KP or YKP in settings in North America
[146148], South America [149], Asia [150,151] and Africa
[152], although there is less evidence on the impact of these
services on longer term health outcomes [153]. A recent
review evaluated the impact of digital-media-based interven-
tions on sexual health knowledge, attitudes and/or beha-
viours of adolescents in the general population aged 1324
[154]. Of the ten studies reviewed, six studies increased
knowledge of HIV, STI or pregnancy. A recent study among
young MSM showed that an Internet-based, peer-led social
media HIV prevention intervention can increase community
cohesion and uptake of HIV services [155]. These and other
evaluations of Internet interventions for YKP show positive
short-term outcomes for health. Given initial findings from
this and other similar programmes, further evaluation is
needed to gauge the potential benefit of these programmes
on health outcomes over a longer period [156].
Hybrid models that combine the reach of services inte-
grated at PHC level with the peer-based, outreach and
empowerment approaches offered by more flexible commu-
nity-based NGOs are probably the optimal model of service
delivery. Ultimately, decisions about service delivery models
need to be informed by user preferences, and they need
to take into account considerations that are context-specific
and address the age-based needs of YKP, as well as respond
to their specific risk behaviours, the epidemic setting and the
social, legal and political complexities associated with service
delivery for this group. To this end, efforts should be focused
on making YKP more visible through research and monitoring,
so that their needs are recognized and prioritized by public
health systems.While the provision of linked non-HIV-specific
services requires significant investment and innovation, sig-
nificant gains in coverage can be achieved with modest
increases in resources [157]. Finally, given the strong influence
of socio-structural factors on adolescent health, coupled
with the fact that many factors that influence YKP’s risk
are outside of their immediate control, interventions that
address the structural barriers to care are a critical part of
an effective HIV response for YKP. In addition to changes in
laws and policies that promote stigma and discrimination,
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specific interventions that address the age of consent are
more essential for this age group.
Conclusions
Despite the dearth of age-specific data, YKP have significant
non-HIV-related health needs, and face significant obstacles
to accessing care as a result of their age and membership
of KP. While YKP face significant hardship and risk, they also
represent the greatest hope for reducing the harms associated
with their behaviours, and preventing new HIV infections.
Now that normative guidance exists for the optimal set of
interventions for KP, priority needs to be placed on evaluat-
ing optimal approaches for the delivery of a comprehensive
package of care of YKP. Investments in providing linked, non-
HIV but related services that also address critical enablers
of programmes are likely to have significant benefits for HIV
prevention across all populations.
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Abstract
Introduction: The 50% increase in HIV-related deaths in youth and adolescents (aged 1024) from 2005 to 2012 highlights the
need to improve HIV treatment and care in this population, including treatment adherence and retention. Youth and adolescents
from key populations or young key populations (YKP) in particular are highly stigmatized and may face additional barrier(s) in
adhering to HIV treatment and services. We reviewed the current knowledge on treatment adherence and retention in HIV care
among YKP to identify gaps in the literature and suggest future directions to improve HIV care for YKP.
Methods: We conducted a comprehensive literature search for YKP and their adherence to antiretroviral therapy (ART) and
retention in HIV care on PsycInfo (Ovid), PubMed and Google Scholar using combinations of the keywords HIV/AIDS, ART,
adolescents, young adults, adherence (or compliance), retention, men who have sex with men, transgender, injection drug users,
people who inject drugs and prisoners. We included empirical studies on key populations defined by WHO; included the terms
youth and adolescents and/or aged between 10 and 24; examined adherence to or retention in HIV care; and published in
English-language journals. All articles were coded using NVivo.
Results and discussion: The systematic search yielded 10 articles on YKP and 16 articles on behaviourally infected youth and
adolescents from 1999 to 2014. We found no studies reporting on youth and adolescents identified as sex workers, transgender
people and prisoners. From existing literature, adherence to ART was reported to be influenced by age, access to healthcare, the
burden of multiple vulnerabilities, policy involving risk behaviours and mental health. A combination of two or more of these
factors negatively impacted adherence to ART among YKP. Collectively, these studies demonstrated that future programmes
need to be tailored specifically to YKP to ensure adherence.
Conclusions: There is an urgent need for more systematic research in YKP. Current limited evidence suggests that healthcare
delivery should be tailored to the unique needs of YKP. Thus, research on YKP could be used to inform future interventions to
improve access to treatment and management of co-morbidities related to HIV, to ease the transition from paediatric to adult
care and to increase uptake of secondary prevention methods.
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Introduction
According to WHO, youth and adolescents have become
increasingly vulnerable to HIV infection [1]. In 2012, it was
estimated that of the 35.3 million people living with HIV
(PLHIV) globally, 5 million were aged 1024. In the same year,
over a third of new HIV-positive cases occurred among these
age groups. During 20052012, while the global number of
HIV-related deaths fell by 30%, the corresponding number
among youth and adolescents increased by 50% [1]. The factors
contributing to the higher mortality among HIV-positive youth
and adolescents were the lack of awareness of sero-status
[24], poor linkages between testing and treatment services
[5], difficulty in retention in care [6] and lack of adherence to
antiretroviral therapy (ART) regimes [7,8].
Youth and adolescents living with HIV can be broadly cate-
gorized into two groups according to routes of transmission:
(1) infection at birth, that is, perinatally infected youth and
adolescents (PIY), and (2) acquired by high-risk behaviours
through injecting drug use and/or having condomless sex,
that is, behaviourally infected youth and adolescents (BIY).
It is important to note that adolescence can act as a transi-
tional phase towards adulthood in which drug use and sexual
experimentation are initiated, thus increasing the risk of con-
tracting HIV [9,10]. For example, a national survey of high
school students in the United States highlighted that
40.9% of adolescents had not used a condom in their last
sexual encounter [11].
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The WHO guidelines on testing and treatment of youth
and adolescents aged 1024 has identified men who have
sex with men (MSM), transgender persons, people who inject
drugs (PWID), sex workers and prisoners as young key popu-
lations (YKP). The term YKP recognizes that people belonging
to these groups are at heightened risk of contracting HIV
due to specific behaviours and social and legal environments
which curtail their ability to protect themselves [7,12].
Currently little is known about how YKP engage with
healthcare services while managing dual stigmas related to
their HIV status as well as belonging to a marginalized section
of the population. In order to understand these issues, it is
useful to learn from the broader literature on youth and
adolescents living with HIV in general. Research on PIY found
a unique set of individual and environmental-level barriers to
adherence and retention in HIV-related healthcare services.
On the individual level, psychosocial barriers, such as depres-
sion and anxiety, have consistently been found to have an
adverse effect on adherence of PIY to ART [1315]. A cohort
study of perinatally infected children and adolescents on ART
in the United States found that depression or anxiety was
predictive of non-adherence [16]. Meanwhile, on the envir-
onmental level, stigma [14], social or familial support [17] and
socioeconomic status [15] can impact usage of healthcare
services by youth and adolescents. People belonging to YKP
can be stigmatized for their engagement in risk behaviours.
Some HIV-positive YKP may, as a consequence, experience
heightened socioeconomic and cultural barriers to accessing
services owing to the fact that their already stigmatized status
leaves them with few social or financial resources [9].
Previous reviews on adherence and retention in care in
youth and adolescents have mostly focused on those who
contracted HIV perinatally [13,18]. Although these reviews
provide useful guidance on what types of individual and
environmental-level barriers may affect HIV-positive YKP,
individuals belonging to this group may have a slightly dif-
ferent set of needs to those who contracted it perinatally.
For example, YKP who contracted HIV through injecting drug
use could be in need of methadone treatment in addition
to ART [19]. This literature review thus identified previous
research on adherence to ART and retention in HIV-related
care in YKP, discussed the current knowledge of individual
and environmental-level barriers and facilitators to usage of
healthcare services among these individuals, and suggested
future directions in research to fill the gaps of knowledge and
services in order to improve adherence to and retention in
HIV care in these vulnerable populations.
Methods
A comprehensive search for adherence to ART and retention
in HIV care in YKP was conducted on PsycInfo (Ovid), PubMed
and Google Scholar using combinations of the keywords
HIV/AIDS, antiretroviral therapy, adolescents, young adults,
adherence (or compliance), retention, MSM, transgender,
injection drug users, PWID and prisoners. In addition, biblio-
graphies of relevant articles were reviewed for supplementary
studies. The inclusion criteria of the current review are
empirical studies that (1) included key populations defined
byWHO; (2) included the terms youth and adolescents or aged
between 10 and 24; (3) examined adherence to or retention
in HIV care; and (4) published in English-language journals.
There were studies on adherence to and retention in HIV
care among participants with wide age range but data were
not disaggregated by age and therefore findings could not
be inferred on the younger age group (1024 years). These
studies were excluded from the review. All articles were coded
using NVivo. The systematic search yielded 26 articles dating
from 1999 to 2014.
Results and discussions
Our literature search yielded 26 studies overall, 20 of
which were conducted in the United States (Table 1). Sixteen
of these studies examined the adherence behaviours of
BIY, where HIV was acquired through sexual risk behaviour
or injecting drug use [2031,33,34,39,42,43]. Seven other
studies focused specifically on the treatment needs of HIV-
positive young MSM (YMSM) belonging to ethnic minorities
[32,3638,40,41,44]. Finally, only two studies specifically
assessed the adherence of young HIV-positive PWID [19,35].
Belzer et al. [42] focused on both BIY in general and
YMSM.
Research that specifically focused on adherence to ART
regimes in HIV-positive youth and adolescents was relatively
sparse because many clinical studies on treatment classified
children and young adults into the age groups of around
014 and 1524 [45,46], which overlaps the WHO definition
of youth and adolescent of 1024 years. These studies may
fail to uncover factors affecting adherence which would be
unique to HIV-positive adolescents (age 1018) and young
adults (age 1924), simply due to different age categoriza-
tion. There was even more of a dearth of literature on YKP,
partly because it is more challenging to recruit HIV-positive
young sexual minorities, sex workers, PWID and prisoners
into research studies.
The literature search, thus, revealed that current knowl-
edge on adherence to ART and retention in care in YKP was
limited as research was heavily concentrated in the United
States and focused on key populations which are of concern
to that particular setting, including YMSM of ethnic mino-
rities. To the best of our knowledge, there were no peer-
reviewed articles that focused specifically on the treatment
needs of young female sex workers, transgender youth and
adolescents, and young offenders. There were, consequently,
glaring gaps in the literature, as there appeared to be little
to no research on adherence in YKP in developing countries,
where most PLHIV live [46]. Furthermore, we were unable to
find any studies that explored possible gender determinants
of ART adherence, although 16 studies from the 26 studies
reviewed here did involve female subjects.
The following section categorizes studies according to BIY in
general and the different categories of YKP as per WHO classi-
fications. We focus on individual and environmental factors
related to adherence to ART and retention in care which
were deemed as unique to each group. The final section of
the results explores studies of interventions addressing the
treatment needs of YKP.
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retention in HIV care Method Intervention Main findings
Belzer et al.
1999 [20]
Los Angeles, USA BIY 1524 31 Self-reported
adherence
Quantitative (survey) No  Medication adherence
most significantly
correlates with stability of





BIY 1321 25 Self-reported
adherence
Quantitative (retrospective
analysis of medical charts)
No  61% of subjects reported
90% compliance with
their medications in the
previous 90 days.





















USA BIY N/Aa 288 Viral load and CD4
count
Quantitative (evaluation) Yes  Only 18 of 288
participants received full
TREAT programme, which




13 cities in USA BIY 1219 114 Self-reported
adherence and viral
load (HIV-1 RNA level
in plasma)




 Only 28.3% of
adolescents reported




















































































































retention in HIV care Method Intervention Main findings
Flynn et al. 2004
[25]
28 sites in the US
and Puerto Rico in
USA
BIY 822 120 Self-reported
adherence and viral
load












Quantitative (survey) No  Adolescents in the later
HIV disease stage were
less likely to be adherent
compared with those in
the earlier disease stage.
 Less alcohol use and
being in school were
associated with
adherence by adolescents








Yes  Most participants found
the calls to be helpful and
the level of intrusion into
their daily lives acceptable.
 Using cell phone reminders
to assist patients does not
require an extensive
amount of daily staff time.
Naar-King et al.
2006 [28]































































































































retention in HIV care Method Intervention Main findings
Rao et al.
2007 [29]
Chicago, USA BIY 1725 25 Self-reported
adherence
Qualitative No  Half of respondents
indicated that they
skipped doses because
they feared family or
friends would discover
their status, suggesting
that HIV stigma impacts
treatment for youth on







































1624 60 Routine pharmacy pill
count and self-
reported. CD4 and VL.
Quantitative (survey) No  The first study to measure
adherence measurement































































































































1624 224 Retention defined as
programme visits
every three months
Quantitative (cohort study) No  Retention associated with
B21 years old, history of
depression, receipt of
programme services,
feeling respected at clinic.
Comulada et al.
2003 [33]






Quantitative (survey) No  Almost all youth had been
offered ART (84%); 77%
had ever used it, 54%
were currently using and
63% of users adhered to
90% of their medications.
 Compared to non-users,
users were more likely to
be female, Latino or AA.
Agwu et al.
2011 [34]





No  Youth PLHIV less likely to
report injecting drug use
behaviour.
































Quantitative (cohort study) No  Young adults (age B29)
were less adherent and


















































































































retention in HIV care Method Intervention Main findings
Wohl et al.
2011 [36]
Los Angeles, USA AA and
Latino
YMSM






Yes  Highlights the critical
needs of HIV-positive AA
and Latino YMSM and
demonstrate that a clinic-












Mean age 21 81 Retention defined as
1 medical visit every
four months
Quantitative (cohort study) Yes  Interventions on
adherence need to








Quantitative (RCT) Yes  Supportive relationships






BIY, PIY 1321 166 Assessed HIV
knowledge





Houston, USA AA YMSM Mean 19.9 47 Retention in care
defined as completion
of physician visits 90
days after linkage to
care
Quantitative (survey) No  Greater conspiracy beliefs
were associated with
negative medication



















Quantitative (survey) No  Ethnic identity affirmation
and HIV-positive identity
were associated with

















































































































retention in HIV care Method Intervention Main findings
missed appointments in
the past three months.







BIY, YMSM 1524 37 Self-reported
adherence
(dichotomized at
90%), viral load data
abstracted from
medical record




was significantly higher in
intervention group than
in the control group.
Saberi et al. 2014
[43]
USA BIY, PIY 1224 1317 Self-reported





Quantitative No  Pillbox was the most
endorsed adherence
device.




 BIY more likely to be gay,
adherent to ART and
never been to jail.
Hussen et al. 2014
[44]
Atlanta, USA YMSM 1324 20 Self-reported
adherence




 Detrimental impact of HIV
on development was
moderated by the degree
of physical illness at
diagnosis.
aOnly specify participants as from REACH project; bthese two studies were conducted on the same cohort. AAAfrican American; ARTantiretroviral therapy; BIYbehaviourally infected youth and
adolescents including sexual behaviour and injecting drug use; HAARThighly active antiretroviral therapy; HIVhuman immunodeficiency virus; PIYperinatally infected youth and adolescents;
RCTrandomized control trial; REACHReaching for Excellence in Adolescents Care and Health; TGtransgender; TREATTherapeutic Regimens Enhancing Adherence in Teens; YCMyouth-focused





































































































Research on ART adherence among BIY did not focus on
one particular key population, which resulted in some studies
not differentiating participants according to their route of
transmission and risk groups. Nonetheless, these studies do
provide a useful overview of types of factors which may
affect retention in care in YKP and how their adherence
behaviours may differ from those of PIY.
Nine studies on BIY which included young people who
inject drugs (YPWID) recruited participants from the Reaching
for Excellence in Adolescent Care and Health (REACH) pro-
ject [2226,30,34,42,43]. REACH was originally designed as
an observational study of HIV-positive patients attending
‘‘adolescent-specific medical care centres’’ in the United
States [22]. Participants between the ages of 12 and 18 who
contracted HIV through high-risk behaviours, such as con-
domless sexual contact or injecting drug use, were intention-
ally sampled in order to compare their behaviours to that of
HIV-negative adolescents who engaged in similar behaviours
and PIY. These studies found that risky sexual behaviours or
injecting drug use, self-efficacy and positive mental health
outcomes were associated with greater ART adherence.
Studies sampling from REACH suggested that adherence to
ART in YKP were affected by a combination of individual and
environmental-level barriers. At the individual level, younger
age and history of depression were significantly associated
with failure to adhere to complex medical regimes [26]. At
the environmental level, unstable housing conditions [30] and
lack of attendance at school acted as barriers to adherence
[34]. Although there was no association between the owner-
ship of medical insurance and initiation of ART, it was found
that the type of medical insurance could influence their usage
of healthcare services [34]. Those who were in receipt of
publicly funded insurance were more likely to discontinue
their treatment than those who had no insurance or private
medical coverage. There was a possibility that ‘‘the small pres-
criptions co-payment that may be associated with publicly
funded insurance programmes . . . may potentially serve as
an impediment to . . . (art) continuation’’, suggesting that
participants with few financial resources may face many more
difficulties in adhering to treatment [34, p. 6].
These studies also indicated that YKP who experienced a
combination of both individual and environmental level
barriers simultaneously may experience heightened difficul-
ties in adhering to treatment. Rudy et al. [30] statistically
tested the impact that the amount and type of barriers
including not having healthcare insurance, having dropped out
of school, homelessness and/or having spent time in deten-
tion facilities), as well as the existence of a mental disorder,
had on adherence. It was found that 73% of participants with
no barriers were adherent in comparison to 62% of those
experiencing one barrier and 40% of those who reported two
or more barriers. Moreover, 69% of respondents who had a
low level of self-efficacy, a mental disorder and experienced
at least one structural barrier were non-adherent.
Some HIV-positive youth and adolescents may attempt
to mitigate the impact of individual and environmental level
barriers on to adherence through actions which are not always
beneficial towards their overall treatment. A focus group study
of HIV-positive BIY on how they managed their HIV diagnosis
found that many participants would conceal their sero-status
from family and friends in order to avoid being stigmatized
[29]. This resulted in half of the respondents skipping doses
due to the fear that others would learn of their condition.
A few studies did, however, demonstrate that BIY were
able to overcome environmental and individual level barriers
in order to be more adherent to ART than their perinatally
infected counterparts [31]. In a multi-clinic survey of HIV-
positive youth and adolescents who were prescribed ART,
Saberi et al. [43] found that full adherence was correlated
with the behavioural route of infection, MSM behaviour,
never being jailed and not using alcohol or illegal drugs]. It is
possible that BIY may have more knowledge and awareness
of their condition [39] than PIY due to the fact that they are
expected to take charge of their treatment in the absence of
family and social networks [17].
Although research on BIY provided a useful overview
on individual and environmental level barriers which could
potentially impact adherence to ART and retention in health-
care in YKP, very few studies distinguished between beha-
vioural routes of transmission among their participants
[26,31,33,34]. This resulted in different groups of YKP with
varying treatment needs, such as YPWID and YMSM, being
included into one category.
The other methodological issue was that many studies
tested respondents’ socio-demographic characteristics against
outcome variables without having a priori theory on how
these factors may impact respondent’s adherence to treat-
ment [21,27,31,34]. Moreover, these studies often failed to
include measurements of factors which could impact adher-
ence and retention in care for youth and adolescents in
general, let alone those belonging to key populations, such as
their transition from child to adult healthcare services [44].
Research on YMSM
Our literature search revealed only seven peer-reviewed
publications yielded from research studies specifically on
YMSM, most of which were conducted in the United States
[32,3638,40,41,44]. Six of these studies employ quantitative
methods [3638,40,41,44], such as randomized control trials
and surveys, to examine factors which could impact adher-
ence to treatment regimes in YMSM, including age, ethnicity
and sexual identity, while one study uses qualitative research
methods [44].
In contrast to studies on treatment behaviours of BIY,
research on African American YMSM was strongly informed
by theories that took into account factors which were
particular to their age, ethnicity and sexual identity. As a
consequence, these studies were able to explore at length
factors which could be unique to this particular YKP. One
study examined respondents’ ‘‘conspiracy beliefs’’ in relation
to HIV, namely the beliefs that the government was involved
in the spread of HIV, had highlighted that many African
Americans held these attitudes [40]. It was found that
participants with greater ‘‘conspiracy beliefs’’ also had
negative attitudes towards medication. None of these
conspiracy beliefs, however, were correlated with CD4 counts
at diagnosis, nor linkage and retention in care in the study,
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which suggested that participants were still willing to use
treatment even if they did not fully trust their doctors.
As these studies incorporated theories and measurements
which were relevant to YMSM, they were able to demon-
strate that this population suffered from intersecting vulner-
abilities due to increased stigma from belonging to three
marginalized populations: ethnic minority, MSM, and HIV-
positive. In a survey on HIV-positive YMSM of African
American and Latino origins from Chicago, participants who
held negative attitudes towards being gay and HIV-positive
and strongly identified as belonging to an ethnic minority
were more likely to miss clinical appointments [41]. These
findings demonstrated the importance of understanding the
development of multiple identities when treating YMSM
from ethnic minorities.
In addition, YMSM belonging to ethnic minorities may
experience environmental level barriers to adherence, such
as poverty. For instance, in an assessment of a youth-focused
case management intervention targeting HIV-positive YMSM
from ethnic minorities, over three quarters of participants
were in urgent neeed of stable housing, nutritional support,
drug rehabilitation and mental health services at baseline
[36]. These barriers to adherence were mitigated through
increased number of intervention visits, more hours in the
intervention and prescription of ART.
Finally, these studies were also able to identitify possible
facilitators to adherence to ART and retention in care. A
qualitative study of experiences of living with HIV and
adherence to ART among African American YMSM found
that their treatment behaviours were influenced by the
developmental goals that they created as part of transition-
ing towards adulthood [44]. Participants who were able to
attain self sufficiency through the development of a positive
gay and HIV-positive identity were better able to adhere to
medication than those who viewed their condition and
sexual orientation in negative terms. These findings indicated
that future interventions may need to tailor care of HIV-
positive YMSM to engage with their developmental needs as
well as their negotiation of multiple identities.
Research on YPWID
The literature search identified only two studies, both came
from a cohort study that investigated adherence behaviours
of YPWID in Canada between 1996 and 2008 [19,35]. These
studies did not focus on the youth and adolescent population
as defined by the WHO; however, they did investigate factors
which could impact ART adherence and retention in care
in this particular group. One of these studies used age
categorization of young adult (1829 years) which did not
fit into the WHO definition (1824 years) [35]. Furthermore,
the study did not disaggregate the data by age group, thus
the results could not be inferred to the 1824 age group.
In the other study, participants who were younger than
25 years, female, and not receiving methadone treatment
displayed a lower likelihood of being adherent to 95% of
medication [19]. These findings suggest that female YPWID
may experience greater barriers to adherence than their
male counterparts, suggesting a gender bias. Further, female
adult PWID were revealed to be harder to identify and
procure healthcare services as they secure drugs from their
abusive male partners [47].
Research on interventions targeted towards YKP
From the 26 articles covered here, only seven intervention
studies either described the latest programmatic develop-
ments or assessed the efficacy of a particular intervention
focusing on adherence to ART and retention in healthcare
services in the United States in YKP [23,27,32,3639,42].Three
of these targeted BIY [27,39,42] with two of these studies
using mobile phone technology to aid and monitor adherence.
The other four intervention studies were conducted on African
American YMSM. A randomized control trial of a cell phone
adherence support intervention was conducted among HIV-
positive BIY in comparison to PIY, where participants were
reminded through daily telephone contact to take their
ART medication [42]. There appeared to be no differences in
adherence behaviours between BIY and PIY. Self-reported
adherence was found to be significantly higher among parti-
cipants belonging to the intervention group than that of the
control. There were also medium to large effect sizes on self-
reported adherence and viral load during the course of the
study. These results indicated that mobile phone technology
could be harnessed to encourage youth and adolescents to
adhere to medications.
The other four studies covered interventions that are de-
signed to improve ART adherence among HIV-positive African
American YMSM [32,3638]. These programmes provided
care which was directed to the unique and complex psycho-
social and physical health needs of this particular YKP. The Los
Angeles County Department of Public Health actively targeted
African American YMSM through community-based out-
reach services which encouraged participants to visit clinics
for counselling and testing [32]. HIV-positive African American
YMSM were referred to a youth-focused case management
intervention. A study team from the Special Projects of
National Significance then assessed these beneficiaries and
found that over the first two years of study, only 11% of
beneficiaries missed appointments for unknown reasons.
Other factors that were associated with retention were feeling
respected by medical staff and being in receipt of programme
services. These findings suggested that the ‘‘youth centred’’
nature of these programmes may increase retention in
treatment as YMSM feel respected and are given access to
other services which catered to their psychosocial needs.
A few interventions that focused on treatment of HIV-
positive YMSM tried to increase retention in healthcare
services through developing and nurturing social and medical
networks which could assist YMSM in overcoming individual
and environmental level barriers to attending facilities [37,38].
For instance, Project nGage attempted to harness existing
social support networks of HIV-positive YMSM to identify
‘‘support confidants’’ who provided beneficiaries with psy-
chosocial assistance [38]. In addition, the Strength Through
Youth Livin’ Empowered intervention used social marketing
campaigns to target the social and sexual networks of
potential peer leaders, which were later cultivated to provide
the basis of a medical support network for those who had
been newly diagnosed as HIV-positive [37]. Over a three-year
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period, 81 men were diagnosed or re-engaged in healthcare
services and the odds of patients attending clinic visits
increased two fold.
In summary, there have been programmes which have
attempted to cater to the unique needs of this population
using innovative methods, such as mobile phone technology.
Magnus et al. [32] collected data from eight clinics across the
United States to assess such programmes, and demonstrated
that it was possible to refine existing youth-centred pro-
grammes to increase retention in care in YKP through the
development of networks of providers, peer support groups
and community-based services. Unfortunately, many of these
studies reported the findings of small-scale pilot interven-
tions which often had small sample sizes and were under-
powered, hence limiting the generalizability of the results to
the wider population of YKP [36,42]. For example, in Puccio
et al. [27], the evaluation of an intervention using mobile
phone technology had a sample of only eight participants.
Conclusions
As the paradigm of HIV prevention has shifted to treatment-
as-prevention strategies, it is necessary to identify factors that
promote adherence to and retention in care to antiretroviral
regimens among HIV-positive youth and adolescents [13].
Our literature search identified only a handful of studies on
adherence to and retention in ART among YKP; seven of them
on YMSM and two on YPWID. We expanded the review
to include 16 studies on BIY; some of these studies did not
specify risk behaviours thus we cannot be confident as
to whether these studies have included YKP. Nonetheless,
studies on BIY do provide a useful overview of types of factors
which may affect retention in care in YKP and how their
adherence behaviours may differ from those of PIY.
Most studies focused on YKP that are relevant to the
HIV epidemic in the United States and Canada, which were
BIY, YMSM belonging to ethnic minorities and YPWID. We
were unable to find any research on certain groups of YKP
identified by the WHO, including female sex workers and
transgendered youth; although, it has been reported that
these populations are more susceptible to HIV infection due
to sexual exploitation, poverty, violence and stigma [9,48], all
of which have the potential to impede their access to HIV
services should they contract HIV.
Research on BIY and YKP highlighted that they suffered
from a combination of individual- and environmental-level
barriers to adherence, as a result of intersecting vulnerabil-
ities owing to the fact that they experience from multiple
forms of oppression. In many studies, the bulk of respondents
belonged to ethnic minorities who have been historically
marginalized in a Western context, were sometimes isolated
from their social and familial networks and experienced bouts
of imprisonment and housing instability. It was noted by
researchers that respondents’ adherence to medication was
found not necessarily to be affected by the existence of
barriers but rather by the intensity and nature of these
barriers. It was found in a few studies that respondents who
took recreational drugs, experienced depression and were
unable to afford private medical insurance were less adherent
than those who did not report these barriers [19,26,34,35].
A recent study demonstrated that YKP were able to
overcome these barriers and in some cases display higher
rates of adherence to ART than their perinatally infected
counterparts [18]. The results of these studies broke down
common stereotypes associated with YKP by demonstrating
that many adopted a responsible stance towards their treat-
ment as they had few social or familial networks to rely on.
This finding also suggested some YKP demonstrated strength
and resilience in coping with challenges in engaging in HIV
medical care.
In contrast, there exist a worrying paucity of research on
adherence in YKP in developing countries as their health
behaviours can vary by area. A systematic meta-analysis of
studies mostly assessing adherence to ART in PIY illustrated
that respondents living in Asian (84%, 95% CI 7791) and
African (84%, 95% CI 7989) countries displayed higher rates
of adherence than those located in North America (53%, 95%
CI 4659) [18]. As none of the studies conducted in Africa
or Asia recorded the route of transmission or specifically
targeted YKP, it was difficult to know if there was a unique set
of factors influencing their adherence to treatment.
Taking all these findings together, we conclude that among
YKP, individual and environmental factors including access
to psychosocial support, experience of stigma, access to
social and behavioural support, and socioeconomic status are
important determinants to adherence behaviours. Existing
intervention studies suggest that mobile phone technology,
social marketing and support for social network may improve
adherence among YKP, particularly YMSM. More research
on young female sex workers, young transgenders and young
offenders is urgently needed. While these populations are
hidden and difficult to access, research studies in the United
States and Canada demonstrate that accessing these popu-
lations is possible through developing research networks
between academic institutions and clinics that provide ser-
vices to these populations. The contexts in which other YKP
seeking treatment and engaging in HIV care continuum
are likely to be different and each YKP will require culturally
tailored interventions to promote retention in and adherence
to ART.
Structural factors such as added stigma and discrimination,
marginalization, lack of social and family support, and poverty
would most likely be barriers that impede YKP from continu-
ing HIV care and treatment. Policy guidelines thus must
undergo a paradigm shift to focus specifically on YKP and their
unique needs as opposed to their adult counterparts.
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Abstract
Introduction: The patterning of the HIV epidemic within young key populations (YKPs) highlights disproportionate burden by
mental disorders in these populations. The mental wellbeing of YKPs is closely associated with biological predispositions and
psychosocial factors related to YKPs’ sexual and gender identities and socio-economic status. The purpose of this paper is to high-
light sources of risk and resilience, as well as identify treatment and supports for mental health disorders (MHDs) among YKPs.
Discussion: This paper utilizes Bronfenbrenner’s Bioecological Systems Theory and the Social Stress Model to explore the risk
and protective factors for MHDs across YKPs’ ecological systems, and identify current gaps in treatment and support for MHDs
among these youth. We emphasize the fluidity and intersections across these categorizations which reinforce the vulnerability
of these populations, the lack of concrete data to inform mental health interventions among YKPs, and the need to ground YKP
interventions and programmes with human rights principles stipulated in the convention on the rights of a child.
Conclusions: We put forth recommendations for future research and strategies to address the mental wellbeing of YKPs,
including the need for integrated interventions that address the multiplicity of risk factors inherent in the multiple group
membership, rather than single-focus interventions whilst addressing the unique needs or challenges of YKPs.
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Introduction
HIV infection disproportionately affects youth [13], and
the patterning of the HIV epidemic within young key popu-
lations (YKPs) underscores the role of mental health disorders
(MHDs) in structuring vulnerability of these populations to
HIV. For the purposes of this article, YKPs will be defined as
sexual minority youth (including gay, bisexual, and lesbian
youth and young men who have sex with men regardless
of their sexual orientation identity); gender minority youth
(specifically transgender and gender non-conforming youth);
youth who inject drugs; youth involved in sex work; runaway
and homeless youth; and detained or incarcerated youth.
MHDs may increase YKPs’ vulnerability to HIV, and/or
alter the course of infection among those already living with
HIV [46]. Among YKPs, MHDs have been linked to HIV risk
behaviours such as early sexual debut, high numbers of sexual
partners, low condom use, transactional sex, needle sharing,
and drug/alcohol use [413]; lower uptake, adherence to,
and retention in HIV care [14,15]; and increased risk of AIDS
mortality [16]. Moreover, HIV infection also increases the risk
of MHDs among YKPs [17,18].
Epidemiology of MHDs among YKPs
Although adolescence and emerging adulthood is a time of
relative positive physical health as measured by traditional
indicators such as rates of mortality, chronic disease burden
and hospitalizations, it is also a peak time for develop-
ing MHDs [1921] and health-related challenges stemming
from participation in high risk behaviours [22,23]. Studies
have consistently reported higher rates of MHDs such
as major depression, anxiety, conduct disorder, attention-
deficit/hyperactivity disorder (ADHD), substance use disorder,
alcohol dependence and abuse, suicide, and post-traumatic
stress disorder (PTSD) among sexual minority youth [2428],
gender minority youth [25,27,29,30], youth who inject drugs
[20,31], detained or incarcerated youth [3236], runaway
and homeless youth [3739] and youth involved in sex
work [4042], relative to comparable youth populations. It is
important to note that the higher rates of MHDs among
YKPs are not due to any inherent dysfunction within these
youth, but are closely associated with their membership in
socially stigmatized minority groups that experience exces-
sive stress in the form of prejudice-related stressful life
events, discrimination, rejection and violence [4345].
Sexual minority adult populations have a two-fold excess
in suicide attempts, and rates of depression, anxiety and
substance use disorders are almost twice as high among sexual
minorities compared to heterosexual populations [28]. Among
sexual minority youth, a review of MHDs found that one third
of participants met the criteria for any MHD including 17%
for conduct disorder, 15% for major depression and 9% for
PTSD [25]. Studies have reported even higher rates of MHDs
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among gender minority youth relative to comparable youth
populations. A cross-sectional study of 515 gender minority
persons found that 60% of participants were depressed;
the prevalence of attempted suicide in this sample was 32%
[29]. A cross-sectional study of 55 transgender youth found
that 45% of participants had seriously considered suicide
and 26% had attempted suicide [46], while another study of
571 male-to-female transgender persons in New York found
that the lifetime prevalence of major depression among youth
in this study was 54.7% [47].
More than two thirds of runaway and homeless youth
meet the criteria for two or more MHDs including depres-
sion, conduct disorders, ADHD and PTSD [4852]. Rates of
attempted suicide among runaway and homeless youth who
self-identify as sexual minorities range between 2 and 42%
[26]. Detained or incarcerated youth are 10 times more likely
to suffer from psychosis and depression compared to youth
in the general population [32]. A nationwide review of 57
juvenile justice agencies (N9, 819) found that 51.9% of
youth met the criteria for a MHD; one third met the criteria
for more than one disorder and about a quarter met the
criteria for multiple clusters disorders. In this study, 20.4%
reported anxiety, 27% reported disruptive behaviour disorder,
14% reported lifetime suicide attempts and 7.9% reported
affective disorders [53]. Data on the mental health of youth
involved in sex work are rare, but a study in Goa, India, found
that 41.5% of female sex workers under 20 years of age had
attempted suicide in the past three months [40]. Rates of
physical and sexual violence among youth involved in sex
work are high, ranging between 18 and 67% [54,55].
Current data point to sex/gender differences in prevalence
of MHDs among YKPs. Gay/bisexual male youth have higher
rates of panic and depression disorders, while lesbian/bisexual
female youth have higher rates of substance abuse [56].
A study of sexual and gender minority youth found that
transgender youth had a lower prevalence of all MHDs com-
pared to gay/bisexual youth [25]. Among runaway and
homeless youth, rates of drug abuse among were 10 times
higher among male youth and 17 times higher among female
youth as compared to youth in a nationally representative
sample, and alcohol abuse was significantly higher among
male youth [52]. Almost twice as many female runaway and
homeless youth (25%) had attempted suicide at least once
compared to male runaway and homeless youth (14%) [26].
Among detained or incarcerated youth, rates of major de-
pression were twice as high among female youth compared to
male youth (29% vs. 10.6%), while young men reported higher
rates of psychotic illness (3.3% vs. 2.7%) [32]. These sex/
gender differences underscore the diversity in experiences
and needs within specific YKPs, which may have significant
implications for intervention development. However, more
studies are needed to elaborate on these differences.
Cross-cutting issues
The needs and challenges of YKPs vary with their age, sex,
race/ethnicity, gender identity, sexual identity, socio-economic
status and geographic region. However, YKPs also share a host
of socio-ecological experiences, broadly engendered by their
sexual orientation and gender identities, which confer selec-
tive risks and vulnerabilities for MHDs and HIV. The categor-
izations of YKPs are not mutually exclusive (see Figure 1):
there is high fluidity and intersections across these categories
[57,58]. For example, approximately 3045% of clients served
in homeless youth services are sexual minority youth [59];
compared to heterosexual female youth, lesbian and bisexual
youth are over-represented among detained or incarcerated
Figure 1. Intersection of group membership and identities among young key populations.
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youth [60,61]; homelessness is associated with greater risks
for substance abuse [62]; and runaway and homeless youth
who also self-identify as gay are more likely to report being
tested or treated for HIV compared to bisexual or heterosexual
youth [58,63] and are also more likely to engage in substance
and alcohol abuse [64].
This intersectionality of oppressed identities and multiple
memberships among YKP categories that experience social
marginalization may increase the presence of MHDs. This is
supported by the syndemic production theory, which posits
that for some marginalized groups (e.g. sexual minority
youth), there is a syndemic process of interacting physical
and psychosocial challenges (e.g. HIV, substance use, depres-
sion, violence) that cause poor health outcomes within
these populations [65,66]. For this reason, we emphasize
the importance of developing interventions that address the
intersectionality of social and cultural identities possessed
by YKPs and the multiplicity of risk and resilience factors that




This paper utilizes two theoretical frameworks based on
diathesis-stress models, to situate the epidemiology of MHDs
among YKPs: Bronfenbrenner’s Bioecological Systems Theory
(BST) [67,68], and the Social Stress Model (SST) [6971].
Generally, diathesis-stress models assert that all people have
some level of pre-disposing risk factors (biological diathesis)
for any given MHD, and that stress activates a diathesis,
transforming the potential pre-disposition into an MHD
[7274]. BST is useful in understanding the linkages between
biological factors and psychosocial factors in the development
of MHDs among YKPs [69,70]. It proposes that an individual
is continually impacted by four successive and interconnected
levels of influence (i.e. microsystem, mesosystem, exosystem
and macrosystem) over their life course; the biological
diatheses and ecological stressors may act directly or syner-
gistically to increase an individual’s risk for MHDs. SST posits
that one’s disadvantaged position in the social hierarchy
leads to more stressful conditions and fewer resources to
counteract these stressors, resulting in greater rates of MHDs.
The microsystem comprises the complex relations between
the developing person and the environments in the immedi-
ate settings containing the person. The mesosystem is a set
of microsystems constituting an individual’s developmental
niche within a given period of development; mesosystems
are more challenging to quantify and represent the assump-
tion that microsystems do not function independently. The
exosystem is composed of contexts that do not directly involve
the developing person but have an influence on the person’s
behaviour and development. The macrosystem is the super
ordinate ecological level of human development, involving
culture, macro-institutions and public policy [75].
BST also provides a useful theoretical framework for
understanding nested ecological system factors that influence
the mental health and HIV risk/protective behaviours of
YKPs, and the reciprocal relationships between youth and
their environments. Both the BST and SST enable examination
of youth within their social contexts, thereby allowing iden-
tification of contextually relevant cultural and developmental
risk and protective factors.
Figure 2 illustrates the adaptation of the SST to MHDs
among YKPs. We argue that MHDs among YKPs result from
their disadvantaged positions in the social hierarchy within
their ecological systems, and this positioning is closely linked
to their sexual orientation identity, gender identity and/or
socio-economic status [76,77]. Consistent with our diathesis-
stress framework, we argue that biological predispositions
and ecological stressors may act independently, additively
or synergistically to create MHDs and maladaptive HIV risk
behaviours, and these pathways may be moderated by
resilience factors [78]. This model highlights the reciprocal
relationship between maladaptive behaviours and MHDs,
which is also moderated by resilience factors.
Risk factors
Microsystem factors could be sub-divided into intrapersonal
and interpersonal factors. Intrapersonal factors include
biological or cognitive factors that contribute toward certain
abnormal states or conditions including genetic factors,
inherited traits, neurological anomalies and patterns of
psycho-physiological stress responses [73,74,79]. HIV may
affect central nervous system structures involved in the
regulation of emotion and behaviour, thereby increasing
youth’s risk of MHDs [80,81]. Additionally, normative devel-
opmental processes such as identity development and in-
creased propensity for risk-taking, psychosocial distress
manifested by self-esteem, poor self-image, hopelessness,
helplessness and internalized homophobia may increase
MHDs and HIV risk behaviours among YKPs [45,8286].
Adolescence is a peak time for traumatic injuries, which, in
turn, increase the risk of MHDs and HIV risk behaviours among
youth [87,88]. MHDs such as depression, conduct disorder
and PTSD and related dimensions of behaviour including
coping strategies have been linked to diatheses such as
genetic factors, depressogenic cognitive structures, traumatic
brain injury and ecological stressors [72,73,8789].
Interpersonal factors include experiences of victimization,
family conflict, family/peer rejection, social isolation, poverty
and housing instability [24,42,45,9098]. Studies have found
high rates of childhood maltreatment (physical and sexual
abuse) among youth involved in sex work and runaway
and homeless youth [99102]. Childhood maltreatment,
especially childhood sexual abuse, has been associated with
alcohol use, delinquency and sexual risk behaviour [103106]
and MHDs such as depression and PTSD [107109]. The
pathways through which childhood physical and sexual abuse
result in MHDs and HIV risk behaviours are not clearly
elucidated but several authors hypothesize that these traumas
could influence the development of maladaptive coping skills,
maladaptive social information processing, and feelings of
hopelessness, vulnerability and loneliness [110,111], leading
to MHDs and HIV risk behaviours.
Exosystem factors include school and neighbourhood
safety, neighbourhood poverty, stereotypes and representa-
tion of YKPs in communities, absence of caring adults, negative
experiences with service providers, dearth of trained mental
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health providers, and geographical and financial barriers to
accessing comprehensive and sensitive mental health services
[85,112116]. Exposure to violence, including war and civil
strife, contributes significantly to MHDs, especially among
youth in low-income countries [117,118]. The macrosystem
factors include stigma, discrimination, social and economic
marginalization, criminalizing or disenfranchising public poli-
cies, and cost of health care services.
All of these systems of influence act individually or
synergistically to heighten YKPs’ risk for MHDs and HIV risk
behaviours [42,45,112,119122]. Different types of stressors
(acute or chronic) may play different roles in the aetiology of
MHDs and HIV risk behaviours. However, within the current
research, there is a lack of theoretical attention to the nature
and quality of the stressors, and the complex interactions
through which biological diatheses and ecological factors
influence the development of MHDs among YKPs.
Resilience factors
Despite the host of powerful negative forces, not all YKPs
have MHDs or engage in HIV risk behaviours. Many have
multiple resilience factors  personal traits or characteristics
of their social environment that protect young people from
harm and reduce the likelihood of MHDs among vulnerable
youth [123125]. Intrapersonal resilience factors include high
self-esteem, positive self-image, positive coping strategies,
spirituality/religiosity, hopefulness, positive future expecta-
tions and participation in support or advocacy networks
[85,90,98,123,126,127]. Interpersonal factors such as family
and peers play an important role in youth development.
Social support is generally hypothesized to be a protective
factor that buffers individuals against the potential negative
consequences of stressful events [128]. However, social
support from family and peers may have differential effects
for YKPs, including positive effects [129133] or no effects
at all [91,96,134]. For example, parental support may be
more predictive of future MHDs than peer support [135,136].
Family connectedness and positive family acceptance have
also been associated with positive mental health outcomes,
particularly for sexual and gender minority youth who are
grappling with issues of sexual orientation and gender
identity [64,85,93,137140]. Strong peer group affiliations
may enhance risky health behaviours such as substance
abuse and survival sex among runaway and homeless youth
[141143].
Exosystem factors include the availability of support from
caring adults including teachers, case managers, programme
facilitators and health providers; access to comprehensive
youth-friendly social services with trained providers; non-
discriminatory and anti-bullying policies in schools, homeless
Figure 2. A framework using the Social Stress Theory to depict evolution of mental disorders among young key populations.
Mutumba M and Harper GW. Journal of the International AIDS Society 2015, 18(Suppl 1):19429
http://www.jiasociety.org/index.php/jias/article/view/19429 | http://dx.doi.org/10.7448/IAS.18.2.19429
57
shelters and detention facilities; and child protection policies.
These factors prevent MHDs, increase access to and utiliza-
tion of health services, and promote YKPs’ ability to desist
HIV risk behaviours [63,85,112,122,127,129,144]. Within the
exosystem, organizations such as schools, churches, youth
centres and health facilities are well positioned to provide
safe environments and prevent MHDs among YKPs. For
example, health providers could prepare youth and their
families for changes related to pubertal development, under-
stand and accept the gender and sexual identity of their
children, provide parents/guardians with the skills needed
to fully support YKPs and facilitate family re-integration
(when appropriate). Schools, detentions centres, homeless
shelters and foster homes can institute policies to prevent
victimization of YKPs in these environments and advocate
for the rights of YKPs. However, the success of these preven-
tive actions requires providers who are knowledgeable and
sensitive to the specific needs of YKPs.
Programmes and interventions
Interventions to prevent or improve MHDs and HIV risk
behaviours among YKPs are critical to addressing the HIV
epidemic among youth. MHDs among youth are addressed
through treatment with pharmacological agents or psychoso-
cial interventions [145]. Current treatment guidelines discou-
rage use of pharmacotherapy among children and adolescents
[146]; rather pharmacological agents should only be pre-
scribed if psychosocial interventions prove ineffective. How-
ever, compared to adults, the evidence base for management
of MHDs and HIV risk behaviours among youth is less
established. For example, depression and PTSD are some
of the most common MHDs among YKPs [147], but evidence
for the effectiveness of medications for treatment of these
MHDs among adolescents remains elusive [146,148,149].
Globally, there is a paucity of programmes addressing
MHDs and HIV risk among YKPs, and even fewer of these pro-
grammes exist in low- and middle-income countries [150].
Psychosocial interventions for management of MHDs among
YKPs include interpersonal psychotherapy, cognitive beha-
vioural therapy, behavioural therapy, psychodynamic therapy,
structured physical activity programmes, relaxation training,
problem-solving therapy and motivational interviewing.With-
in the adult literature, there is an extensive body of knowledge
on the effectiveness of these psychosocial interventions
[151] but even so, understanding the exact mechanisms by
which these interventions achieve their effects and consensus
over the relative effectiveness of different psychosocial
therapies is lacking [145,152,153].
There is a paucity of interventions to prevent MHDs among
YKPs. Universal and targeted prevention programmes have
been developed to address alcohol and substance use and
HIV risk behaviours among YKPs [154156], but results
from systematic reviews of these interventions indicate
that the majority do not obtain significantly better mental
health outcomes compared to controls [150], and reduc-
tions in HIV risk behaviours, if realized, are often short-lived
[150,154,157160]. These findings suggest a need to re-
consider strategies for engaging and promoting sustainability
of behavioural gains among YKPs.
The persistent fragmentation of services, often with single-
focus programmes targeting specific YKPs or MHDs, disregards
the co-occurrence of MHDs among YKPs [161] and multiplicity
of needs across these intersecting populations, thus limiting
the efficacy of these interventions. Commonly cited compo-
nents of integrated MHD services include comprehensive
screening for all MHDs, development of a common treat-
ment plan addressing all conditions, a multi-disciplinary team
that includes a specialist in co-occurring disorders and
psychosocial and pharmacological interventions, and services
such as assertive outreach, coordinated care and supported
employment [162].
The World Health Organization advocates for treatment of
mental and psychosocial problems within primary care
settings, but several concerns abound with this strategy
including lack of organizational resources and expertise, gaps
in provider knowledge regarding the developmental and
mental health needs of YKPs, and lack of cultural competency
in addressing needs of YKPs [163,164]. Additionally, YKPs
may have significant challenges in accessing services within
primary care settings, due to lack of health insurance coverage
and concerns about confidentiality and privacy.
Conclusions
Promoting the wellbeing of YKPs requires culturally and
developmentally appropriate primary prevention interven-
tions to eliminate or reduce risk factors for MHDs and HIV risk
behaviours, and foster resilience factors throughout YKPs’
ecological environment. In addition, culturally and develop-
mentally appropriate HIV care and mental health services
are needed for youth living with HIV and/or MHDs, as well as
secondary prevention interventions that promote healthy
functioning and life course development for affected YKPs.
All youth programmes and services need to address the
intersectionality of marginalized identities and group mem-
bership often found among YKPs. They should be grounded
in the latest theoretical and empirical data related to risk
reduction and health promotion, and attend to the cultural
and developmental needs of these youth.
While there is a growing body of knowledge regarding
MHDs in some YKPs (e.g. sexual minority youth, runaway and
homeless youth, detained or incarcerated youth), the litera-
ture on other populations such as gender minority youth
and youth involved in sex work as well as YKPs in low-income
countries continues to lag behind. The majority of studies on
YKPs have been conducted in the United States; less is known
about the psychosocial challenges or burden of MHDs among
YKPs outside of the United States. This challenge is exacer-
bated by the lack of consistency in how MHDs are conceptua-
lized and measured across countries and cultures [165168],
and differences in how adolescence is defined as a develop-
mental period across settings [169,170]. Future research
should focus on developing and validating mental health
measures for non-US based populations and assessing the
efficacy of these interventions in both US and non-US popu-
lations, keeping in mind the importance of tailoring interven-
tions to local contexts.
Additional research is needed to increase understanding
of key issues that influence the MHDs and HIV-related
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behaviours of YKPs, and to inform the development of
effective interventions to address the unique needs of these
young people. Of particular importance are studies elaborat-
ing on the complex pathways through which biological and
ecological diatheses influence the development of MHDs
and HIV risk behaviours among YKPs, the relative effects of
the different types of stressors and appropriate strategies for
management of MHDs in young people.
Interventions and research among YKPs would benefit from
utilizing a BST framework for understanding the range of
ecological factors that impact the MHDs and HIV-related
risk and resilience of YKPs and in developing culturally and
developmentally appropriate MHD and HIV-focused primary
and secondary prevention interventions for YKPs. More
research is needed to better understand the burden of MHDs
in YKPs (especially outside of the US) and the interaction of
MHDs and HIV-related risk and resilience. Such research
should be sensitive to the multiple group membership of
YKPs in often marginalized populations, addressing the multi-
plicity of risk and resilience factors across YKPs.
Given the high levels of stigma and discrimination experi-
enced by YKPs globally, we argue that youth interventions
should be rooted in the key human rights principles advanced
in the convention on the rights of a child [171] including:
(1) protection from physical and mental harm and exploita-
tion; (2) utilization of evidence-based practices in establishing
programmes and services for children; (3) provision of secure
conditions that ensure dignity and promote self-reliance
and (4) participation in decision-making processes taken in
their regard. These human rights principles should supersede
any social, cultural, political and other hegemonic ideologies,
which may serve to oppress YKPs.
Below, we provide recommendations for practitioners and
researchers on the best practices to promote the mental
health and reduce HIV risk behaviours among YKPs:
1) Consolidate youth services to address the multiplicity
of risk factors, and resulting MHDs and HIV risk behav-
iours. Develop partnerships across public, private and
civil organizations to address the multiplicity of risk
factors and special needs within YKPs, whilst attending
to the individual needs of each youth. Such services
should promote YKPs’ access to and sustained engage-
ment in mental health services, HIV continuum of care
and youth development programmes.
2) Tailor programmes and interventions to biological,
cognitive, social and identity development stage of
YKPs because there are wide variations in developmental
differences between adolescents and young adults
within YKPs.
3) Expand training for providers in mental health, particu-
larly in low- and middle-income countries with a dearth
of trained clinicians. This training should equip providers
with the knowledge and skills to promote positive
adolescent development and address the needs of YKPs
through affirmative and respectful approaches.
4) Create supportive environments within programmes
and services, and foster positive youth development
by strengthening family, peers, school and community
support systems. Family-centred interventions that en-
hance parent’s/guardian’s ability to connect with and
support youth grappling with various psychosocial issues
especially gender and sexual identity, and prevent risk
factors such as family abuse, rejection and poor parent-
youth communication and support are critical to pre-
venting MHDs and HIV risk behaviours among YKPs.
5) Develop youth capabilities and critical consciousness by
equipping youth with knowledge, skills and resources
to counter their varied challenges [172] and provide
opportunities for YKPs to participate in their socio-
political environments.
6) Develop and enforce formal child protection systems,
policies and guidelines in institutions such as schools
and juvenile justice systems to prevent re-victimization
of YKPs, and ensure access to mental health and HIV
care services as well as positive youth development
programmes within these contexts.
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Abstract
Introduction: At the epicentre of the HIV epidemic in southern Africa, adolescent girls and young women aged 1524 contribute
a disproportionate 30% of all new infections and seroconvert 57 years earlier than their male peers. This agesex disparity in
HIV acquisition continues to sustain unprecedentedly high incidence rates, and preventing HIV infection in this age group is a
pre-requisite for achieving an AIDS-free generation and attaining epidemic control.
Discussion: Adolescent girls and young women in southern Africa are uniquely vulnerable to HIV and have up to eight times
more infection than their male peers. While the cause of this vulnerability has not been fully elucidated, it is compounded by
structural, social and biological factors. These factors include but are not limited to: engagement in age-disparate and/or
transactional relationships, few years of schooling, experience of food insecurity, experience of gender-based violence, in-
creased genital inflammation, and amplification of effects of transmission co-factors. Despite the large and immediate HIV
prevention need of adolescent girls and young women, there is a dearth of evidence-based interventions to reduce their risk.
The exclusion of adolescents in biomedical research is a huge barrier. School and community-based education programmes are
commonplace in many settings, yet few have been evaluated and none have demonstrated efficacy in preventing HIV infection.
Promising data are emerging on prophylactic use of anti-retrovirals and conditional cash transfers for HIV prevention in these
populations.
Conclusions: There is an urgent need to meet the HIV prevention needs of adolescent girls and young women, particularly those
who are unable to negotiate monogamy, condom use and/or male circumcision. Concerted efforts to expand the prevention
options available to these young women in terms of the development of novel HIV-specific biomedical, structural and
behavioural interventions are urgently needed for epidemic control. In the interim, a pragmatic approach of integrating existing
HIV prevention efforts into broader sexual reproductive health services is a public health imperative.
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Introduction
Southern Africa is at the epicentre of the global HIV epi-
demic, bearing almost 40% of the global burden of infection
despite being home to less than 2% of the global population
[1]. In this endemic setting, the dominant mode of transmis-
sion is through heterosexual sex. UNAIDS has described the
epidemic as a generalized and hyper-endemic to reflect the
continued unprecedentedly high (10%) population preva-
lence [1,2]. However, generalizability should not be equated
to uniformity, as significant heterogeneity exists in terms of
where and in whomHIV infections occur, with certain localities
and populations being consistently more vulnerable to infec-
tion than others [1,3]. Focusing HIV prevention efforts on such
high-incidence locations and populations is likely to enable the
greatest gains to be made in altering current epidemiological
trajectories toward control of the HIV epidemic [4].
An important key population in the southern African
setting is young women aged 1524 years, who contribute
nearly 30% of all new HIV infections in the region [1,5,6]. In
South Africa, this percentage translates to 113,000 new
infections in young women per year, more than four-times
the number contributed by their male peers (Figure 1) [5].
Such disproportionately high HIV incidence in young women
compared to young men is explained by a striking and char-
acteristic feature of the HIV epidemic in this region: the age
sex disparity in HIV acquisition, wherein young women
acquire HIV around five to seven years earlier than young
men, often synonymously with sexual debut (Figure 2) [5,7].
As a result of the agesex disparity in HIV acquisition, HIV
prevalence in young women is high, and represents a sub-
stantial treatment burden [5,8]; for example, between 2009
and 2013, 27% of women less than 20 years attending ante-
natal clinics in a rural sub-district of KwaZulu-Natal were found
to be HIV positive (unpublished). On a population level, the high
incidence in young women is sustaining intergenerational trans-
mission of HIV and contributes to the overall disproportionate
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burden of HIV in women compared to men [9]. Indeed,
approximately 60% of all people living with HIV in sub-Saharan
Africa are women [1]. Clearly, achieving the goal of an ‘‘AIDS-
free generation’’ depends on reducing the burden of new
infection in this key population [10].
However, despite the imperative to prevent HIV acquisition
in young women, there remains a paucity of evidence-based
interventions available to this population. Indeed, current
options are typically limited to promotion of abstinence (or
delayed sexual debut), behaviour change, and condom use,
all of which are somewhat challenging given the underlying
gender-power dynamics of the southern African setting [10].
Further, whilst there has been great optimism following the
recent demonstrations of the prevention potential of antire-
trovirals (ARVs)  both prophylactically to prevent HIV acqui-
sition (pre-exposure prophylaxis, or PrEP) and for treatment
to minimise onward transmission (treatment as prevention,
TasP)  to date none of the PrEP trials have included par-
ticipants B18 years of age, and as such it seems unlikely that
these advances will be of benefit to the full range of those
considered young women (see Box 1) in the immediate future
[10,11].
Box 1. Defining young women.
The standard definition of young women includes all
those falling within the ages of 1524 years. As such,
most epidemiological data, and much of the discussion
here, is presented in terms of this age stratification.
It is, however, important to note that between these
ages, young women undergo significant transitions in
lifestyle, maturity, and legal rights which will place them
at different vulnerabilities at different time points.
It is likely that the significance of the B18 years vs.
18 years divide will increase in significance with the
rollout of PrEP, as few safety studies for PrEP interven-
tions have been conducted in adolescents B18 years.
As such, we would like to encourage the use of this and
other sub-strata by those reporting on HIV surveillance
in young people.
Moreover, a crucial step in addressing the public health
imperative to reduce HIV acquisition in young women is the
validation of the safety of existing technologies and interven-
tions for HIV prevention in young women B18 years [10,12].
Concurrently, a concerted effort is required to better under-
stand both the biological and structural factors driving the
heightened vulnerability to HIV infection in young women
more broadly. Such efforts, in parallel with a consolidation of
the evidence obtained from adolescent- and youth-focused
HIV prevention interventions and programmes conducted
to date, should serve to inform the development of more
efficacious interventions.
The objective of this review is to provide an overview of the
state-of-the-science of HIV prevention in young women and
adolescent girls to inform policy and research direction.
Specifically, we aim to (1) summarise the various behavioural
and biological factors that predispose adolescent girls and
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Figure 1. Disproportionate HIV incidence in young women in
South Africa.
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Figure 2. Agesex disparity in HIV acquisition.
Adapted from Shisana et al. [5] and Abdool Karim et al. [8].
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from previous HIV prevention interventions targeted toward
adolescent girls and young women, and (3) discuss future
directions for HIV prevention in adolescent girls and young
women.
Discussion
Why are adolescent girls and young women so vulnerable
to HIV infection?
Socio-behavioural associations of HIV infection in adolescent
girls and young women
Arguably the most convincing driver of the agesex disparity
in HIV acquisition observed in sub-Saharan Africa is the high
prevalence of intergenerational relationships between young
women and older men [13,14]. The aggregating prevalence of
HIV with increasing age means that, ceterius paribus, a young
girl engaging in a sexual relationship with an older man is at
much higher risk of HIV acquisition compared to a young
girl engaging with a male peer (Figure 2) [5]. Further, a young
woman engaging in a relationship with an older man may be
less likely to negotiate condom use given the gender-power
dynamics in the southern African setting, further augment-
ing her risk [13,15]. Consistent with these data, a number
of studies have demonstrated that engagement in an age-
disparate or intergenerational relationship is strongly asso-
ciated with increased HIV prevalence in young women
[13,1618]. Further work is needed to understand how this
association may be changing over time with increasing ARV
therapy (ART) coverage, and survival of both HIV infected
men and women over 25 years of age.
Understanding the complex factors that drive adolescent
girls and young women to engage in sexual relationships
with older men is challenging, but may be critical in terms
of adequately addressing the prevention needs of these
key populations. In many cases, young women have reported
feeling flattered by the attention of older men, and many re-
lationships are likely to be built on genuine romantic con-
nections [19,20]. In other instances, young women may be
motivated primarily by the increased financial or social capital
available through engaging in relationships with older men;
indeed, many adolescent girls and young women report in-
volvement in these ‘‘transactional relationships,’’ which have
significant additional implications for HIV risk [21,22].
Beyond engagement in age-disparate relationships, other
risk factors for HIV infection in young women include early
sexual debut, few years of schooling, food insecurity, loss
of a family member, and experience of gender-based violence
[8,17,2328]. Many of these factors may mediate their ef-
fects on HIV acquisition via increasing the relative value
of financial capital available through engagement in transac-
tional relationships with older men [21,2932]. However,
independent pathways of riskmediation are also likely to exist.
Food insecurity, for example, may also make young women
biologically more susceptible to HIV [33].
Possible biological mechanisms for heightened vulnerability
to HIV infection in adolescent girls and young women
The per-coital act HIV incidence rate in adolescent girls and
young women is so high that it seems unlikely that it can be
explained by behavioural risk alone [34,35]. Indeed, many
young women become infected after just a few coital en-
counters, and on a population level, acquisition seems almost
synonymous with sexual debut [17,36]. As such, there has
been significant investigation into potential biological fac-
tors that might augment behavioural risk, and a number of
mechanisms have been hypothesised to result in heightened
vulnerability to infection in young women, compared both to
men and to older women.
For example, a number of studies focused on sero-
discordant couples have highlighted a higher per-act risk of
HIVacquisition in women compared tomen [3740]. A portion
of this effect may be attributed to the higher viral load typically
observed in men, but the phenomena may also be explained
at least in part by physical factors that result in increased
exposure to HIV in women, compounded both from the com-
paratively larger surface area of the cervico-vaginal mucosa
and from the increased HIVmucosal exposure time (semen can
remain in the female genital tract up to three days post-coitus)
[41,42]. The higher per-act risk of HIV acquisition in women
could also result from the relatively high levels of activation
of the immune cells in the female genital tract, the increased
expression of HIV co-receptors in cervical cells compared
to foreskin cells, and/or a mucosal surface more likely to
acquire micro-abrasions during sex: together, these factors
result in more accessible portals for HIV entry in women
[35,4346].
Further, youngwomen aremore susceptible to HIV infection
compared to older women, and there are a number of bio-
logical factors that have been promulgated to explain this age-
variability in vulnerability. For example, the immature cervix
has a greater proportion of genital mucosa exposed to HIV
that is highly susceptible to infection, and young women
have relatively high levels of genital inflammation which have
consistently been reported to increase HIV acquisition risk
[23,35,4749].
When considering the apparently uniquely high per-act
HIV acquisition risk in young women, it is also necessary to
consider other relevant contextual factors that may mediate
the infection environment, including other sexually trans-
mitted infections (STIs) and contraceptive use. For example,
many bacterial and viral STIs are associated with increased
risk of HIV infection, and are much more prevalent in young
women compared to young men [50,51]. A recent school-
based survey conducted in rural KwaZulu-Natal, South Africa,
found the trend in herpes simplex virus-2 (HSV-2) acquisition
to mirror the agesex disparity in HIV infection, with young
female students acquiring HSV-2 soon after sexual debut, and
a more than three-fold higher prevalence of HSV-2 compared
to their male peers (Figure 3) [8]. Interestingly, recent HSV-2
infection may confer the greatest impact in terms of in-
creasing vulnerability to HIV, such that the female genital
tract in the immediate years following HSV-2 acquisition may
be particularly susceptible to HIV infection [52,53].
Beyond STIs, other biological risk factors may also be
amplified in young women. For example, one study has shown
that the use of the hormonal contraceptive depot medrox-
yprogesterone acetate (DMPA) increases the risk of HIV
acquisition in young women (1824 years), while decreasing
HIV acquisition risk in older women (]25 years) [54]. Further,
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although establishing causal relationships is challenging,
intra-vaginal cleaning practices are more prevalent in younger
women, suggesting thesewomen are consequentlymore likely
to have an altered vaginal flora, potentially heightening their
HIV susceptibility [55,56].
Together these biological factors may create a ‘‘perfect
storm’’ of conditions in recently sexually debuted adoles-
cent girls and young women in southern Africa making them
uniquely vulnerable to HIV infection when exposed to the
virus via engaging in unprotected sex with an HIV-positive
partner.
Effectiveness of current HIV prevention interventions
available to adolescent girls and young women
In-school interventions
Schools provide convenient venues for HIV prevention edu-
cation, and not surprisingly a vast number of youth-targeted
HIV, STI, and pregnancy prevention programmes operate in
schools throughout sub-Saharan Africa [57]. The effectiveness
of such programmes in young people in sub-Saharan Africa
has been the subject of a considerable number of systematic
reviews [5871]. To summarise the evidence, several pro-
grammes have been demonstrated to be effective in improv-
ing knowledge and attitudes concerning HIV and the uptake of
HIV testing. These data follow a general trend in sub-Saharan
Africa of increasing comprehension and understanding about
HIV in young people [1]. Those interventions demonstrating
the most success are characterised by a number of factors,
including but not limited to: iterative and context-specific
session programmes, HIV prevention and sexual and repro-
ductive health (SRH) curricula that include tasks focused
toward more general skills and knowledge development,
and delivery by trained facilitators [57]. In contrast, abstinence-
only and peer-led in-school interventions tend to be ineffective
[57,62].
Despite some apparent successes, few rigorously con-
ducted trials have assessed the impact of interventions
on biological outcomes, including HIV, STI and/or pregnancy
incidence. Those trials that have demonstrated no significant
effects of any school-based intervention on these biological
outcomes, in spite of reporting positive impacts on self-
reported behaviour change in adolescents [7274]. These
results may stem from the relatively strong prevention effect
of being in school itself, which may dwarf the effect of any
behavioural intervention. However, the burden of HIV in
school-attending adolescents, while lower than out-of-school
adolescents, remains significant, and thus there is also con-
cern that the results might point to differential desirability
bias by trial arm, which questions the validity of significant
changes in self-reported markers of behaviour change re-
ported by other studies. The data from school-based trials
also underscore that while knowledge is a pre-requisite
for HIV prevention, it is in itself insufficient to prevent HIV
infection.
Attempts to make health services youth-friendly
Other interventions to prevent HIV infection in young people
have focused on health systems strengthening in an effort to
address barriers to healthcare access by increasing the pro-
vision of high-quality, youth-friendly HIV and SRH services.
Such interventions are potentially critical, as there is sig-
nificant demand for more comprehensive SRH services that
recognise the inter-relationships between HIV and broader
SRH and thus the importance of integrated service delivery
[1,57].
Interventions to make health services more youth-friendly
have typically focused on a different combinations of training
of service providers, outreach activities, and provision of
mobile services targeted toward specific high-risk adolescent
populations [66,7577]. Many of these interventions have
been successful in terms of increasing uptake of services
by young people. However, similarly to in-school interven-
tions, there is a notable dearth of biological-outcome-based
assessment.
Community-level interventions
HIV prevention interventions implemented at the community
level are highly heterogeneous, including sporting events,
mentoring and youth centres [78]. Evaluation of these in-
terventions highlights their largely positive impact on knowl-
edge and attitudes to HIV. However, these interventions
often fail to reach the most HIV vulnerable populations, and
evaluation designs are generally weak. Only one study to our
knowledge has assessed HIV incidence, and this study reported
no evidence of effectiveness [79].
Conditional cash transfers
Cash transfers to young people that incentivise safer behaviour
have recently emerged as a new strategy to reduce young
people’s vulnerability to HIV [1,80]. The evidence in support of
the efficacy of this strategy is limited but promising. Indeed,
a recent randomized controlled trial in Lesotho demonstrated
that a programme of financial incentives reduced the prob-
ability of acquiring HIV by 25%over two years [81]. Similarly, an
independent randomized controlled trial in Malawi reported
that those female high school students who received con-
ditional cash transfers (CCTs) were 64% less likely to be HIV
infected compared to those who were not [82]; however,
baseline HIV infection was not measured. These data suggest
a potential for CCT to prevent HIV in young people, and
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Figure 3. Agesex disparity in HSV-2 acquisition.
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Gaps and future directions
Despite the large and immediate need for HIV prevention
in adolescent girls and young women, there is a dearth of
evidence-based interventions available to them to reduce
their risk. Given the diversity of epidemics within and between
countries, in order to develop more efficacious youth-focused
prevention interventions, a sound understanding of the local
epidemic is required as well as the bio-behavioural nexus
that renders adolescent girls and young women more vulner-
able to HIV infection. The significant SRH needs of young
women should be central to the design of new interventions,
as integration of services is the backbone of a pragmatic ap-
proach to address needs now, even as we refine, develop and
test new and novel approaches [1,83]. A careful review of
previous interventions and their evaluations is needed to
ensure maximum gains. Most notably, it is critical that any
future intervention should be rigorously assessed for effec-
tiveness in controlled trials with biological outcomes prior
to wide-scale implementation to maximise efficiency and
effectiveness of resource allocation. Many researchers would
benefit from engaging the young women themselves as part-
ners in intervention design and implementation, and certainly
encouraging male partner buy-in and female empowerment
will also be important in those settings where gender-power
dynamics augment HIV risk.
A further important direction for future research should be
to develop interventions targeted to hard-to-reach young
people who might be missed by school- or community-based
interventions. The evidence for the best practice in reaching
such populations is particularly limited, despite their often
greater risk of HIV acquisition. However, our own experiences
highlight that some important components of making service
provision palatable and attractive to hard-to-reach adoles-
cents include anonymized testing, flexible clinic hours and
adaptions of respondent-driven sampling. Concurrently, ef-
forts should be made to keep adolescents in school. The task
of developing and evaluating new HIV prevention interven-
tions  particularly those programmes that aim to address
the underlying social vulnerabilities  is substantial, and will
potentially require decades of concentrated action, during
which time adolescent girls and young women will continue
to become infected in their hundreds of thousands. As such,
it is a moral imperative to effectively deliver what we know
works now. The most pressing example of a technology that
we know works but is not being delivered is PrEP, which was
developed specifically with young women in southern Africa
in mind: designed to allow them to exercise their rights over
their health and take control over their own risk without
dependence on their sexual partners. While the number of
randomized controlled trials demonstrating the effectiveness
of PrEP continues to grow, this success has yet to be translated
into product availability in southern Africa. Undeniably, PrEP
is not 100% effective, is limited by adherence and would
benefit from improvements currently in development; how-
ever, one has to question where the threshold of evidence
required for rollout of current forms of PrEP to young women
in southern Africa lies. A simple calculation highlights that
even with a 39% efficiency, rollout of Tenofovir gel to young
women aged 1524 years in South Africa alone might prevent
more than 44,000 infections in one year. Implementation and
policy science are urgently needed to translate research on
PrEP effectiveness into averted infections. Further, there is
also work to be done in ensuring that on rollout, the state-
of-the-science of prevention is not lagging behind in adoles-
cents B18 years because of restrictive ethico-legal guidelines
that often prevent them from participating in biomedical
research in spite of their substantial need [6,10].
This review was restricted to considering HIV prevention in
adolescent girls and young women. However, the treatment
needs resulting from the unprecedentedly high HIV incidence
rates in these key populations should not be underestimated:
in Lesotho for example, almost a quarter of all young people
aged 1524 years are infected with HIV [1]. Adolescent-
focused HIV prevention interventions should also seek to
meet the needs of HIV-positive young people who face
significant barriers to care. Indeed, of note is that adoles-
cents (1019 years) are the only age group in which AIDS
deaths have risen between 2001 and 2012 [1].
Conclusions
Meeting the HIV prevention and SRH needs of adolescent
girls and young women who are at uniquely high risk of HIV
acquisition is a public health and moral imperative and a
requirement to meet the laudable goals of achieving an AIDS-
free generation and/or epidemic control. However, despite
this imperative, evidence-based prevention options available
to adolescent girls and young women remain limited, and even
as efforts get underway to develop more efficacious interven-
tions, they are likely to take many years to reach fruition.
Immediate action is therefore needed to facilitate this key
population to mediate their own risk, including as first steps
rollout of PrEP, adolescent enrolment in biomedical HIV
prevention trials, and provision of accessible and integrated
SRH-HIV prevention services.
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Abstract
Introduction: Evidence suggests that people who inject drugs often begin their drug use and injecting practices in adolescence,
yet there are limited data available on the HIV epidemic and the responses for this population. The comprehensive package
of interventions for the prevention, treatment and care of HIV infection among people who inject drugs first laid out in 2009
(revised in 2012) by World Health Organization, United Nations Office of Drugs and Crime and Joint United Nations Programme
on HIV/AIDS, does not consider the unique needs of adolescent and young people. In order to better understand the values and
preferences of young people who inject drugs in accessing harm reduction services and support, we undertook a series of
community consultations with young people with experience of injecting drugs during adolescence.
Methods: Community consultations (414 persons) were held in 14 countries. Participants were recruited using a combined
criterion and maximum variation sampling strategy. Data were analyzed using collaborative qualitative data analysis. Frequency
analysis of themes was conducted.
Results: Nineteen community consultations were organized with a total of 132 participants. All participants had experienced
injecting drugs before the age of 18. They had the following age distribution: 1820 (37%), 2125 (48%) and 2630 (15%).
Of the participants, 73.5% were male while 25.7% were female, with one transgender participant. Barriers to accessing the
comprehensive package included: lack of information and knowledge of services, age restrictions on services, belief that services
were not needed, fear of law enforcement, fear of stigma, lack of concern, high cost, lack of outreach, lack of knowledge of
HCV/TB and lack of youth friendly services.
Conclusions: The consultations provide a rare insight into the lived experiences of adolescents who inject drugs and highlight the
dissonance between their reality and current policy and programmatic approaches. Findings suggest that harm reduction and
HIV policies and programmes should adapt the comprehensive package to reach young people and explore linkages to other
sectors such as education and employment to ensure they are fully supported and protected. Continued participation of the
community of young people who inject drugs can help ensure policy and programmes respond to the social exclusion and denial
of rights and prevent HIV infection among adolescents who inject drugs.
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Introduction
While the age distribution of the 12.7 million people who
inject drugs globally is unknown [1], evidence suggests that
people who inject drugs begin their injecting practices at a
young age, often in adolescence [2]. Of the total population
of people who inject drugs, 13.1%, or 1.7 million, were living
with HIV in 2013 [1]. Globally, young people aged 1524 years
account for an estimated 35% of all new infections in people
over 15 years of age [3]; yet data on the epidemic and res-
ponse among young people who inject drugs (YPWID) are
limited.
However, the data that do exist paints a stark picture.
A number of countries have reported increases in prevalence
of injecting drug use among young people [4] and high rates
of HIV amongst adolescents who inject drugs [5,6]. YPWID are
especially vulnerable to HIV [7,8]. Young people are more
likely to share non-sterile injecting equipment [9]. As young
people are new to the injecting community, they are less
likely to know safer injecting practices [10]. In addition,
sexual risk-taking takes place amongst YPWID [11] further
increasing HIV risk. Legal age restrictions on harm reduction
services prevents young people from accessing these services
[12] and punitive measures that criminalize drug use further
discourage service use thereby increasing HIV risk [13,14].
The comprehensive package of harm reduction services [15]
has been endorsed by the World Health Organization (WHO),
United Nations Office of Drugs and Crime (UNODC) and
the Joint United Nations Programme on HIV/AIDS (UNAIDS)
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and are critical for reducing drug-related harms amongst peo-
ple who inject drugs. The comprehensive package includes:
1) needle and syringe programmes (NSPs); 2) opiate sub-
stitution therapy (OSTs); 3) HIV testing and counselling;
4) antiretroviral therapy; 5) prevention of sexually transmitted
infections; 6) condom programmes for people who inject
drugs and their sexual partners; 7) targeted information, edu-
cation and communication for people who inject drugs and
their sexual partners; 8) vaccination, diagnosis and treatment
of viral hepatitis; and 9) prevention, diagnosis and treatment
of tuberculosis. However, current guidelines do not consider
the unique needs of adolescent and young people or expand
on how they could be adapted to ensure this age group is
reached with services.
Formative research and/or meaningful community engage-
ment that explore experiences of the ‘‘target population’’
can help develop programmes and policies that are effective
[16]. Yet the participation of YPWID in policy and programme
development cycles is largely absent [13]. To inform the
current effort of the UNAIDS Inter-Agency Working Group on
Key Populations (IAWGKP) to develop technical briefs on
YPWID, Youth RISE with support from UNAIDS, undertook
community consultations with young people who have
experience injecting drugs during adolescence (1019). This
report presents the findings and discusses the implications
for the comprehensive package of harm reduction services.
Methods
Community consultations
Given the dearth of data related to adolescents and YPWID,
community consultations were used to generate in-depth
information for the technical brief. A community consultation
‘‘is designed to recognize and accommodate the relevant
particularities of a given community for a specific project’’ [17].
Consultations were organized in 14 countries, selected for
convenience while ensuring geographical/regional diversity.
Consultations were organized in different settings. In some
countries, two smaller groups were held on the street. In
Nepal and Nigeria, separate male and female consultations
were held. As a result, a total of 19 consultations were
organized: Indonesia (2), Kenya, Kyrgyzstan (2), Lebanon,
Mauritius, Mexico, Nepal (2), Nigeria (2), Portugal, Romania,
Slovenia, Ukraine, United States (2) and Vietnam. All consulta-
tions were conducted between August 2013 and January
2014.
The policy environment for OST and NSPs in the 14 coun-
tries was mapped and crosschecked with the 2012 Global
State of Harm Reduction report [18]. Age of consent laws
were mapped through review of literature [1921].
A standardized consultation toolkit (a semi-structured dis-
cussion guide, a facilitator’s guide, ethics protocol, informed
consent and demographic information form) was developed
by Youth RISE and UNAIDS, together with the community
consultation facilitators. The kit was sent out for wider review
by experts within the harm reduction field. Questions focused
on experiences in accessing the comprehensive package of
harm reduction services and how to improve access.
The consultations were facilitated by local young Youth
RISE members. Facilitators were selected based on their
experience with YPWID. All took part in a project and
methodology workshop.
Participants
Participants were recruited using a combined criterion and
maximum variation sampling strategy [22]; that is, the faci-
litators purposefully recruited diverse participants that met a
set of inclusion criteria.The initial criteria were: 1) have experi-
enced injecting under the age of 18, and 2) aged between 18
and 25 years. Participants under the age of 18 were excluded
due to ethical considerations. Consultation facilitators identi-
fied youthwhomet the inclusion criteria through services and/
or street recruitment. Younger participants were hesitant to
take part; consequently the age range was extended to 30
years of age to enable recruitment.While participants included
both current and former injectors (regular and less regular), all
participants met the inclusion criteria ‘‘having experienced
injecting under the age of 18.’’ The discussions explored the
experiences of adolescents, but as all participants were over 18
this report refers to young people.
Data collection and analysis
The consultations were audio recorded, transcribed and
translated into English where necessary. Data were analyzed
using collaborative qualitative analysis [23]. Facilitators com-
pleted a standardized reporting template and the project
coordinator independently coded the data [23]. The project
coordinator and facilitator analysis were compared, and a
preliminary report reviewed by all facilitators to verify data
interpretation and findings. Once validated, frequency ana-
lysis of themes was conducted [23]. There were a total of 19
complete transcripts. If a theme was present in a majority of
the transcripts (10 ), it was considered a ‘‘strong’’ theme.
If a theme was identified in a third (69), it was considered
moderate. Unique themes were identified three or less of the
transcripts, but offered a unique perspective in relation to
the comprehensive package of interventions.
Ethical protocol
IRB approval for the consultations was not obtained; however,
an ethical protocol was followed, including: informed consent
and confidentiality to protect identity. UNAIDS in-country
offices advised on steps needed to ensure safety of par-
ticipants, including engagement with Governments where
necessary.
Results
The results of the policy mapping on age restrictions are
presented in Table 1 and indicate at what age adolescents can
access these services without parental consent in the
14 countries. At the time of consultations, NSPs and OST
are available in all countries except for Nigeria and Kenya
[18].Whilst the remaining interventions in the comprehensive
package are available in all countries, the coverage of these
programmes varies significantly and may not be specifically
targeted towards people who inject drugs.
Consultations
There were 132 participants in the consultations: age: 1820
(n49 (37%)), 2125 (n63 (48%)), 2630 (n20 (15%));
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male: (n97 (73.5%)); female: (n34 (25.7%)), and gen-
derqueer: (n1 (0.8%)).
Age of initiation into injecting drugs and reasons for
initiation of injecting
Participants reported initiation into injecting as commonly
starting between ages 15 and 18, although age of initiation
was reported as young as nine. A process of progressing
from cannabis, snorting drugs to finally injecting was com-
monly described. In all consultations, the need to get a
more intense high was reported as the primary reason why
injecting was initiated.
Curiosity was reported in a majority of the consultations as
influencing adolescents’ decision to inject. Reduced quality
and potency of drugs, as well as economic efficiency, were also
reported as important reasons. Another was peer-influence:
For me at the beginning I rejected injecting drugs
because I saw the blood inside the syringes and I
know that it is dangerous and it’s also dirty, but after
several times saying no, I started to use the needle
because I am just curious. I start to inject after about
three times my friend offered for me to inject.
(young man, Indonesia)
In the US and Indonesia, participants cited rejection from
society or family as a point where they turned to harder drugs
and/or injecting. ‘‘The reason I started injecting was because
I was angry. I was expelled from school and abandoned
by my own family when they found out I was taking some
drugs. So I thought why not go all the way’’ (young man,
Indonesia).
The gratification experienced from injecting drugs played
an important role in why a young person continues to inject
after their initial experience.
Experiences accessing the comprehensive package of
harm reduction
Participants identified barriers to accessing the interventions
contained in the comprehensive package of harm reduction.
Table 2 summarizes the frequency analysis of themes in
relation to barriers identified.
Structural barriers
One commonly cited reason why participants did not access
NSPs, OST and HIV services were age restrictions and/or
parental consent requirements. While Mauritius has no age
restrictions on NSPs, lack of clarity in the law has led to
rejection of adolescents from NSPs and a lack of awareness
among adolescents that services should be available to them.
In all consultations, age restrictions were raised as a barrier
to adolescents accessing OST. In Kyrgyzstan and Mexico, age
of consent to HIV testing was also cited as a barrier where
positive results are only released in the presence of parents
and/or guardian.
A third of consultations described fear of police harass-
ment and arrest as a reason why young people prefer not to
access NSPs. Fear of law enforcement was also an important
barrier for purchasing syringes from pharmacies. Cost and
distance to services was identified as a barrier to accessing
OST, HIV testing, viral hepatitis testing, and ART, as was the
need to travel to centralized locations.
Social barriers
Fear of being exposed as a person who uses drugs led
to hesitance amongst young people to access NSPs, and a
preference for obtaining injecting equipment from pharma-
cies, which were perceived as more discrete.
In Kyrgyzstan, concern was raised about the registration
of methadone clients and the impact that has on a young
person’s life, ‘‘Nobody wants to start on methadone at 18
because they will register you at once [. . .], You will have
no normal life after that, no driving license, and they will
give data on you everywhere, at school, local police and to
doctors’’ (young female, Kyrgyzstan).
The two female-only consultations held in Nepal and
Nigeria, as well as the mixed-group consultations, provided
insights into how the needs of females differ. Participants
indicated that females start injecting at a similar age as
Table 1. Age restrictions on harm reduction services and HIV testing in countries where consultations took place
Country City/location Age restrictions (NSP) Age restrictions (OST) Age restrictions (HIV testing)
Indonesia Bandung; Medan None Yes (18) None
Kenya Nairobi None No services None
Kyrgyzstan Bishkek None None Yes (16)
Lebanon Beirut None Yes (18) No information identified
Mauritius Port Louis None Yes (18) None
Mexico Hermosillo Yes (18) Yes (18) Yes (18)
Nepal Kathmandu; Pokhara None Yes (18) Yes (14)
Nigeria Abuja No services No services Yes (18)
Portugal Porto None Yes (18) Yes (16)
Romania Bucharest Yes (18) Yes (18) No information identified
Slovenia Ljubljana None 16 (methadone); 15 (Subutex) Yes (15)
Ukraine Rivne Yes (14) Yes (14) Yes (14)
United States San Francisco Varies by state (none in California) Yes (18) No information identified
Vietnam Hanoi Yes (16) Yes (18) Yes (16)
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males; however, young women are less likely to be in contact
with services and are more concerned about their drug use
being exposed. A number of participants explained how their
male partners initiated them into injecting, while heavy
reliance on their partners for injecting equipment meant that
accessing services was not necessary.
Lack of youth-friendly services
The presence of older users at harm reduction services and
their attitude towards younger users made young people
uncomfortable. ‘‘I think that we should have other types of
services to young people under 18 years old. Because the CAT
[Government run drug service in Portugal] is a bit aggressive.
Table 2. Adolescent and young people’s identified barriers to accessing the comprehensive package of harm reduction services
Intervention and identified barriers Theme strength
Needle and syringe programmes
Lack of knowledge of services Strong
Belief that services are not needed Strong
Fear of police Moderate
Fear of exposure of drug use Moderate
Limited hours of operation Moderate
Lack of youth-friendly services Moderate
Age restrictions/parental consent requirements Unique
Requirement of identity card Unique
One-for-one exchange policies Unique
Opiate substitution therapy
Age restrictions/parental consent requirements Strong
Belief that services are not needed Strong
Lack of knowledge of service Moderate
Cost Moderate
Negative perception of OST and its side effects Moderate
Registration of people who use drugs and lack of confidentiality Unique
HIV testing and counseling
Lack of concern Strong
Cost Strong
Lack of knowledge of services Moderate
Stigma and fear of result Moderate
Un-friendly staff Moderate
Age of consent and/or parental consent requirements Unique
Antiretroviral therapy
Cost Moderate
Age restrictions/parental consent requirements Unique
Low testing and knowledge of status Unique
Retention in ART services Unique
Prevention of sexually transmitted infections and condom programmes for IDUs and their sexual partners
Lack of concern Strong
Effect of drugs on decisions around safe sex Strong
Distribution of low quality condoms Unique
Conservative social climate Unique
Targeted information, education and communication for IDUs and their sexual partners
No information received in adolescence Strong
Lack of outreach Strong
Prevention, diagnosis and treatment of viral hepatitis
Lack of knowledge of HCV Strong
Lack of concern Strong
Cost Moderate
Prevention, diagnosis and treatment of tuberculosis
Lack of knowledge of tuberculosis Strong
Lack of concern Strong
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Can you imagine going into a CAT, in the middle of all that
junkies on methadone and shit, we think, ‘What is this??’
[laughs]. Like this, young people don’t feel like going into a
CAT if they are having problems!’’ (Male, Portugal).
Judgemental attitudes of staff members towards young
people who access HIV testing and counselling was repeatedly
raised as a deterrent. Whilst young people largely preferred
accessing injecting equipment from pharmacies, participants
also reported that pharmacists’ attitudes were negative and
that they sometimes refused to sell syringes.
Lack of information and risk-perception
Lack of knowledge of services was an important barrier to
accessing all services. An adolescent who is new to the
injecting community was unlikely to know of NSPs. A lack of
knowledge of OST was also reported, particularly in adoles-
cence; some apprehension about OST also existed with par-
ticipants hearing about issues such as loss of teeth and a
more intense withdrawal from methadone than heroin.
In a majority of the consultations, the participants said
they had no knowledge of HIV testing in their adolescence. It
was also suggested that YPWID only become aware of HIV
testing sites when they begin drug treatment. Low knowl-
edge of viral hepatitis and tuberculosis testing sites was
reported in a majority of the consultations.
Information received about HIV prevention and treatment,
safe sex and safe drug use varied considerably across con-
sultations from very good information (e.g. US and Portugal)
to none at all (e.g. Nigeria). However, in the majority of
consultations, it was reiterated that information was only
received after risky behaviours had already taken place.
Concern about STIs, viral hepatitis and tuberculosis was
low across consultations. Whilst condoms were generally
accessible according to participants, in a majority of the
consultations it was reported that concern for safe sex
disappeared after using drugs. ‘‘If you are high you do not
care’’ (young man, Romania). In a majority of consultations,
participants said that they were not concerned enough to get
tested for HIV, believing it was a problem for ‘‘older users.’’
The belief that services are not needed emerged strongly
from the consultations. Participants described enjoying their
drug use and not experiencing many negative consequences
yet, and thus did not feel it necessary to seek out services.
In the Ukraine, a participant put it simply: ‘‘We don’t need
services. We have no problems.’’ Similarly, a young woman in
Slovenia said, ‘‘But when you are under age you mostly don’t
want OST. Cos those are the years when things are still good
even if you are already addicted.’’
Beyond the comprehensive package: additional support
needs
Participants expressed that they require support beyond the
comprehensive package of harm reduction. The following
interventions were suggested in a third or more of the con-
sultations: safe injecting advice; vocational training, removal
of stigma and policy barriers to employment; parental engage-
ment and education; support for street-involved youth;
improved school drug education with a greater focus on risk
reduction; legalization of softer drug; and legal education.
Young users need to be taught a) how to use,
b) how to use correctly, and c) how not to die.
(young man, US)
Discussion
The consultations show that a person who injects drugs in
their adolescence differs from older persons who inject drugs,
which put them at greater risk of harm. The implications
of the findings from the community consultations for the
comprehensive package of harm reduction services recom-
mended by WHO [15] is now discussed.
Participants agreed that young people begin using other
drugs before using and injecting opiates. In a number of
the consultations, perceived changes in drug trends amongst
young people were discussed, generally from heroin to legal
highs and synthetic drugs including amphetamine-type-
stimulants (ATS). This trend has been reported elsewhere
[1,24]. Whilst these drugs are more often not injected,
injecting of synthetic and stimulant drugs also occurs [25].
Use of stimulant drugs in the party scene is commonplace
amongst many young people [26], a population often not in
contact with traditional harm reduction services. ATS users
rarely use harm reduction services as they do not see these
services as relevant [27]. In developing services to address
adolescents and young people, different outreach strategies
will be needed to reach both non-injecting and non-opiate
substance use.
Reaching young people before they start injecting is an
opportunity to prevent initiation into injecting, and/or to
provide support and education to inject safely if injection drug
use is initiated. Where young people experienced rejec-
tion by family, school and society over using ‘‘softer’’ drugs
and started injecting as a coping-strategy also shows the
importance of a more supportive response to non-injecting
substance use.
While teaching an adolescent how to inject drugs may
raise serious ethical and legal considerations for many
policy makers and service providers, the fact that safe in-
jecting education was identified as a need by participants
within the majority of the consultations deserves further
exploration.
Given the social context of initiation, working through
social networks to prevent initiation into injecting may be an
effective approach [28]. Initiatives and research on effective
models is limited however, and further work is needed.
Consistent with other research [29], consultations found
that even when NSPs are available for minors without parental
consent, young people in the consultations consistently pre-
ferred to access their injecting equipment from pharmacies
or friends, making the risk of sharing syringes greater. If
adolescents prefer to obtain their syringes from pharmacies, it
may be important to ensure pharmacies are able to provide
information and education, engage in behavior change and
link to drug treatment programmes and HIV testing and
treatment programmes.
The consultations suggested that young people may
be uncomfortable accessing services that older injectors
frequent. Services that include a range of services that are
not drug-specific may be more effective in engaging and ser-
ving adolescents. Integration of harm reduction interventions
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into other services already in contact with at-risk youth may
also be a good approach. Lack of knowledge of services was
another recurring theme, suggesting that a need for specific
outreach strategies in order to reach younger people is
necessary.
Adolescence is a period of experimentation and for many
this includes experimentation with drug use [2]. During the
initial period of drug use, consultations showed that young
people may not necessarily identify themselves as ‘‘drug
users at risk and/or in need of services.’’ The participants in
the consultations often stressed pleasure as a key motivator
for using drugs, and during this period where they may not
be experiencing too many adverse effects, they are unlikely
to reach out for support.
This has implications for how to successfully establish
initial contact and engagement into services. More creative
methods are needed to engage a young person who does not
see him/herself as a ‘‘drug user,’’ whilst re-orienting services
to be responsive to people who engage in experimental
and enjoyable drug use as opposed to being services only
relevant for those who are experiencing difficulties and/or
want to stop using drugs may also lead to more successful
engagement of younger people.
Under current WHO guidelines, there are no recommended
age restrictions on NSP or OST programmes, yet these pose
clear barriers to accessing NSPs and OST for adolescents [30].
The comparative review of age restrictions and parental con-
sent requirements in the countries where consultations were
organized indicate arbitrary restrictions, and such restrictions
were repeatedly mentioned as a reason why young people
who participated in the consultations were unable to access
services. Countries should consider harmonizing their age-
restrictions to international guidelines.
Another important yet often overlooked issue that arose
consistently across the consultations was the impact of
drug use on unsafe sex practices amongst adolescents, which
supports previous research [31]. Programmes that better
address the connection between sexual health and drugs are
needed, particularly for adolescents.
Young women who use drugs are more vulnerable to HIV
due to a number of age- and gender-specific vulnerabilities to
both injection and sexual transmission routes [32]. Consulta-
tions indicated that young women are less willing to access
services, have less knowledge about services, HIV, Hepatitis
and TB, and frequently share injecting equipment with their
male partners [33]. Outreach strategies are especially im-
portant for young women as they may be more dependent on
their partners for injecting equipment and are fearful of the
greater stigma placed on them, thereby resisting accessing
services. Comprehensive health services that also address
their sexual and reproductive health needs are needed [34].
Study limitations
While working through a network of community activists
proved an invaluable asset in building trust, some facilitators
noted difficulties in recruiting participants due to fear of
exposure as a person who uses drugs. In addition, all parti-
cipants were over 18 and were questioned about their experi-
ences of injecting drugs under 18. Recall bias inherent in this
approach and self-reporting introduces further respondent
biases. Whilst all participants reported that they currently
inject drugs or have done so in the past, there was no pro-
cess to verify whether participants did inject under the age
of 18. Given the highly sensitive topic of drug use, the group
rather than individual consultation approach may have led
to minority perspectives not being raised. To mitigate this,
the facilitators were selected based on their closeness to
the community and were trained.
Conclusions
The findings presented in this paper provide a rare insight
into the lived experiences of YPWID and the challenges
they face in accessing harm reduction services. Interestingly,
experiences were fairly consistent across the 14 different
countries. For example, the fact that YPWID do not identify as
a ‘‘drug user in need of services’’ may provide insights into why
current approaches to outreach and service delivery may
be failing. The consultations indicated that adolescents and
young people require significant support beyond the compre-
hensive package of harm reduction, with clear linkages to
other sectors such as social security, education and employment.
While the findings are not representative, they speak of
the importance of conducting formative and action research
together with young people who use drugs to understand
context specific barriers, social norms within the community,
and the dissonance between legal and policy environment
and practice. In addition, the empowerment process from
participatory approaches should be valued in its own right.
While drug use among adolescents and young people is
a sensitive topic, it is hoped that the lived experiences of
young people themselves can engender more honest con-
versations on how to best address the reality of injecting
drug use among young people to reduce risk and harm.
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Abstract
Introduction: There is a strong evidence base that the stigma, discrimination and criminalization affecting adolescent key
populations (KPs) aged 1017 is intensified due to domestic and international legal constructs that rely on law-enforcement-
based interventions dependent upon arrest, pre-trial detention, incarceration and compulsory ‘‘rehabilitation’’ in institutional
placement. While there exists evidence and rights-based technical guidelines for interventions among older cohorts, these
guidelines have not yet been embraced by international public health actors for fear that international law applies different
standards to adolescents aged 1017 who engage in behaviours such as selling sex or injecting drugs.
Discussion: As a matter of international human rights, health, juvenile justice and child protection law, interventions among
adolescent KPs aged 1017 must not involve arrest, prosecution or detention of any kind. It is imperative that interventions not
rely on law enforcement, but instead low-threshold, voluntary services, shelter and support, utilizing peer-based outreach
as much as possible. These services must be mobile and accessible, and permit alternatives to parental consent for the provision
of life-saving support, including HIV testing, treatment and care, needle and syringe programmes, opioid substitution therapy,
safe abortions, antiretroviral therapy and gender-affirming care and hormone treatment for transgender adolescents. To ensure
enrolment in services, international guidance indicates that informed consent and confidentiality must be ensured, including by
waiver of parental consent requirements. To remove the disincentive to health practitioners and researchers to engaging with
adolescent KPs aged 1017 government agencies and ethical review boards are advised to exempt or grant waivers for
mandatory reporting. In the event that, in violation of international law and guidance, authorities seek to involuntarily place
adolescent KPs in institutions, they are entitled to judicial process. Legal guidelines also provide that these adolescents have
influence over their placement, access to legal counsel to challenge the conditions of their detention and regular visitation from
peers, friends and family, and that all facilities be subject to frequent and periodic review by independent agencies, including
community-based groups led by KPs.
Conclusions: Controlling international law specifies that protective interventions among KPs aged 1017 must not only include
low-threshold, voluntary services but also ‘‘protect’’ adolescent KPs from the harms attendant to law-enforcement-based in-
terventions. Going forward, health practitioners must honour the right to health by adjusting programmes according to
principles of minimum intervention, due process and proportionality, and duly limit juvenile justice and child protection
involvement as a measure of last resort, if any.
Keywords: young key populations; adolescent key populations; young drug users; harm reduction; commercial sexual
exploitation of children; sexually exploited children; juvenile prostitution; young sex workers; young people; minimum intervention.
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Introduction
It is well settled that adolescent key populations (KPs) face
heightened health risks as a result of law and policy barriers
to accessing HIV treatment, diagnostic and prevention services
and that the stigma, discrimination and criminalization ex-
perienced by adolescent KPs aged 1017 is intensified, as
compared to their older cohorts. Those adolescents who sell
sex or inject drugs more often face aggravating circumstances
such as family rejection and street-involvement, combined
with legal constructs concerning consent and age of majority.
These constructs may condition access to life-saving treatment
on parental consent or proof of ‘‘emancipation,’’ or lower the
age of consent to sell sex or use drugs as compared to general
consent-to-sex law, resulting in increased police encounters
and commitment to state custody [1,2].
This commentary addresses only adolescent KPs aged
1017 and not adolescents aged 1819 in order to spotlight
the specific, legal guidelines for health and protective inter-
ventions that apply to persons under the legal age of majority.
It must be cautioned that developmentally adolescence is a
dynamic state and that major differences may exist in identity,
understanding and behaviour between adolescents within
this range. While it is true that adolescents aged 1017 who
are transgender (TG) or young men who have sex with men
(YMSM) face related challenges [3,4], in order to tailor recom-
mendations to the special legal framework applicable to these
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populations, this paper narrows its scope to adolescents who
sell sex or use drugs, including the disproportionate number of
adolescent TG and YMSM who do so.
There is a strong and emergent evidence base that law
enforcement-based interventions targeting adolescents aged
1017 who sell sex or use drugs result in affirmative harm
to the very same adolescents they are intended to protect
[1,2,57]. The daily reality reported by many adolescents who
sell sex or use drugs is dominated by harassment, theft, deten-
tion, deportation, and physical and sexual violence by law en-
forcement andmilitary personnel, including rape and extortion
in exchange for release [1,2,810].This lived experience of vio-
lence and corruption instills fear in adolescents and prevents
adolescent victims from reporting the crimes committed against
them [1,2,8]. It similarly poisons relationships with service
providers who may be compelled to report adolescents to law
enforcement as a result of mandatory reporting laws [1,2].
What is more, adolescent KPs report abuse by health practi-
tioners themselves, including discrimination and service denial,
and even physical and sexual violence, forced abortions,
breach of confidentiality and mandatory HIV testing [1,2,8].
Despite this frightening reality, a child protection frame-
work is frequently applied at the country level to justify
arrest-based interventions without reference to international
human rights law governing the administration of juvenile
justice, child protection and the right to health. The over-
whelming majority of low- and middle-income countries pos-
sess little to no specialized child protection services. Thus
‘‘child protection’’ falls to precisely those persons identified
by young KPs as perpetrators of violence: uniformed serv-
ices, primarily police and military personnel. Even in high-
income countries, arrest-based interventions are relied upon,
with diversion to ‘‘services,’’ if at all, only after arrest in vio-
lation of international law and without clear guidelines for
appeal or periodic review of the conditions of confinement
[1,8,11]. Ironically, the very same interventions championed
in the name of ‘‘child protection’’ are therefore increasing
the numbers of one such KP  adolescents in prisons and
other closed settings.
The confusing policy and programme environment has
caused many healthcare providers to limit or cease services
to adolescents aged 1017 who sell sex or use drugs. In effect,
implementation of international legal principles has drawn a
red line at the age of majority that health practitioners dare
not cross. The strong, evidence-based technical guidelines
that exist for rights-based health interventions among sex
workers and injecting drug users over the age of majority
decline to extend rights-based recommendations to KPs
aged 1017 even when medical science invites an equivalent
approach [12,13]. This commentary calls for a reexamination
of the treaty framework, situating child-protective interven-
tions firmly within international law and guidance governing
the right to health, and regulating juvenile justice and child
welfare interventions according to principles of minimum
intervention, last resort, due process and proportionality.
These important principles clarify that state obligations to
respect, protect and fulfil the rights of KPs aged 1017 are
not simply directed at the prohibition of behaviours, but also
to protect vulnerable young people from the inherent harms
of certain law enforcement-based interventions undertaken
for the purposes of ‘‘protection,’’ which are a direct result of
the current misreading of the international legal framework.
The commentary also advances concrete guidelines for
framing health programme interventions, specifying that:
1) The principle of non-criminalization mandates non-
compliance of healthcare providers with arrest-based
interventions, an immediate end to arrest and prosecu-
tion of adolescent KPs aged 1017, and the abolition
of involuntary custodial placement in the name of
‘‘rehabilitation’’;
2) Voluntary, confidential and adolescent-friendly primary,
sexual and reproductive health services;
3) The right of adolescents aged 1017 who sell sex or
use drugs to be heard includes meaningful participation
in policy and decision-making in health services and
other programmes that concern them, as well as reli-
able complaint procedures and remedies for rights
violations;
4) Parental consent waiver for life-saving sexual and re-
productive health services, HIV and harm-reductionist
treatment;
5) Client-centred informed consent and right to refuse
or consent to participation in medical treatment and
research trials.
Discussion
The Convention on the Rights of the Child is organized
around the principle that ‘‘[i]n all actions concerning children
. . . the best interests of the child shall be a primary con-
sideration’’ [14, art. 3(1)]. This principle expressly includes
non-state actors such as civil society groups and medical
practitioners whose actions concern children [14]. This deter-
mination depends on a variety of individual circumstances,
such as the nature of the decision being made, the age and
the level of maturity of the child, the views of the child, the
capacity and circumstances of caregivers to provide adequate
food, clothing and medical care, and the safety and health
risks of the alternative circumstances proposed. As such the
proposed programmatic guidelines must be adjusted to the
individual circumstances of the adolescent. Nonetheless, this
commentary advances several preliminary guidelines based
on international law, with the expectation that international
agencies and civil society groups led by those adolescents
affected will revisit them.
The principle of non-criminalization
The categories ‘‘respect, protect and fulfil’’ are often used to
summarize the obligations of States parties as signatories to
human rights treaties. States parties are obliged to ‘‘respect’’
by not interfering with the enjoyment of human rights, to
‘‘protect’’ individuals and groups against human rights abuses
and to ‘‘fulfil’’ by taking positive action to facilitate the enjoy-
ment of basic human rights [15]. In reference to adoles-
cents aged 1017 who sell sex or use drugs, the obligation
to ‘‘protect’’ has suffered from a perverse misapplication at
the country level. The child protection framework has been
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used to justify law enforcement-based interventions without
reference to international human rights law governing the ad-
ministration of juvenile justice, child protection and the right
to health.
The four guiding principles identified by the CRC Commit-
tee include non-discrimination (article 2); devotion to the
best interests of the child (article 3); the right to life, survival
and development (article 6); and respect for the views of
the child (article 12) [16]. With the exception of the non-
discrimination principle, these guidelines largely rely on an
understanding of adolescents’ ‘‘positive’’ rights, as in an ado-
lescent’s right to receive life-saving medical treatment or
right to have her view respected. Yet in prioritizing these
principles, the Committee neglects the Convention’s pro-
tection of ‘‘negative’’ liberties, primarily those international
standards governing the application of judicial measures, in-
stitutional placements and protective interventions targeting
persons under the age of majority. The CRC Committee has
repeatedly ruled that no provision of the Convention may be
read in isolation from other provisions more conducive to the
rights of the child [17,18].
This neglect of the Convention’s principles of negative
liberty likely stems from the Convention’s article 33 and 34
stipulations that States parties must ‘‘take all appropriate
measures . . . to protect children from the use of narcotic
drugs and psychotropic substances’’ and to ‘‘protect the child
from all forms of sexual exploitation . . .’’ [14, arts. 3334].
The Optional Protocol to the Convention on the Rights of
the Child on the Sale of Children, Child Prostitution and Child
Pornography (OPSC) also requires States parties to adopt
criminal, civil and administrative penalties for the sale of
children, child prostitution and child pornography [19]. The
Protocol also expands the Convention’s guarantee of protec-
tion of the rights and interests of child victims in criminal
proceedings against their perpetrators [19]. The initial dif-
ficulty is that these treaties remain silent on the definition
of ‘‘appropriate measures’’ for protective interventions. The
qualifier ‘‘appropriate’’ is said to have been intended to act
as a prophylactic against ‘‘arbitrariness, disproportionate mea-
sures and abuses of human rights in pursuit of protecting
children . . ..’’ [7, p. 37, ’ 73]. Commentators have interpreted
the term to indicate that protective interventions must be
based on adequate data, targeted and effective and propor-
tionate such that they are in pursuit of a legitimate aim and
tailored such that they are no more than necessary for the
achievement of that aim [7, pp. 3839, ’ 76].
While a comprehensive framework regulating protective
measures has eluded the CRC Committee, it has articulated
certain limits. The CRC Committee has stated in the context
of adolescents aged 1017 who sell sex that the obligation to
protect extends to ending their arrest and prosecution under
national criminal or other laws [20]. The CRC Committee
has consistently noted in its dialogue with States parties to
the Optional Protocol that those adolescents who sell sex
should ‘‘be neither criminalized nor penalized, and that all
possible measures should be taken to avoid their stigmatization
and social marginalization’’ [21, p. 8, ’ 25]. The Committee
has specifically criticized States parties with inadequate legi-
slation and contradictory provisions on this issue [20,21]. The
jurisprudence on arrest-based interventions for adolescents
aged 1017 who use drugs is slightly less certain, although
the Committee’s Concluding Observations in reference to
article 33 protection from drug use and dependence use
similar phrasing, namely that a child who uses drugs is to be
‘‘seen as a victim, not a criminal’’ [7, p. 41, ’ 81]. It therefore
is beyond argument that an arrest or prosecution brought
for the purpose of bringing an adolescent aged 1017 who
sells sex or uses drugs before a juvenile or criminal court is
violative of international law.
The question then becomes whether the non-criminalization
principle bars the custodial arrest of adolescents aged 1017
who use drugs or sell sex for purposes of bringing state custody
proceedings against the adolescent for commission of a status
offence or an abuse or neglect proceeding.While this question
is beyond the scope of this article and will be addressed in a
future writing, it is the author’s position that custodial arrests
are, as a form of temporary detention and by virtue of the
involvement of uniformed services, a per se violation of the
non-criminalization principle contained in international gui-
dance such as the Riyadh Guidelines and the 2010 UN
Guidelines on the Alternative Care of Children.
The CRC Committee’s jurisprudence also specifically con-
templates the health-related dangers of law enforcement-based
interventions on adolescent KPs aged 1017. The Committee’s
General Comment on HIV/AIDS acknowledges that rape and
other sexual abuse by child protection officers, law enforcement
and detention personnel expose adolescents to increased risk
of sero-conversion [18]. The Committee’s General Comment on
Adolescent Health and Development recommends comprehen-
sive health services specific to adolescents who sell sex and
notes that it is the obligation of States parties to treat such
youth ‘‘as victims and not as offenders’’ [22, p. 10, ’ 37] and
that States parties should also ‘‘ensure adolescents affected by
poverty who are socially marginalised are not criminalised’’ [22,
p. 4, ’ 12].
Despite the clarity of the Committee’s decisions concerning
the principle of non-criminalization, its periodic reporting
guidelines fail to adequately apprise or require reporting on
States parties’ attendance to the health consequences specific
to adolescents in conflict with the law. The CRC Committee’s
periodic reporting mechanism would be improved were it
to more strictly account for health consequences affecting
adolescents in conflict with the law. While the protection of
adolescents from drug use and dependence is now appro-
priately dealt with under the ‘‘disability, basic health and
welfare’’ cluster, the protection of adolescents from sexual
exploitation and sexual abuse, children in street situations,
and children in conflict with the law improperly remain under
the ‘‘special protection measures’’ cluster [23,24]. Under the
‘‘disability, basic health and welfare’’ cluster, States parties are
required to take into account the General Comment on HIV/
AIDS [23,24]. While the CRC Committee requires that States
parties take into account the Committee’s jurisprudence on
children’s rights in juvenile justice under the ‘‘special pro-
tection measures’’ cluster, it is rarely the case that States
parties do so in the context of adolescents who sell sex or use
drugs [23,24].
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The right to voluntary, confidential and adolescent-friendly
health services
It is common for legal analyses of health interventions
relevant to KPs aged 1017 to rely on a ‘‘right to health’’ lens.
The reliance on the right to health provisions is fitting for
a movement organized around ‘‘universal access,’’ as the
Convention clarifies that no adolescent aged 1017 must be
‘‘deprived of his or her right of access to such health care
services’’ [14, art. 24(1)]. Article 24 of the Convention re-
quires that signatories ‘‘recognise the right of the child to the
enjoyment of the highest attainable standard of health and
to facilities for the treatment of illness and rehabilitation
of health’’ [14]. States parties are also obligated ‘‘to promote
physical and psychological recovery and social reintegration of
a child victim of: any form of neglect, exploitation, or abuse
. . .’’ [14, art. 39]. It is important to note that this principle is
to be read in tandem with the Committee’s jurisprudence on
the principle of non-criminalization such that involuntary
‘‘rehabilitation’’ is violative of international law.
The right to health must not be restricted to health and
mental health services, but include the article 26 right to
social security and article 27 right to a standard of living
adequate for adolescent development, particularly clothing,
nutrition and, if desired, immediate shelter and long-term
housing [1,2,14,25,26]. It is therefore advisable that health
practitioners working with adolescents aged 1017 who use
drugs or sell sex integrate comprehensive social services into
health programmes, and establish a reliable and safe referral
network.
The ‘‘health and human rights’’ framework is also ap-
pealed to in support of adolescents’ sexual and reproductive
health and rights. The CRC Committee’s General Comment
No. 15 in particular elaborates on these principles [25]. The
Committee stipulates that freedoms inherent in children’s
right to health ‘‘include the right to control one’s health and
body, including sexual and reproductive freedom to make
responsible choices’’ [25, p. 8, ’ 24]. The Committee has
interpreted this right rather broadly in reference to services, to
include a right to access a range of facilities and goods as well
as prevention, treatment, rehabilitation and palliative care
services [25].
On the other hand, the CRC Committee has been less
clear on the parameters of parental consent. The Committee
suggests waiver is necessary for life-saving treatment but at
the same time attenuates the right to sexual and reproductive
health according to the Convention’s principle of ‘‘evolving
capacities,’’ contained in article 5 of the Convention [14,22].
This principle is also leveraged to support the view that States
parties bear responsibility to build adolescents’ capacity for
informed decision-making in these matters through compre-
hensive sexuality education and access to confidential and
adolescent-friendly sexual and reproductive health services
[15,16].Thosewho provide healthcaremay also rely on the fact
that many forms of sexual and reproductive health services are
life-saving in nature, including but not limited to prevention,
care and treatment of HIV, access to safe abortion and access
to gender-affirming treatment for TG adolescents.
The Convention also firmly guarantees the right to privacy
(article 16), particularly in the context of HIV prevention,
treatment and care of adolescents [14,18]. The CRC Commit-
tee’s General Comment on HIV/AIDS states that State par-
ties ‘‘must protect the confidentiality of HIV test results . . .
including within health and social welfare settings, and
information on the HIV status of children may not be dis-
closed to third parties, including parents, without the child’s
consent’’ [18, p. 8, ’ 24]. Nonetheless, health professionals
and other service providers report a conflict between their
reporting obligations and the young person’s expectation of
confidential care [1,2,8]. The CRC Committee has yet to rule
definitively on the right to privacy in relation to mandatory
reporting, and contrary domestic laws may be in force.
While there already exists powerful guidance on consent
and confidentiality for young adult and adult KPs [12,13,27],
international actors are cautious in advancing similar recom-
mendations for KPs aged 1017. The WHO has recommended
HIV testing and counselling, with linkages to prevention,
treatment and care, for adolescents from KPs in all epidemic
scenarios, and specified that consent and confidentiality
must be ensured so that services are not used in punitive or
coercive ways for adolescent KPs [28]. Yet in still other cases
bold and necessary recommendations for rights-based health
programming are lacking. For instance, while the UN system
endorsed a core package of nine essential harm-reduction
services for people who inject drugs which have been shown
to reduce HIV infections [13], they are not youth-focused,
and key issues regarding young people, IDU and HIV may be
falling between the priority areas of different international
organizations [29].
It is clear from the Committee’s decisions that it not only
rejects this trepidation but also argues for the opposite view,
namely that the more vulnerable the adolescent, the more
critical the right to informed consent and confidentiality. The
CRC Committee has specifically held in its General Comment
on HIV/AIDS that the Convention requires States parties to
ensure access to voluntary, confidential HIV counseling and
testing and that prevention programmes must ‘‘acknowledge
the realities of the lives of adolescents’’ [18, p. 4, ’ 11]. The
CRC Committee has repeatedly emphasized the importance
of adolescent-friendly health services that are ‘‘friendly and
supportive, provide a wide range of services and information,
are geared to their needs, give them the opportunity to par-
ticipate in decisions affecting their health, are accessible,
affordable, confidential and non-judgemental, do not require
parental consent and are not discriminatory’’ [18, p. 7, ’ 20].
The World Health Organization’s quality of care framework
provides a useful metric for ‘‘adolescent-friendly services’’ in
practice for adolescent KPs: available, accessible, appropriate,
equitable and effective [3032]. In certain locales, health ser-
vices such as first- or second-line antiretroviral drugs (ARV)
or safe abortions are simply not available to anyone regardless
of age [30,33]. Where health services are available, however,
adolescents may yet find them not accessible due to unafford-
ability, remoteness of location or incongruity of hours, or
restrictive laws and policies, such as denial of services to
non-citizens or migrants, bans on provision of contraception
to unmarried adolescents who sell sex, prohibitions on sterile
injecting equipment and hormone treatment for adolescents
who inject drugs and TG adolescents, or stringent identification
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requirements [30,33]. Still other services that are available and
accessible may yet be delivered in such a way that adolescents
are not willing to use them because they are not acceptable
or safe for young people, for instance, by a doctor known to
criticize YMSM who sell sex about the origin of STIs or their
feminine appearance, or engage in regular breaches of con-
fidentiality as to the young person’s behaviour or HIV status
[30,33]. Further, health services must be appropriate such that
the health services an adolescent actually needs are provided,
such as an adolescent who sells sex seeking PrEP and not simply
condom distribution or counseling, and effective in that the
right health services are provided in the right way, and make a
positive contribution to the adolescent’s health [32]. Finally,
health services must be equitable to the extent that they do not
cater to some adolescent groups and not others, such as a clinic
that provides confidential HIV prevention, care and treatment
to young people from high-income backgrounds but does not
reach street-based young people [30,31]. In other words, all
adolescents and not just selected groups are able to obtain the
health services that are available [32].
The right of meaningful participation in decision-making
regarding policy and health programmes
The CRC Committee has identified the article 12 right to be
heard as one of the four general principles of the Convention,
and repeatedly emphasized it is also to be considered in the
interpretation and implementation of all other rights [14,34].
The Committee has specified that this right includes the
meaningful participation of adolescents in decision-making,
policymaking and preparation of laws, as well as the adoption
of complaint procedures and remedies [34]. The CRC Com-
mittee’s General Comment on HIV/AIDS notes that States
parties must provide adolescents with the means ‘‘to fully
participate at both community and national levels in HIV
policy and programme conceptualization, design, implemen-
tation, coordination, monitoring and review’’ [18, p. 5, ’ 12].
In the context of adolescents aged 1017 who sell sex or
use drugs, in crediting this right it is particularly important
that health practitioners consider the greater capacity of
adolescents 1017 who are living independently, have no
parents/guardians or no contact with them, have abusive
parents/guardians, or who are pregnant [1,2,34].
Article 12 of the International Covenant on Economic, Social
and Cultural Rights (ICESCR) further reinforces the right of all
people to the highest attainable standard of physical and
mental health [35]. The ESCR Committee’s General Comment
14 recommends States parties ensure adolescent-friendly
healthcare, and adolescents’ ‘‘opportunity to participate in de-
cisions affecting their health, to build life-skills, to acquire
appropriate information, to receive counselling and to negoti-
ate the health-behaviour choices they make’’ [36, p. 9, ’ 23].
The right to informed consent and to refuse treatment and
research trials
The mixed policy and programme environment has re-
sulted in longstanding limitations on data collection, service
provision and medical treatment to adolescent KPs aged
1017 [1,2,37,38]. The reluctance by international actors to
take a position is reflected in the dearth of medical trials,
monitoring or evaluation of adolescent KPs aged 1017
who sell sex or use drugs. Even where surveys do monitor
prevalence and trends of drug use among young people,
they are almost always still based on school samples that
neglect street-based and out-of-school youth, and people
who inject drugs remain largely invisible in the official stati-
stics on youth drug use [29].
The ‘‘solutions’’ to the research gap proposed by interna-
tional health actors remain incomplete as a result of unclear
international legal guidance. For instance, in a series of joint
UNAIDS and WHO meetings regarding ethical guidelines for
engaging PWID in HIV prevention trials, it was recommended
that researchers seek the adolescents’ permission to disclose
use of injecting drugs before making contact with parents,
and if they are not willing to do so, they should not be in-
cluded in the study [37,38].While the approach appropriately
honours the right to privacy and right to refuse or consent to
participation in medical treatment or research trials by pre-
venting disclosure of drug use or the sale of sex to guardians, it
fails to confirm the right of adolescents to confidentiality and
at the same time the positive right to go forward with said life-
saving treatment [18]. As a result, service providers may resort
to not asking clients their age in order to provide them with
assistance, and to avoid enforcement of age restrictions on
accessing harm-reduction services, preventing the disaggrega-
tion of data by age [7].
The right to treatment and waiver of parental consent
Current treatment guidelines fail to honour the right of ado-
lescents to life-saving treatment. In the joint UNAIDS and
WHO Eastern Europe & Central Asia experts meetings regard-
ing ethical guidelines for engaging adolescents aged 1017
who inject drugs in HIV prevention trials, researchers con-
cluded that absent parental consent for medical treatment
for HIV or STIs, NSP or OST, researchers may not provide this
life-saving treatment to adolescents where parental consent
is required by domestic legislation [38]. In the words of the
consultation report, ‘‘[r]esearchers should not conduct trials
with proven interventions with the aim of bringing about
change in law and policy’’ [37, p. 27].
The Committee recently explained that children, in accor-
dance with their evolving capacities, should have access to
confidential counselling without consent of a guardian or a
parent [14,34]. In addition, states should consider ‘‘allowing
children to consent to certain medical treatments and in-
terventions without the permission of a parent, caregiver, or
guardian, such as HIV testing and sexual and reproductive
health services, including education and guidance on sexual
health, contraception and safe abortion’’ [25, p. 9, ’ 31]. It
should go without saying that life-saving medical treatment
for HIV or STIs, and critical harm-reduction resources such as
NSP and OST, must be made available to all adolescents 
whose right to life and health trumps a guardian’s right to care
and custody. It is incumbent on the Committee on the Rights
of the Child to elaborate on these opinions, and make clear
that even the most marginalized adolescents are provided
life-saving medical treatment.




The ‘‘cure,’’ as the idiom goes, may be worse than the prob-
lem it intends to remedy. This is precisely the case for health
interventions among adolescents aged 1017 who use drugs
or sell sex. Without full implementation of the above principles,
funders, researchers, health practitioners and community-based
KP groups may ignore the urgent needs of KPs aged 1017
in order to protect themselves from prosecution. Without ap-
propriate guidance, the medical analogue to the principle of
minimal intervention  ‘‘first, do no harm’’  may persuade peer
andother health practitioners to practice life-saving interventions
in the shadow of threatening and outdated interpretations of
the law.
Author’s affiliation
Technical Advisor, HIV Young Leaders Fund
Competing interests
The author has no competing interests to declare.
Author information
Brendan Michael Conner, Esq., is a Staff Attorney at Streetwise and Safe, where
he provides civil legal representation and policy support to LGBTQQ youth of
color who experience police encounters and government benefits discrimina-
tion in New York City, including youth with experience in trading sex for survival
needs. He has served as an expert on international law and young key
populations, including as Technical Advisor to the HIV Young Leaders Fund. He
has worked both independently and in partnership with the Fremont Center
on projects for clients such as Safe Horizon’s Streetwork Project, the UN
Development Programme (UNDP), the United States Agency for International
Development (USAID) and the Open Society Institute. The opinions expressed in
this article are the author’s own and do not necessarily reflect the views of
Streetwise and Safe.
Acknowledgements
Sarah Middleton-Lee and Ayesha Mago contributed to the background paper
on sexual and reproductive health needs of adolescents 1017 engaged in
selling sex in the Asia Pacific, which inspired this commentary.
References
1. WHO, UNAIDS, IAWG. HIV and young people who sell sex: a technical brief.
Draft report. Report no: UNAIDS/JC2666, WHO/HIV/2014.16. Geneva: World
Health Organization; 2014.
2. WHO, UNAIDS, IAWG. HIV and young people who sell drugs: a technical
brief. Draft report. Report no: UNAIDS/JC2666, WHO/HIV/2014.17. Geneva:
World Health Organization; 2014.
3. WHO, UNAIDS, Inter-Agency Working Group on Key Populations (‘‘IAWG’’).
HIV and young men who have sex with men: a technical brief. Draft report. Report
no: UNAIDS/JC2666,WHO/HIV/2014.14. Geneva: World Health Organization; 2014.
4. WHO, UNAIDS, IAWG. HIV and young transgender people: a technical brief.
Draft report. Report no: UNAIDS/JC2666, WHO/HIV/2014.18. Geneva: World
Health Organization; 2014.
5. Global Commission on HIV and the Law. HIV and the law: risks, rights and
health. Final report. Geneva: UN Development Programme; 2012.
6. Rahman F. Legal and policy considerations in reaching young key popula-
tions. 20th International AIDS Conference; 2014 Jul 2025; Melbourne,
Australia: International AIDS Society.
7. Barrett D, Veerman P. Article 33: protection from narcotic drugs and
psychotropic substances. Leiden: Martinus Nijhoff; 2012.
8. Conner B, Mago A, Middleton-Lee S. Sexual and reproductive health needs
and access to health services for adolescents under 18 engaged in selling sex in
Asia Pacific. Amsterdam: HIV Young Leaders Fund; 2014.
9. Youth Voices Count. Policy brief on self-stigma among young men who have
sex with men and young transgender women and the linkages with HIV in Asia.
Bangkok: Youth Voices Count; 2013.
10. UNESCO, UNFPA, UNAIDS, UNDP, Youth Lead. Young people and the law in
Asia and the Pacific: a review of laws and policies affecting young people’s
access to sexual and reproductive health and HIV services. Final report.
Bangkok: UN Educational, Scientific and Cultural Organization; 2013.
11. McClure C, Chandler C, Bissell S. Responses to HIV in sexually exploited
children or adolescents who sell sex. Lancet. 2014. pii: S0140-6736(14)
60933.
12. WHO, UNFPA, UNAIDS, NSWP. Prevention and treatment of HIV and other
sexually transmitted infections for sex workers in low-and-middle-income
countries: recommendations for a public health approach. Final report.
Geneva: World Health Organization; 2012.
13. WHO, UNODC, UNAIDS. Technical guide for countries to set targets for
universal access to HIV prevention, treatment and care for injecting drug users.
Geneva: World Health Organization; 2009.
14. UN Convention on the Rights of the Child, G.A. res. 44/25, annex, 44 UN
GAOR Supp. (No. 49) at 167, UN Doc. A/44/49 (1989), entered into force Sept.
2, 1990.
15. Schabas W, Sax H. Article 37: prohibition of torture, death penalty, life
imprisonment and deprivation of liberty. Leiden: Martinus Nijhoff Publishers;
2006.
16. CRC Committee. General Comment No. 5: general measures of imple-
mentation of the Convention on the Rights of the Child, UN Doc. CRC/GC/
2003/5 (2003).
17. CRC Committee. General Comment No. 13: right of the child to freedom
from all forms of violence, UN Doc. CRC/C/GC/13 (2011).
18. CRC Committee. General Comment No. 3: HIV/AIDS and the rights of the
child, UN Doc. CRC/GC/2003/3 (2003).
19. Optional Protocol to the Convention on the Rights of the Child on the Sale
of Children, Child Prostitution and Child Pornography, adopted by G.A. Res. 54/
263, opened for signature 25 May 2000 (entered into force 18 January 2002).
20. Muntarbhorn V. Article 34: sexual exploitation and sexual abuse of
children. Leiden: Martinus Nijhoff; 2007.
21. Report of the Committee on the Rights of the Child, General Assembly,
Sixty-third Session, Supplement No. 41.
22. CRC Committee. General Comment No. 4: adolescent health and
development in the context of the Convention on the Rights of the Child
CRC/GC/2003/4, July 2003.
23. CRC Committee. Treaty-specific guidelines regarding form and content of
periodic reports to be submitted by States parties under article 44, paragraph
1(b) of the Convention on the Rights of the Child, UN Doc. CRC/C/58/Rev.2
(2010).
24. CRC Committee. Revised guidelines regarding initial reports to be
submitted by States parties under Article 12, Paragraph 1 of the Optional
Protocol to the Convention on the Rights of the Child on the Sale of Children,
Child Prostitution and Child Pornography, UN Doc. CRC/C/OPSC/2 (2006).
25. CRC Committee. General Comment No. 15: right of the child to the
enjoyment of the highest attainable standard of health (art. 24), UN Doc. CRC/
C/GC/15 (2009).
26. Eide A, Eide B. Article 24: the right to health. Leiden: Martinus Nijhoff
Publishers; 2006.
27. WHO, UNAIDS, MSMGF, UNDP. Prevention and treatment of HIV and other
sexually transmitted infections among men who have sex with men and
transgender people: recommendations for a public health approach. Geneva:
World Health Organization; 2011.
28. WHO. Consolidated guidelines on the use of antiretroviral drugs for
treating and preventing HIV infection: recommendations for a public health
approach. Geneva: World Health Organization; 2013.
29. Fletcher A, Krug A. Excluding youth? A global review of harm reduction
services for young people. In: Stoicescu C, editor. The global state of harm
reduction 2012: towards an integrated response. London: Harm Reduction
International; 2012. p. 13745.
30. WHO. Adolescent-friendly health services: an agenda for change. Geneva:
World Health Organization; 2003.
31. WHO. Making health services adolescent friendly: developing national
quality standards for adolescent friendly health services. Geneva: World Health
Organization; 2012.
32. WHO. Quality assessment guidebook. A guide to assessing health services
for adolescent clients. Geneva: World Health Organization; 2009.
33. Conner B. ‘‘First, do no harm’’: an advocacy brief on sexual and
reproductive health needs and access to health services for adolescents
1017 engaged in selling sex in the Asia Pacific. Amsterdam: HIV Young Leaders
Fund; Forthcoming.
34. General Comment No. 12: right of the child to be heard, UN Doc. CRC/C/
GC/12 (2009).
Conner B. Journal of the International AIDS Society 2015, 18(Suppl 1):19437
http://www.jiasociety.org/index.php/jias/article/view/19437 | http://dx.doi.org/10.7448/IAS.18.2.19437
83
35. International Covenant on Economic, Social, and Cultural Rights, opened
for signature Dec. 16, 1996, 993 U.N.T.S. 3, 6 I.L.M. 360 (entered into force Jan.
3, 1976).
36. Committee on Economic, Social and Cultural Rights (‘‘CESCR’’), General
Comment No. 14: the right to the highest attainable standard of health, UN
Doc. E/C.12/2000/4 (2000).
37. WHO, UNAIDS. Ethical engagement of people who inject drugs in HIV
prevention trials. Meeting report of the consultation for Eastern Europe and
Central Asia; 2010 Jun 1618; Geneva: World Health Organization; 2010.
38. WHO, UNAIDS. Ethical engagement of people who inject drugs in HIV
prevention trials. Meeting report of the consultation for Latin America and the
Caribbean; 2011 Apr 2729; Geneva: World Health Organization; 2011.




Young key populations and HIV: a special emphasis and
consideration in the new WHO Consolidated Guidelines on HIV
Prevention, Diagnosis, Treatment and Care for Key Populations
Rachel Baggaley§,1, Alice Armstrong1, Zoe Dodd2, Ed Ngoksin3 and Anita Krug4
§Corresponding author: Rachel Baggaley, HIV Department, World Health Organization, 20, Avenue Appia, CH-1211 Geneva 27, Switzerland. (baggaleyr@who.int)
Received 1 September 2014; Revised 24 November 2014; Accepted 18 December 2014; Published 26 February 2015
Copyright: – 2015 Baggaley R et al; licensee International AIDS Society. This is an Open Access article distributed under the terms of the Creative Commons
Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
WHO released its new Consolidated Guidelines on HIV Pre-
vention, Diagnosis, Treatment and Care for Key Populations
[1] at the International AIDS Conference in Melbourne in
July 2014. This guidance addresses five key populations: men
who have sex with men, people who inject drugs, people in
prisons and other closed settings, sex workers and transgender
people. For the first time in its work on key populations,WHO
chose to specifically address adolescent and young key pop-
ulations, considered specific adolescent issues relating to all
recommendations and implementation considerations, high-
lighted case examples and discussed challenges and barriers
to acceptable and effective service delivery. In addition, four
technical briefs, developed by the Interagency Working Group
of Key populations, on HIV and young men who have sex
with men, young people who sell sex, young people who inject
drugs and young transgender people have been included as
annexes to the guidelines.
High HIV risk: limited data
In all epidemic contexts, HIV incidence remains high or is
increasing among key populations (Figure 1). Currently, there
is a lack of global data pertaining to estimates of adolescent
and young key populations, as well as their risks and needs.
Where accurate surveillance data for young key populations
are available, the HIV prevalence among these groups is often
found to be significantly higher than that of the general youth
population [3]. Available data are often not disaggregated
by age, and those under 18 years are underrepresented in
research. However, what we do know paints a stark picture.
According to the report of the Commission on AIDS in Asia,
nearly all (95%) new HIV infections among young people in
Asia occur in young key populations. In this region, however,
over 90% of HIV resources for young people are focused on
programming for ‘‘low-risk youth’’ [4]. Furthermore, studies con-
sistently demonstrate that young key populations are even more
vulnerable than older cohorts to sexually transmitted infections,
including HIV and other sexual and reproductive health concerns
[59].
Available data also suggest adolescent key populations are
disproportionately affected by HIV in almost all settings [10].
For example, pooled data show significantly higher HIV
prevalence and increasing rates of new HIV infections among
adolescent men who have sex with men than among men
of the same age in the general population [11,12]. Among
adolescent males aged 1319, in the United States, 92.8% of
all diagnosed HIV infections were attributed to male-to-male
sexual contact [13,14]. HIV infection rates ranging from 9 to 22%
have also been reported in a variety of small, non-representative
samples of adolescent transgender females [15,16]. Such reports
are notable and significantly higher than the HIV prevalence re-
ported in other adolescent study samples [9,17]. Adolescent
transgender females with a history of selling sex may be more
than four times as likely to be HIV-infected than their peers [18].
The age at which young people start to engage in be-
haviours that place them at higher risk of HIV is diverse and
varies by country and context; however, evidence shows some
begin high-risk behaviours during adolescence. In community
consultations, most young people reported starting to inject
drugs between 15 and 18 years [19]. In a study among 1019
year olds living or working on the streets in four cities of
Ukraine, 45% of those who reported injecting drugs said
that they began doing so before they were 15 years old [20].
Behavioural surveillance indicates that in India 17% of female
sex workers initiated selling sex before the age of 15 years,
while those in Papua New Guinea reported a mean age of
initiation of 1719 years [21,22].
Although there are unique and diverse issues which con-
tribute to the particular vulnerabilities of adolescent and
young key populations, it is also important to recognize their
strengths, capacities and resilience, and to recognize these
in developing and supporting services and responses to their
needs.
Barriers to services: poor service provision
Young key populations are not adequately reached with ap-
propriate and acceptable HIV prevention, treatment and care
interventions and services. Many barriers limit their access to
these essential services, or exclude them from using formal
health services altogether. Notably, policy and legal barriers
related to age of consent to accessing a range of health
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services including HIV testing and counselling, sexual and
reproductive health, harm reduction, and other services
provided specifically for key populations limit the ability of
young individuals to exercise their right to independent
decision-making and prevent them from accessing essential
services. For example, in sub-Saharan Africa at least 33
countries have age-based criteria for consenting to HIV
testing; 14 of which assert that only a person 18 years of
age and above can consent to an HIV test [23].
Adolescents from key population groups are also often sub-
ject to significant levels of stigma, discrimination and vio-
lence. In many settings, laws that criminalize behaviours such
as drug use, sex work and same-sex relationships further
marginalize young people and perpetuate their social exclu-
sion from their communities and essential support services.
Fearing discrimination and possible legal consequences, many
adolescents from key population groups are reluctant to at-
tend HIV testing and treatment services. As such, they remain
hidden from services and support networks and are often
reluctant to disclose their HIV status to parents and family
members in fear of revealing their identity or risk behaviour.
Additionally, most health services are not designed to care
for, and address the needs of, adolescents and young people
from key populations. Often services are delivered by staff
who do not have experience or training in providing care and
services for adolescents, and therefore may lack the sen-
sitivity required to work with adolescent key populations. In
other settings, services are simply not available, for example,
for young transgenders. Available data indicate that young key
populations may find services delivered through community
and outreach-based programmes more acceptable than those
provided in government facilities. This may be in part due to
the impact of discriminatory policies including age restric-
tions, lack of confidentiality, mandatory registration and atti-
tudes towards adolescent and young key populations within
facility-based services [24].
The new WHO guidelines
The new Consolidated Guidelines on HIV Prevention, Diagnosis,
Treatment and Care for Key Populations have been developed
in collaboration with key partners including community-based
networks led by and/or for young key populations. They were
based on reviews of available peer-reviewed published and
grey literature (literature not available through the usual
bibliographic databases, for example, programme and project
reports), community consultations with young key popula-
tions and an extensive effort to collect case examples of
good practices from programmes and organizations providing
services to key populations. The case studies provide concrete
practical examples of services or young key populations and
highlight examples of their critical roles in developing and
delivering these, including in youth-led advocacy, leadership
and empowerment. They summarize the key issues facing key
populations and underscore the importance of implement-
ing a comprehensive package of evidence-based services
and developing a national strategy to address their unique
and diverse needs (Table 1).
This comprehensive package recommends interventions
and strategies relevant for adolescents and adults. The guide-
lines bring together relevant existing adolescent recommen-
dations such as on HIV testing and counselling as well as
provide additional specific adolescent considerations for
overall recommendations. For example, in addressing legisla-
tive and policy barriers, additional adolescent considerations
regarding age of consent barriers are specified.
Furthermore, the guidelines highlight that it is urgent for
countries to review their legal policies, initiate the provision
of services as well as improve services, include adolescent
Figure 1. New infections attributable to key populations.
From Ref. [3].
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and young key populations in developing acceptable services
and offer opportunities for their meaningful inclusion in de-
fining their HIV and health service needs, developing effective
services and participating in research. The resourcefulness
and expertise of adolescents and young people is widely re-
cognized, and their empowerment and inclusion in the de-
sign and delivery of research, services and interventions is
promoted in many settings. In relation to HIV, much can be
learned from listening to and involving young people regard-
ing the strategies they already use in keeping themselves and
their peers and partners safe, and in finding ways to more
easily, safely and sustainably engage with health and other
forms of care and support, despite the often considerable
barriers and constraints.
Urgent attention must however be given  and practical
ways of working within legally constrained settings sought 
in order to provide services for young key populations and to
prevent their continuing vulnerability to and risk of HIV
infection, and to ensure equitable access to HIV testing,
treatment and care. We hope that the new guidelines will
catalyze better programming for adolescent and young key
populations and legitimize their role in designing, de-
veloping and delivering them.
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